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Abstract
The IX-14 mutant was first found as a mutation affecting neuroblasts and imaginal
discs and later characterised as a mutant affecting chromosome condensation. Base on its
sequence, IX-14 may be classified as a metalloprotease that is a homologue of
leishmanolysin. IX-14 have a wide range of functions in cell cycle and cell migration,
probably through its alternative spliced forms or its diverse substrates.
In this study, I have showed that IX-14 mutants have a chromosome structure
defect besides a length-wise chromosome hyper-condensation phenotype. The turnover
of three nuclear envelope proteins (lamin DmO, otefin and lamin A/C) was affected in IX-
14 mutants. One of them, lamin DmO, has been shown to be cleaved by IX-14 in vitro,
which suggests it is a substrate of IX-14.
I have also shown Drosophila IX-14 mutant embryos have a germ cell migration
defect, germ cells failing to form gonads at stage 13 after passing through the midgut.
This was consistent with the suggestion that IX-14 might play a migration role based on
the observation that IX-14 localized to the leading edge of macrophages and as
invadopodia-like structures in some HeLa cells.
Due to the presence of a signal sequence at the N-terminus and a GPI anchor
sequence at the C-terminus of DmIX-14,1 could not purify DmIX-14 since it keeps
losing its tags on both the N-terminus and the C-terminus in the baculovirus system.
Methods to express large scale active IX-14 still need to be found.
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1.1 Cell cycle and chromosome condensation
The cell cycle is made up of four phases. S phase refers to the period ofDNA
replication. Mitosis is when a somatic cell divides into two daughter cells. The two gaps
between them are called the G1 and the G2 phases, which with S phase are referred to as
inteiphase. Mitosis involves a dramatic reorganization of both the nucleus and cytoplasm
brought about by activation of a number of protein kinases, including Cdkl-cyclin B and
can be further divided into six phases, among which are prophase, prometaphase,
metaphase, anaphase, telophase and cytokinesis. Besides cyclins and cyclin-dependent
kinase, chromosome passengers, anaphase-promoting complex and polo like kinase are
all contribute to the process ofmitosis (Pollard and Eamshaw 2002).
People are interested in chromosome condensation since the DNA will face such
catastrophes as sister-chromatid entanglement and cleavage of trailing chromatin during
cytokinesis, which may result in loss of or damage to vital genes without proper
condensation. At the first level of organization, two tight superhelical turns ofDNA are
wrapped around a histone octamer consisting of two copies each of the four histone
proteins (H2A, H2B, H3 and H4), generating fibers of-10 nm diameter. Association of
histone HI with the 10 nm fiber causes the fiber to shorten and thicken to -30 nm in
diameter, forming the so-called "30 nm" fiber, which gives the chromosome its next level
of folding. However, this degree of condensation can not meet the required chromatin
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structure in mitosis, higher-order levels of chromatin folding are required for mitotic
chromosome. Topoisomerase II, condensin complex, AKAP95 (A Kinase-Anchoring
Protein 95) and titin were reported to involved in this higer-order of chromosome
condensation (Heck 1997).
1.2 Background of Invadolysin (IX-14)
The advantage of using Drosophila melanogaster as a model organism
Drosophila melanogaster is a fruit fly, a little insect about 3 mm long for adult, of
the kind that accumulates around spoiled fruit. It is one of the most valuable organisms
in biology research and has been used as a model organism for research for almost a
century.
Drosophila has extensive advantages as a research model. There is a high level of
conservation of genes, pathways and cellular processes between Drosophila and other
higher metazoa. Although Drosophila has a lower number of genes (14,392) and a small
genome (180 Mb) compared to human (23,758 genes and 3069 Mb respectively), 68% of
2746 human disease gene entries in OMIM
(www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM. Online Mendelian Inheritance in
Man, a catalog of human genes and genetic disorders with links to literature references,
sequence records, maps, and related databases) have strong matches to one or more
sequences in the Drosophila database (Homophila, www.superfly.ucsd.edu/homophila.
the human disease to Drosophila gene database). Drosophila also displays advantages in
6
its short life cycle (only 10 days or so), affordability and ease to keep in large numbers,
simplicity ofmanipulating genetics, availability of its entire genome and mutant flies
which have defects in any of several thousand genes. Its four relatively large and easily
identifiable mitotic chromosomes are easier for studying mitosis and chromosome
structure than those of yeast. In addition, many cell lines are available (mainly from
Drosophila embryonic tissues) and the advent of techniques such as dsRNA-mediated
interference facilitates the study of protein function at the level of single cells.
Drosophila melanogaster has a life cycle about 10 days (Figure 1.2A). Starting from
the fertilisation of an egg, the embryo goes through 16 morphologically distinct stages
until it hatches into a fist instar larva. This takes approximately 24 hours. During the
first four stages, fertilized eggs go through 13 rapid and synchronous cycles of nuclear
divisions consisting of only S and M phase. This is known as the syncytial divisions.
These are completed within two hours. The details of the 16 embryonic stages will be
introduced in Chapter 4. The first instar larva eats its way though food for 24 hours until
it moults into a second instar larva. The second instar larva eats similarly and moults
after 24 hours into a third instar larva. The third instar larva eats for two days and then
emerges from the food medium and wanders on the vial wall until it pupates when the
body is completed remodelled. Four days later, an adult fly encloses from the pupal case.
Larval tissue growth occurs mostly by endo-replication and increase in cell size (e.g., in
the salivary glands). Mitotic activity only occurs in tissues that will be used to form the
adult fly, e.g. the brain and imaginal disc, and histoblasts.
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Figure 1.2A: The life cycle of Drosophila me/anogaster.
After the Drosophila egg is laid, it takes approximately one day to develop and
hatch into a worm-like larva. There are three larval moults at one day, two
days and four days after hatching for 1st, 2nd and 3rd instar larva. The third
instar larvae moult to form an immobile pupal case, inside which the body is
completely remodelled. Four days later, an adult fly (male or female) encloses
from the pupal case. Difference in body features help distinguish between
male and female adult. Females are slightly larger and have a light-colored,
pointed abdomen. The abdomen ofmales will be dark and blunt. The male
adult also has sex combs, dark bristles on the upper portion of the forelegs.
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Introduction to proteases
Proteases (peptidases) are enzymes that break peptide bonds between amino acids of
proteins. They appear naturally in all organisms and constitute 1-5% of the gene content
(Beynon and Bond 2001). Proteases play roles in digestion, growth, maturation, aging
and death of all organisms. Proteases regulate most physiological processes by
controlling the activation, synthesis and turnover of proteins. Proteases are also essential
in viruses, bacteria and parasites for their replication and the spread of infectious
diseases. Single amino acid changes in some proteases, over or under abundance of a
particular crucial protease or abnormal levels of natural inhibitors/ activators of proteases
can lead to abnormal physiology and disease. There are two groups of proteases: the
endopeptidases and the exopeptidases. Endopeptidases are enzymes that split peptides
and polypeptides into smaller peptides by targeting peptide bonds near the centre of the
molecule while exopeptidases are enzymes that cleave di- and tri- peptides into their
constituent amino acids by targeting terminal peptide bonds. Based on its catalytically
active centre, proteases can also be classified as serine proteases, cysteine proteases,
aspartic acid proteases, glutamic acid proteases, threonine proteases and
metalloproteases. Metalloproteases bind a metal ion such as zinc or calcium in their
active site. The ion usually serves to coordinate two to four side chains and it is
indispensable for the activity of the enzyme. The ion itself is also coordinated by a water
molecule, which is also crucial for catalytic activity.
The first MMP (matrix metalloprotease) was found 40 yeas ago, when researchers
described an 'activity' that was present during metamorphosis in tadpoles and had the
ability to degrade rigid rods of collagen (Gross and Lapiere 1962). This activity turned
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out to be due to interstitial collagenase (MMP-1). Currently 24 members have been
found in the families of human MMPs, all ofwhich share a basic structural organization
comprising a signal peptide that targets them for secretion, a propeptide domain and
catalytic domain. A subfamily ofMMPs associated with the cell membrane has also been
identified and categorized as the membrane-type MMPs (MT-MMPs). The MT-MMPs
can be divided into 2 subgroups, the transmembrane MT-MMPs and the
glycosylphosphatidyl inositol (GPI)-anchored MT-MMPs (Handsley and Edwards 2005).
The catalytic domain ofMMPs contains a catalytic zinc, bound in the sequence
HEXXHXXGXXH by three histidine residues. Glutamic acid is believed to transfer
hydrogen atoms and to polarize a zinc-bound water molecule for nucleophilic attack on
the scissile peptide bond of bound substrate (Stocker and Bode 1995).
The structure ofMMP catalytic domains are highly similar. These consist of a five
stranded (3 sheet and three a helices (Figure 1.2B, panel A). MMPs are normally inactive
because a prodomain cysteine coordinates the zinc. Activation occurs when the
prodomain is removed by proteolytic cleavage. The mechanism of replacing the cysteine
with bound water has been denoted the "Cysteine switch" (Figure 1.2C) (Wasserman
2005). Tissue inhibitors ofmetalloproteinases (TIMPs) are endogenous MMP inhibitors
produced by the same cells which produce MMPs. They act by forming a 1:1 complex
with the activated catalytic zinc in MMPs (Pender and MacDonald 2004). MMPs have
traditionally been thought to cleave various components of the ECM (Extra Cellular
Matrix), a complex structural entity surrounding and supporting cells found within
metazoan tissues. ECM is composed of three major classes of biomolecules: 1)









Figure 1.2B: Secondary structure of catalytic domain of typical
metzincin and leishmanolysin.
A: The catalytic domain ofmetzincin family share conserved structure of
three a helices and five stranded b sheet. Three histidines are bound to the
catalytic zinc iron and a met-turn methionine follows. B: Leishmanolysin
lacks the strand II b sheet and includes three insertions (coloured circles with
number of inserted residues). The arrangement of three zinc binding histidine
and underlying met-turn methionine are present in leishmanolysin as well.





displacement of the pr-odomain
Figure 1.2C: The mechanism of Cysteine switch.
A: Zinc ion is blocked from associating with water molecule by a cysteine in
pro-domain ofGP63. This results in an inactive form of this protease. B: Pro-
domain is removed by chemical or proteolytic factor which release the blockage
ofzinc ion. This make the zinc associate with water molecular and allow
nucleophilic attacks to the substrate.
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laminin etc, 3) proteoglycans. MMPs may be divided into subclasses according to their
primary matrix substrate specificities: the collagenase (MMP-1, -8, -13, -18), the
gelatinises (MMP-2 and -9), the stromelysins (MMP-3, -7,-10 and -11), elastase (MMP-
12), membrane type (MMP-14, -15, -16, -17, -24, -25) and others (MMP-19, -20, -23, 26,
-27 and -28) (Pender and MacDonald 2004). However, with the discovery of a number
of non-matrix substrates, MMPs have also been shown to be involved in the cleavage of
cell surface receptors, the release of apoptotic ligands, cell behaviors such as cell
proliferation, migration, differentiation, angiogenesis, apoptosis and host defence
(McCawley and Matrisian 2001). MMPs are present at low levels under normal
conditions when they are responsible for normal physiological tissue turnover. However,
under pathology conditions, MMPs are related to a wide range of diseases such as
rheumatoid arthritis, cancer, degenerative eye disease, inflammation, bone disease, etc.
(Brinckerhoff and Matrisian 2002). In Drosophila, two MMPs was found, Dm-MMPl
(others MMPs type in vertebrate) is expressed more specifically during embryonic stages
(Llano, Pendas et al. 2000) and Dm-MMP2 (membrane bound type) apparently through
out development (Llano, Adam et al. 2002). Tissue remodelling is disrupted in single
Dm-MMP mutants. Larval tracheal growth and pupal head eversion defects are seen in
Dml-MMP mutants and larval tissue histolysis and epithelial fusion defects are observed
during metamorphosis in Dm2-MMP mutants. Double mutants of the two Drosophila
MMPs have shown no defects in embryonic development, larval mitosis and cell
migration (Page-McCaw, Serano et al. 2003).
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Leishmanolysin (GP63)
Leishmania sp. are a kind of protozoa causing leishmaniasis (black fever) in humans
which is characterized by persistent fever, enlarged liver and spleen, dark and scaly skin,
etc (Murray, Berman et al. 2005). Its life cycle requires a sandfly vector and a
mammalian host (e.g. human). Leishmaniasis is transmitted by the bite of sandflies. The
sandflies inject promastigotes into the human body during their blood meals.
Promastigotes are then phagocytosed by macrophages and transform into aflagellated
amastigotes. Amastigotes multiply in infected cells and affect different tissues, causing
the clinical manifestations of leishmaniasis as describe above. Sandflies could be
infected by ingesting macrophages containing amastigotes from a infected human during
blood meal. In the sandfly's midgut, the amastigotes differentiate into promastigotes,
which migrate to the proboscis of sandflies (Yao, Donelson et al. 2003). The major
surface glycoprotein, leishmanolysin (GP63, derived from glycoprotein of 63 kDa),
contributes to Leishmania sp.'s virulence and pathogenicity. It is involved in the
interaction of the promastigotes with the host's macrophages and the resistance of
promastigotes to be lysed by the defensive system (Russell and Wilhelm 1986).
Although an unexpected 62 amino acid was inserted between the glycine and third
histidine residue of the metzincin (a family of proteins share topologically similar
structure, ofwhich MMPs are also members, Figure 1.2B panel B) motif
(HEXXHXXGXXH), GP63 is clearly a metzincin according to the similar arrangement
of the three zinc ligand histidine side chains and the underlying met-turn methionine to
metzincin class zinc proteinases (Schlagenhauf, Etges et al. 1998). However, GP63 could
not be categorised within an MMP family because the 62 amino acid insertion diverts the
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catalytic domain of it from that ofMMPs. The protein is synthesised in the endoplasmic
reticulum where the signal sequence is cleaved post-translationally and the C-terminal
residues are replaced with a GPI membrane anchor structure. GP63 may be activated by
means of a cysteine switch in the same manner as MMPs (Schlagenhauf, Etges et al.
1995). GP63 is also post-translationally modified by N-glycosylation which contributes
to Leishmanial virulence (Kink and Chang 1988). GP63 degrades many protein
substrates including casein, hemoglobin, gelatin, fibrinogen and CD4 molecules on
human T cells (Yao, Donelson et al. 2003).
MRP (MARCKS-related protein) was reported as a substrate for GP63, with a
predominant cleavage site between Ser92 and Phe93 within ED (Effector Domain).
MARCKS (Myristoylated alanine-rich C kinase substrate) and MRP are major protein
kinase C substrates expressed in diverse cell types, including macrophages. They are
implicated in coordination ofmembrane-cytoskeletal signalling events, such as cell
adhesion, migration, secretion, and phagocytosis in a variety of cell types. A highly basic
sequence in MRP or MARCKS known as ED binds with high affinity to actin,
calmodulin and acidic phopholipids. The ED also contains the serine residues that are
subject to PKC-dependent phosphorylation. PKC-dependent phosphorylation ofED
serine residues prevented MRP degradation by GP63 in a cell-free assay (Corradin,
Ransijn et al. 1999; Ramsden 2000; Sundaram, Cook et al. 2004).
Background of IX-14 (Invadolysin)
1(3)IX-14' is a late larval lethal mutation that was generated by abdominal injection
of the acridine compound ICR-170 (which preferentially cause frame-shift mutations),
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when Shearn and Garen searched for mutants affecting the imaginal discs (which contain
the cells that will form the epidermal structures such as the legs and wings of the adult fly
during pupation) of Drosophila (Shearn, Rice et al. 1971). It was subsequently
characterised not as a developmental defect, but as a mutation affecting chromosome
condensation (Gatti and Baker 1989). The protein, IX-14, was latter named invadolysin
by the Heck laboratory to take into account leishmanolysin and invadopodia.
Further work on the l(3)IX-14l mutation was initiated by Sue Ann Kruase, a former
Ph.D. student in the Heck laboratory who was able to generate a P element insertion
allele of1(3)IX-14' by local hopping of a nearby P element. This allele was termed
l(3)IX-144) . Both l(3)IX-14' and 1(3)1X-144' have defects in mitotic and polytene
chromosome architecture. In third instar l(3)IX-14' mutant neuroblasts, metaphase
chromosomes are hypercondensed in length and some loosely condensed chromatin was
found surrounding the hypercondensed chromosomes. In salivary glands from third
instar l(3)IX-14' mutant, polytene chromosomes lose the distinctive banding pattern along
the chromosome arms and the chromosome arms seem to be twisted and frayed instead.
The chromocenter which contains the clustered centromeres of the endoreduplicated
chromosomes could not be distinguished in the 1(3)1X-141 mutant polytene chromosomes.
1(3)1X-14! heterozygous flies also have redder eyes in a PEV (position effect variagation)
assay compared to the control wm4 allele. Thus l(3)IX-14' acts as a Suppressor of
Variagation (Su(var)) which indicates an effect on gene expression, possibly through
chromatin structure.
l(3)IX-14' also shows spindle and centrosome abnormalities. The spindle defects
include monopolar spindles, asymmetric bipolar spindles and completely disorganised
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spindles. It was not surprising then to see the checkpoint component BubRl on the
mitotic chromosomes of this mutant because of the aberrant mitotic spindles attachment
has never been assessed (Hoyt, Totis et al. 1991). In addition, most mutant mitotic cells
have only one centrosome, or dumbbell-shaped centrosomes which suggested replicated,
but unseparated centrosomes, close to one another.
l(3)IX-14' also has replication defects, as shown by low levels of BrdU
incorporation which suggest the cell cycle was blocked or delayed earlier than mitosis.
There is no anaphase observed in l(3)IX-14' and more cells entered to apoptosis, as
indicated by TUNEL (Terminal deoxynucleotidyl transferase biotin-dUTP Nick End
Labeling) staining.
The l(3)IX-141 allele was mapped to the 85E10-F16 region by crossing to deficiency
lines with known breakpoints. The responsible gene was identified by inverse PCR
cloning ofDNA flanking the l(3)IX-144Y1 allele P element. A 3.6 kb cDNA was
identified in Drosophila adult head library EST. The Drosophila IX-14 gene has 9 exons,
spread over 15 kb of genomic DNA with the first intron about 9 kb. It contains an ORF
of 2052 nucleotides encoding a protein of 683 amino acids. The insertion site of the P
element was 40 base pairs upstream of the start of transcription (Figure 1.2D, panelA). In
human, there are at least two splice variants that have been found while only one has been
found in Drosophila so far. Some conserved motifs were found in the homologous
sequences. Besides the HEXXH catalytic motif, there is a signal sequence in the N-
terminus of 2 human variants and the Drosophila IX-14 which targets proteins to the ER
(endoplasmic reticulum) through docking with the signal recognition particle. In
addition, there is a C-terminal GPI (Glycosylphosphatidylinisotol) anchor recognised site
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that helps to insert proteins in the plasma membrane. The sequence also have some
destruction motifs (D-box and KEN box) which direct protein turnover by ubiquitin.
Invadolysin also have SUMO-ylation signal just upstream the HEXXH motife (Figure
1.2D, panel B). There are fours variants of Invadolysin exist in human. HsINV variant 1
and 1A37 differ from variant 2 and 2A37 in their longer N-terminal regions. Variant 1
and 2 differ from variant 1A37 and 2A37 in the presence (variant 1 and 2) or absence
(variant 1A37 and 2A37) of a 37 amino acid (aa) insertion that was encoded by a separate
exon. As a result, variant 2 and 2A37 would not target to ER nor become GPI anchored
to the membrane. Variant 1 EST was appeared in testis and brain while the variant 1A37
EST was appear in embryonic stem cells, colon and melanoma. Variant 2 EST was
appear in testis and placenta. There was no EST found for variant 2A37, but there are
expected size band for it shown in RT-PCR on HeLa cells done by Dr. Neville Cobbe.
The IX-14 gene has homologues in Homo sapiens, Mus musculus, Caenorhabditis
elegans, Oryza sativa, Arabidopsis thaliana, Dictyostelium discoideum and Leishmania
(leishmanolysin, also called GP63), which share a HEXXH catalytic motif, and
surprisingly 14 conserved cysteines (Figure 1.2E, panel A). Nine region of sequence
were shared among higher eukaiyotic orthologues but absent in leishmanolysin/gp63.
These map to the surface of the leishmanolysin structure and may likely mediate
interactions with substrates, regulators, or binding other partners and could potentially be
used for tagging and antigen for antibody injection (Figure 1.2E, panel B). Based on its
sequence homology to the active motif ofGP63, the protein that the 1X-14 gene encodes
was identified as a novel zinc-metalloprotease whose substrates are still
18
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Figure 1.2D: Drosophila invadolysin gene and invadolysin
variants in Drosophila and human.
A: DmINV cDNA has 9 exons and the P-element insertion is 40 bp upstream of
the starting point of transcription in the 4Y7 allele. The first intron is 8.6kb and
not shown to scale. B: DmINV has only one variant while four splice variants
of Invadolyisn have been found in human. They share some common motifs
like signal sequences in N-terminal region, GPI anchor site near the C-terminus,
an HEXXH catalytic motif, SUMO-ylation signal, KEN-Box and D-Box. In
human, variant 1 and vlA3 7 contains the signal sequence which was missing in
v2andv2A37. VIA37 and v2A37 miss a 37 amino acid insertion which is
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Figure 1.2E: Homologues of invadolysin and structure of
leishmanolysin.
A: T-COFFEE alignment showing homologues of invadolysin conserved
between Caenorhabditis elegans (Ce), Homo sapiens variant 2 (HsV2), Mus
musculus (Mm), Drosophila melanogaster (Dm) and Leishmania major (Lmajor)
with the conserved HEXXHXXG (and third required H) zinc-metalloprotease
motif (red box). Although the homology between leishmanolysin and the other
proteins appears to be largely limited to regions surrounding the metalloprotease
motif, the placement of 14 cysteines (asterisks) is strikingly conserved. Nine
regions (insertions relative to leishmanolysin) shared among the higher
eukaryotic orthologues (absent from leishmanolysin) are indicated by blue boxes
with the numbers above them. The green line and triangles delimit the region of
the leishmanolysin protein that is shown in B. B: Stereo pair of the three-
dimentional structure of leishmanolysin. The black numbered spheres represent
the insertions that map to the surface of the leishmanolysin structure. The
internal magenta sphere represents the zinc ion required for catalysis.
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unknown. Although the appearance of the common sequence ofHEXXH is conserved
between MMPs, the IX-14 productor GP63, does not seems to belong to MMPs base on
its distinct catalytic domain. The Heck laboratory is currently using bioinformatics way
to ascertain relationship between MMPs and IX-14.
Three lines of evidence indicate that mutation of1X-14 is responsible for the cellular
phenotypes observed in IX-14 mutant flies. 1) An expected 3.6 kb mRNA was absent in
the two alleles of Invadolysin homozygous mutants, 1(3) IX-141 and 1(3) IX-144' ', but was
present in wild type and heterozygous extracts of the two alleles (larval extracts in all
case). 2) The phenotype of IX-14 RNAi in Drosophila S2 cells, are similar to that of the
two IX-14 mutant alleles with regard to centrosome and spindle morphology. 3) A
proteolytic activity was missing in l(3)IX-141 larval brains which is consistent with the
assumption that IX-14 was a protease based on its sequence (McHugh, Krause et al.
2004). The band which was missed in homozygous mutant could be certified as IX-14 by
in gel proteolysis followed by mass spectrometry. IX-14 has a cytoplasmic localisation
pattern in both Drosophila S2 cells and human HeLa cells (Figure 1.2F, panel A and B).
Strikingly, HsIX-14 shows a distinct ring-like structure in the cytoplasm ofHeLa cells.
These ring-like structures are not specific to HeLa cells as they are also observed in
Jurkat (T cell derived) and CF-PAC cells (pancreas carcinoma cell line). However the
ring-like structures are specific to interphase cells since they seem to be dispersed in
mitosis. These structures resemble invadopodia, in which a protrusion of 200-nm-wide
and up to 3-p.m-long extends into the extracellulas matrix. Invadopodia is an actin rich
structure that contain actin associate protein (WASp, Arp2/3 etc), MMPs (MMP2,
MMP9, MT-MMP1 etc), adhesion molecules (Integrin etc), signal protein (RhoA etc)
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A B
Figure 1.2F: Localisation of invadolysin in human and
Drosophila cells.
A: GFP-DmlNV was localized to the cytoplasm ofDrosophila S2 cells
compared to the whole cell localization ofGFP alone. B: HsINV-EGFP was
localized to the cytoplasm in HeLa cells and shown as distinct ring-like
structures compared to the whole cell localization of EGFP vector. C:
HslNV showed the punctate staining in the cytoplasm of stationary
macrophages but was localised to the leading edge ofmigrating macrophages.
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(Gimona and Buccione 2006). These are prominent in invasive cells and function in
degrading the ECM (Baldassarre, Pompeo et al. 2003). Like invadopodia, the ring-like
structures containing Invadolysin are localized to the lower third of the cell close to the
substratum. Invadolysin staining on stationary macrophage cells was performed and a
punctate staining in the cytoplasm was observed. Surprisingly, all the Invadolysin
localized to the leading edge ofmigrating macrophages which suggest a role for
Invadolysin in cell migration (Figure 1,2F, panel C).
l(3)IX-141 neuroblasts have abnormally high levels of lamin Dm(), a nuclear
envelope protein, during mitosis (McHugh, Krause et al. 2004). Therefore, lamin is a
good candidate substrate for Invadolysin, based on its accumulation in 1X-14 mutant
brains. Beside its proteolysis by caspase during apoptosis, Drosophila lamin has not
reported to be proteolysed by any other protein or at any stage in the cell cycle. Thus
invadolysin might shed new light on Drosophila lamin turnover. More details about
nuclear envelope proteins will be introduced in Chapter 3. Interestingly, the mouse
Zmpste24 metalloprotease plays an important role in the processing of prelamin A
(Pendas, Zhou et al. 2002). There is no Zmpste24 homologe in Drosophila has been
identified, so it is possible that invadolysin process lamin DmO in a different way.
Moreover, there is growing evidence that lamins are implicated in DNA replication,
chromatin organization, regulation of transcription and cell division (Wilson and Zastrow
2001). Invadolysin mutants have similar defects. Given the mitotic phenotype, it is also
plausible that molecules important for chromosome condensation or spindle assembly
may be substrates of Invadolysin.
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In Drosophila, 27 proteins were reported as potential interactors of Invadolysin
through a genome-wide yeast two-hybrid screen (Giot, Bader et al. 2003). Among these,
CG6268 (mask) and CG4719 are annotated as structural constituents of the cytoskeleton,
which might indicate links to the observed spindle defects of the Invadolysin mutant and
forming the invadopodia structure in human cell lines. CG12789 and CG3212 are
involved in a defence response which might provide a link to the observed leading edge
localization of Invadolysin in macrophages. Thus there are many potential interactors
which may play a role in Invadolysin localization or activity in mitotic and cell migration.
It was at this point that I began my Ph.D. in the Heck laboratory with the aim of further
characterising the role of this novel, essential metalloprotease and discerning potential
substrates of Invadolysin.
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Chapter 2 Materials and Methods
2.1 Abbreviations
BrdU Bromodeoxyuridine
BSA Bovine Serum Albumin
C-terminus Carboxyl terminus
CLAP Chymostatin, Leupeptin, Antipain, Pepstatin A
DAPI 4', 6-diamidino-2-phenylindole
DTT Dithiothreitol
dsRNA Double stranded RNA
EBR Ephrussi Beadle Ringer's Solution





EST Expressed Sequenced Tag
FBS Fetal Bovine Serum
GFP Green Fluorescent Protein







ORF Open Reading Frame
PAGE Polyacrylamide Gel Eletrophoresis
PBS Phosphate Buffered Saline
PCR Polymerase Chain Reaction
P-H3 Phosphorylated Histone H3
PMSF Phenyl Methyl Sulfonyl Fluoride
PFA Paraformaldehyde
RT-PCR Reverse Transcriptase- Polymerase Chain Reaction
SDS Sodium Dodecyl Sulfate
SMC Structure maintenance of Chromosomes
TAE Tris acetate buffer with EDTA
TBE Tris borate buffer with EDTA
TE Tris buffer with EDTA







Canton S Bloomington Stock Center
l(3)IX-14'/TM6B (AntpHu e' Tb') (Chemical induction) M. Gatti, Rome
1(3)IX-144Y7/TM6B (AntpHu e' Tb') (P-element insertion) S.A.Krause Heck
Laboratory
L(3)IX-14'/TM3, KrGFP (yl w*; D*
gl3/TM3, P{GAL4-Kr.C}DC2, P{UAS-
GFP.S65T}DC10, Sbl)
Bin Yu, Heck laboratory
l(3)IX-144"/TM3 (yl w*; D* gl3/TM3,
P{GAL4-Kr.C}DC2, P{UAS-
GFP.S65T}DC10, Sbl)
Bin Yu Heck laboratory





Escherichia coli XL1 Blue (Stratagene)
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RecA endAl gyrA96 thi-1 hsdR17 supE44 relAl lac [F'proAB lac!qZDM15 TnlO]
Escherichia coli BL21 (Stratagene)
B F' dcm opm T hsdS (r8~ m8~) gal
Escherichia coli MAX Efficiency DH10Bac~ (Invitrogen)
V'mcrA A(mrr-hsdRMS-mcrBC) O801acAZM15 AlacXIA recA 1 endA1 <m/D139 A
(ara, /ew)7697 gal\J galK sdrpsL nupG /pMON 14272 / pMON7124
Escherichia coli TOPIO (Invitrogen)
Y~mcrA A(mrr-hsdRMS-mcrBC) OSOlacAZM 15 AlacXIA recA 1 araD139A(ara-leu)




Common reagents and buffers
Ampicillin (Sigma)
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Stock at 50 mg/ml in 50% EtOH. Used at 50 pg/ml.
Aprotinin
Stock at 1.7 mg/ml in 0.9% NaCl and 0.9% benzyl alcohol. Used at 1.7 pg/ml. (Sigma-
Aldrich)
BSA
Bovine Serum Albumin, 30% Stock solution (Sigma).
BMG medium
100 mM potassium phosphate, pH 6.0, 1.34% YNB. Store at 4°C for no more than two
months.
BMGY medium
1% yeast extract, 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% YNB, 4x10
5% biotin, 1 % glycerol. Store at 4 °C for no more than two months.
BMM medium
100 mM potassium phosphate, pH 6.0, 1.34% YNB, 4 x 10"5% biotin, 0.5% methanol.
Store at 4°C for no more than two months.
BMMY medium
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1% yeast extract, 2% peptone, 100 mM potassium phosphate, pH 6.0, 1.34% YNB, 4 x
10~5% biotin, 0.5% methanol. Store at 4°C for no more than two months.
CLAP
1 mg/ml chymostatin, 1 mg/ml leupeptin, 1 mg/ml antipain, 1 mg/ml pepstatin A (Sigma)
in DMSO. Used at 1-10 pg/ml.
Coomassie Brilliant Blue stain
0.5% Coomassie Blue (Sigma) in 100% methanol.
Coomassie Blue stain diluent
35% methanol, 14% acetic acid.
Coomassie Blue fast destain
35% methanol, 10% acetic acid.
Coomassie Blue slow destain
10% methanol, 7% acetic acid.
Cytoskeletal Buffer
137 mM NaCl, 5 mM KC1, 1.1 mM NaHP04, 0.4 mM KH2P04, 2 mM MgCl2, 2 mM
EGTA, 5.5 mM Glucose, 5 mM PIPES, pH 6.1.
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10X Dulbecco's Phosphate Buffered Saline (PBS)
1.37 M NaCl, 26.8 mM KC1, 14.7 mM KH2P04, 64.6 mM Na2HP04, pH 7.4.
DAPI





Stock at 1M dithiothreitol in dH20 at -20 °C (Fisher).
EDTA
Ethylenediaminetetraacetic acid. 0.5M solution in dH20, pH 8.0.
EGTA
Ethylene glyco-bis (P-amino-ethylether)-N,N,N',N'-tetraacetic acid. 0.25 mM in dH20,
pH 6.8.
10X Ephrussi-Beadle Ringers solution (EBR)
1.3 M NaCl, 47 mM KC1, 19 mM CaCl2, 100 mM HEPES, pH 6.9.
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Ethidium Bromide (EtBr)
Stock at 10 mg/ml in dH20. Used at 350 ng/ml.
Gentamicin (Sigma)
Stock at 10 mg/ml in dH20. Used at 7 pg/ml.
IPTG
Isopropyl p-D-thiogalactopyranoside. 1M solution in dH20.
Kanamycin (Sigma)
Stock at 10 mg/ml in dH20. Used at 50 pg/ml.
Laemmli Upper Gel (stacking) Buffer
0.5 M Trizma base, pH 6.8 with HC1.
Laemmli Lower Gel (resolving) Buffer
1.5 M Trizma base, pH 8.8 with HC1.
Laemmli Gel Running Buffer
25 mM Trizma base, 192 mM Glycine, 1% SDS
Luria-Bertani Broth (LB)
1% Bacto tryptone, 0.5% Bacto yeast extract, l%NaCl, pH 7.4.
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5X Loading Dye for DNA run on agarose gels
17.5% Ficoll 400, 100 mM EDTA pH 8.0, 2.5% SDS, 0.25% Bromophenol Blue.
20X MOPS SDS Running Buffer
1 M 3-(N-morpholino) propane sulphonic acid, 1 M Tris base, 2% SDS, 20.5 mM EDTA,
pH 7.7.
Mowiol Mounting Solution
10% Mowiol (Calbiochem), 20% Glycerol in PBS
PBSTx
Dulbecco's PBS with 0.1% TritonX-100
PBSTw
Dulbecco's PBS with 0.1% Tween-20.
PFA
16% paraformaldehyde ampules (TAAB).
3X Protein Sample Buffer
6% SDS, 150 mM Tris pH 6.8, 30% glycerol, 0.03% Bromo-phenol Blue, 6 mM EDTA.
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Ponceau S
0.2% Ponceau S in 3% TCA
Phenol/CHCb/IAA
Phenol: Chloroform : Isoamyl Alcohol (25:24:1), 10 mM Tris pH 8.0, 1 mM EDTA.
SDS
Sodium Dodecyl Sulphate. Stock normally at 20% solution in H20.
SOB
2% Bacto-tryptone, 0.5% Bacto-yeast extract, 8.6 mM NaCl, 50 mM MgCl2, 2.5 mM
KC1, pH 7.0.
soc
SOB with 20 mM Glucose.
Stripping solution
lOOmM p-mercaptoethanol, 2% SDS, 62.5 mM Tris, pH 6.7.
1XTAE
40 mM Tris-acetate, 1 mM EDTA pH 8.0.
1XTBE
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45 mM Tris-borate, 1 mM EDTA, pH 8.0.
IX TE
10 mM Tris-HCl, 1 mM EDTA, pH 7.6.
Tetracycline (Sigma)
Stock at 5mg/ml in dH20. Used at 10 pg/ml.
Towbin Transfer Buffer
25 mM Tris (Sigma), 20% methanol, 250 mM Glycine (Sigma-Aldrich), 0.1% SDS.
IX Tris Buffered Saline (TBS)
137 mM NaCl, 20 mM Tris-HCl, pH 7.6.
X-Gal
5-Bromo-4-Chloro-3-Indolyl a-D-Galactopyranoside (Sigma-Aldrich). Stock at 2%.
Used at 100 pg/ml.
YNB
Yeast Nitrogen Base powder with ammonium Sulfate without amino acid, stock at 13.4%
in dH20. Store at 4°C for less than one year.
YPDA Medium
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20 g/L Difco peptone, 10 g/L Yeast extract, dextrose (glucose) to 2%, pH 6.5.
Zeocin (Invitrogen)




2 ml of appropriate bacterium culture (e.g. DH5a, BL21, XL-1 Blue) was grown
with shaking at 37°C in SOB magnesium free medium overnight. 0.5 ml of the culture
was then diluted into two 2 litre flasks containing 250 ml SOB each and grown at 37°C to
an OD at 600 nm of 0.8. The flasks were then immediately chilled on ice for 15 to 30
minutes. From then on, all subsequent steps were kept cold, and all resuspension were
performed gently. Cells were harvested by centrifugation in sterile, chilled bottles for 15
minutes at 2500 rpm in a Beckman JLA10.500 rotor at 4°C. For each 250 ml culture,
supernatant was removed as much as possible, and cells were resuspended in 250 ml
sterile ice cold 10% Glycerol in distilled water. The ruspended culture was centrifuged
again at 2500 rpm for 15 minutes at 4°C, and the supernatant was subsequently removed.
Each pellet derived from the original 250 ml SOB was resuspended in 2.25 ml 10%
Glycerol and 200 pi aliquots were snap frozen in 500 pi microfuge tubes by placing them
in liquid nitrogen. The cells were then stored at -80°C.
Electroporation Transformation into E. coli
Aliquot(s) of electroporation competent cells were removed from -80 °C and thawed
on ice. Meanwhile, 1.5 ml Eppendorf tube(s) and 0.2 cm electroporation cuvette(s)
(Invitrogen) were also placed on ice. In each 1.5 ml tube, 80 pi of competent cells were
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mixed with the appropriate amount ofDNA. The mixture was added into a cuvette by
tapping so that the sample can go to the bottom, and then eletroporated at the following
conditions: resistance set at 200 Ohms, capacitance set at 25 p.FD and volts set at 2.5 kV
on a BioRad eletroporator. After the electroration, 1 ml of SOC medium was
immediately added to each cuvette. The mixture were then transferred back to the 1.5 ml
tube and incubated at 37°C for 30-60 minutes. Dilution were plated on agar plates
containing the appropriate antibiotic.
Plasmid DNA extraction
For small scale extraction of plasmid DNA, 3 ml ofE. coli culture were grown
overnight at 37°C with shaking, 2 ml of which were used for plasmid DNA extraction
using the UltraClean'M Plasmid miniprep kit from MoBio or Qiaprep miniprep kit from
Qiagen under manufacturer's instructions and the rest were used for making a frozen
glycerol stock. Larger scale extractions were performed using Qiagen midiPrep kit (up to
50 ml) or Qiagen MaxiPrep kit (up to 500ml) under manufacturer's instructions.
Restriction digestion of DNA
In general, restriction digests were performed in 0.5 ml Eppendorf tube, using
enzymes from New England Biolabs or Promega with the 10X reaction buffer provide
with the enzyme. Digests were normally performed in the 37 °C incubator for 2-3 hours
(20 hours for some PGR product when only several bp were present adjacent to
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restriction enzyme recognized site). If required, the restriction enzyme was then
inactivated by placing the tube at 65°C for 20 minutes.
Ligations
All ligations were performed using T4 DNA ligase from Promega or New England
Biolabs with the appropriate reaction buffer at 16-18°C for overnight. Whenever
possible, an insert: vector molar ratio of 3:1, 1:1 and 1:3 were all used.
Agarose gel electrophoresis
Unless otherwise stated, all agarose gels were made up at 1% of either Seakem LE
Agarose (Flowgen) or High Gel Strength Agarose (Melford) containing 0.3 Lig/ml
ethidium bromide. Then gel was electrophoresed in electrophoresis tanks in IX TBE or
TAE depend on the buffer composition of the gel. Different gel sizes were used
according to the number of samples or the degree of separation required and run under
different conditions. Gel size: mini (50 ml agarose, run at 100V), midi (100ml agarose,
run at 150V) or maxi (300 ml agarose, run at 150V).
Purification of DNA from agarose gels
Electrophoresis was performed in 1.2% low-melt gel (MacroSieve low melting
temperature agarose, Flowgen) in TAE containing 0.3 pg/ml ethidium bromide (run in
TAE buffer). Desired bands were excised under UV illumination using a glass coverslip
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and placed into 1.5 ml Eppendorf tubes. DNA was purified from the agarose gel by using
the Perfectprep Gel Cleanup Kit (Eppendorf) or Qiaquick Gel Extraction kit (Qiagen)
under manufacturer's instructions.
PCR Amplification of Plasmid DNA
Most PCR reactions were performed by using either Pfu (Promega) or Expand High
Fidelity DNA polymerase (Roche).
For products smaller than 2 kb, PCR reactions were usually performed using Pfu
DNA polymerase under the following conditions:
1 OX Pfu DNA polymerase buffer with MgSCE 5 pi
dNTPs (2.5 mM each) 4 pi
primer mix ( 100 pM each) 2 pi
MgS04 (25 mM) 0-4 pi
Pfu DNA polymerase (2-3 U/pl) 0.5-1 pi
DNA template (50-200 ng) Variable
Sterile deionised water up to 50 pi (final volume)
PCR reactions were performed in a Biometra Personal Cycler or a Biometra Gradient
Cycler, according to the following protocol:
Initial Denaturation 95°C 2 minutes
{Denaturation cycle 95 °C 30 seconds
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Annealing cycle 55-65°C
Extension cycle 74 °C
Final Extension 74 °C
Hold 4°C
30-60 seconds 30-35 cycles
2-5 minutes}
5 minutes
For products larger than 2 kb, PCR reactions were usually performed using Expand
High Fidelity DNA polymerase under the following conditions:
10X Expand High Fidelity PCR System Buffer 2 5 pi
dNTP (2.5 mM) 4 pi
primer mix (100 pM each) 2 pi
Expand High Fidelity DNA polymerase 1 pi
DNA template (50-200 ng) variable
MgSCE (25 mM) 0-4 pi
Sterile deionised water up to 50 pi
PCR reactions were performed in a Biometra Personal Cycler or a Biometra Gradient
Cycler, according to the following protocol:
Initial Denaturation 95 °C 2 minutes
{Denaturation Cycle 95 °C 30 seconds
Annealing Cycle 55-65 °C 30-60 seconds
Extension Cycle 68 °C 2-5 minutes}
Final Extension 68 °C 7 minutes
Hold 4°C
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DNA purification from PCR reactions
DNA products from PCR reactions were usually purified by using the UltraCleanIM
PCR Clean-up DNA purification Kit (MoBio laboratory) under manufacturer's
instructions.
Sequencing of plasmid DNA
Sequencing reactions were performed using 250-500 ng of template DNA, 3.2 pmol
of the appropriate primer, and 4 pi of Big Dye terminator cycle sequencing kit version
3.1 (Perkin Elmer, Applied Biosystem). The mixture was then brought up to 20 pi with
dEbO and the reaction allowed to proceed in a Biometra Personal Cycler or Biometra
Gradient Cycler according to the following protocol:
95 °C 5 minutes
{95 °C 30 seconds
55 °C 15 seconds 25 cycles
60 °C 4 minutes}
Hold 15 °C
The reactions were then transferred to 0.2 ml PCR strip tubes and taken to the ICMB
sequencing facility for loading on to an ABI prism sequencer.
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RT-PCR of total RNA isolated from whole flies
Total RNA from whole flies was kindly provided by Ellada Savvidou. Reactions
were performed using Access RT-PCR system (Promega) under the following conditions
Nuclease-free water 31.5 pi
AMV/777 5 X Reaction buffer 10 pi
DNTP mix (10 mM each) 1 pi
Primer mix (50 mM each) 2 pi
MgSCX (25 mM) 2 pi
AMV reverse transcriptase (5 U/pl) 1 pi
Tfi DNA Polymerase (5 U/pl) 1 pi
RNA template 1.5 pi
The reactions were performed in a Biometra Personal Cycler or a Biometra Gradient
Cycler according to the following protocol:
first strand DNA synthesis:
Reverse transcription 48°C 45 minutes
AMV RT inactivation 94 °C 2 mintutes
















10 pi of each reaction was analysed by 1% agarose gel electrophoresis.
Preparation ofConcanavalin A-treated coverslips
12 coverslips (22 x 22 mm/1.5 thick, VWR) were put into a small ceramic cradle in
order to best expose surfaces. Coverslips were washed twice in deionised water for 15
minutes each time before being incubated in 0.5 M HC1 for 30 minutes. Coverslips were
then washed twice again in deionised water for 15 minutes each time before being placed
in absolute ethanol for 30 minutes. Excess ethanol was drained off and individual
coverslips were dipped in Concanavalin A solution (0.5 mg/ml in dfTO) for 30 seconds.
Finally coverslips were dried on clean blotting paper and sterilised for lh by UV
irradiation prior to use.
Preparation Poly-L-lysine treated slides
Microcope slides (76 x 26 mm/ 1.0 mm thick, Berliner Glass KG) were washed
overnight in deionised water containing diluted detergent, Decon (1:10 in deionised
water). Then the slides were rinsed with dFl20 several times until no bubbles could be
seen, before being washed with 95% ethanol for 3 hours and rinsed with dH20 again.
Next, slides were incubated in 0.1% poly-L-lysine solution (Sigma-Aldrich) for 45
minutes. Finally, slides were rinsed with dH20 and dried.
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Cell Culture
Drosophila S2 cells were maintained in serum free Schenider's Insect Medium
(Sigma, SI046) with 10% Insect qualified Fetal Bovine Serum (Gibco). Cells were
grown at 27°C in a humidified atmosphere (Hera Cell, Heraeus) and were passed at 1:10
dilution every 5 days.
SF9 cells (derived from the parental Spodopterafrugiperda IPLB-Sf-21-AE cells)
were maintained in serum free SF-900 II medium (Gibco). Cells were grown at 27°C in a
humidified incubator (Hera Cell, Heraeus) and were maintained by passing the culture at
1:10 dilution every 5 days.
High Five cells (derived from the parental Trichopulsia ni cell line) were maintained
in serum free Express Five SFM medium (Gibco). Cells were grown at 27 °C in a
humidified incubator (Hera Cell, Heraeus) and were maintained by passing the culture at
1:20 dilution every 3 days.
HeLa cells were grown in RPMI medium (GibcoBRL) +10% Fetal Bovine Serum
(Gibco) under normal conditions (37°C and 5% C02) in a humidified incubator (Hera
Cell, Heraeus). They were passed at 1:10 every 2 days. In brief, after the medium was
aspirated, cells were washed with 5 ml PBS which was in turn aspirated before allowing
cells to stand in 0.1% trypsin in PBS for 5 minutes. When the cells were seen rounding
up under microscope, cells were detached from the bottom surface by banging on the side
of the flask. 10 ml ofRPMI+10% FBS was added to the cells before they were diluted
into new flasks containing up to 30 ml RPMI + 10% serum.
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Preparation of Cultured Cell protein Extracts
Cells (S2, SF9, High Five, HeLa,) were centrifuged at 300g for 5 minutes and
washed with PBS with protease inhibitors (1 pg/ml CLAP, 1 pM/ml PMSF, 1.7 pg/ml
aprotinin). The volume of PBS was used according to the confluence of cells for easy
counting (start from 0.5 ml if large amount was applied, otherwise it is difficult to
completely resuspended the cell clumps). Cells were then counted using a
hematocytometer before being centrifuged again at 300g for 5 minutes. The pellet was
resuspended at a specific concentration (normally 5 xlO4 cells/pl for SF9, S2 and High
Five cells, 104 cells/pl for HeLa cells) in sample buffer (3X Sample buffer 1/3; DTT 5%;
aprotinin, CLAP, PMSF 1% each; PBS up to 100%). Finally, cells were lysed by
sonication and boiled at 100°C for 5-10 minutes before being stored at -20°C or loaded
directly on a polyacrylamide gel for electrophoresis.
Preparation of Larval brain protein extracts
Third instar larval brains were dissected under the microscope in IX EBR. 10 wild
type brains or 30 IX-14 mutant brains were lysed in 100 pi ofEBR lysis buffer (IX EBR
+ 10 mM EDTA + 10 mM DTT + 1.7 pg/ml aprotinin, 1 mg/ml CLAP and 1 pM/ml
PMSF) using portable sonicator. 50 pi of 3X Sample Buffer and 10 pi ofDTT were
added to the extracts before the extracts were boiled at 100°C for 5 minutes. The extracts
were then directly loaded on a polyacrylamide gel or stored at -20°C.
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TCA precipitation
In order to concentrate protein samples, 100% trichloroacetic acid (TCA) was
applied to a final concentration of 10%, precipitating on ice for at least 30 minutes.
Samples were then centrifuged for 15 minutes at 13,000 ipm in a bench centrifuge
(Heraeus Instruments) at 4°C. Supernatant was aspirated with a drawn Pasteur pipette,
and the pellet was resuspended by sonicating in 1 ml ofwash buffer (70% Acetone, 20%
Ethanol, 10 mM Tris, PH 7.4, 0.0015% bromophenol blue). The solution was centrifuged
at 13,000 rpm for 10 minutes at 4°C. The pellet was washed a second time again by
sonicating in 1 ml of above wash buffer and centrifuged again in the same conditions.
Finally, the pellet was resuspend by sonicating in the desired volume of IX SDS-PAGE
sample buffer containing DTT. Samples were boiled for 5 minutes before loading on a
gel or freezing at -20 °C.
SDS-PAGE of Protein
Two types of gel were used for protein electrophoresis: Hoeffer 'Vertical Slab Gel
unit' rigs for large gels (16 cm x 18 cm/1-0.75 mm or 1-1.5 mm thick), or small NuPAGE
pre-cast gels (10 cm x 10 cm/1.0 mm or 1.5 mm) (Invitrogen). The Novex pre-cast gels
were used according to manufacturer's instructions and electrophoresed in IX MOPS
Running Buffer at 200 volts while the large gel were prepared as follows:
Two glass plates (16 cm x 18 cm) were washed with dH20, Decon (diluted 1:5 in
dEEO), dFEO again, and finally rinsed with 70% ethanol before wiping with a paper
towel to dry. Washed glass plates were separted by 2 spacers, one at either end, and then
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clamped together with one end sealed with parafilm. The clamped plates were placed on
the gel apparatus and the resolving (lower) acrylamide gel was poured in between the
glass plates from the top first, followed by the stacking (upper) gel. The following table
describe the amounts of each in a varied of final acrylamide percentages:
Resolving (lower) gel:
Recipes for 1-1.5 mm thick gel (Bold text), or 1-0.75 mm thick gel. The lower buffer
consists of 1.5 M trizma-base, PH 8.8. Acrylamide refers to a stock of 30% acrylamide:
0.8 Bis-acrylamide (Severn Biotech Ltd). AMPS is a 10% stock of ammonium
Persulphate in dH20 (Sigma).
Gel percentage 7.5% 10% 12.5%
Lower buffer 10 ml 5 ml 10 ml 5 ml 10 ml 5ml
Acrylamide 10 ml 5 ml 13.3 ml 6.65 ml 18.3 ml 9.17 m
20% SDS 200 pi 100 pi 200 pi 100 pi 200 pi 100 pi
0.5 M EDTA 80 pi 40 pi 80 pi 40 pi 80 pi 40 pi
dH20 19.72 ml 9.86 m 16.42 ml 8.21 m 11.39 ml 5.69 m
10% AMPS 400 pi 200 pi 400 pi 200 pi 400 pi 200 pi
TEMED 40 pi 20 pi 40 pi 20 pi 40 pi 20 pi
After pouring the resolving gel, butanol saturated with 0.25 X lower buffer was layered
over the top in order to create a sharp interface between resolving and stacking gels.
Resolving gels were allowed to polymerise for 15 to 20 minutes at room temperature.
48
The butanol layer was then poured off, washed with dH20, and the stacking gel poured
on top.
Stacking (upper) gel:
All stacking gels were made up in 10 ml containing:
Upper buffer 2.5 ml
Acrylamide 1.33 ml
20% SDS 50 pi
0.5 M EDTA 20 pi
UREA to 8 M 4.8 g
dH20 up to 10 ml
10% AMPS 100 pi
TEMED 10 pi
A plastic comb was placed at the top of the stacking gel to form the wells, and the
gel was then allowed to polymerise for 15 minutes at room temperature. The
polymerised gel slab was then fixed in position in the buffer tank, and IX Laemmli Gel
Running Buffer was poured into the upper and lower chambers. Protein samples were
boiled for 5 minutes before they were loaded into the wells using a Hamilton syringe. 30
pi of a molecular weight marker (SeeBlue Plus 2, Invitrogen) were loaded in wells as
needed. Gels were electrophoresed at 55 V overnight at room temperature.
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Transfer of SDS-PAGE gels onto nitrocellulose membrane
After electrophoresis, SDS-PAGE gels were transferred to Protran nitrocellulose
membrane (Schleicher and Schuell) for immunoblotting. Prior to setting up for transfer,
4 L ofTowbin transfer buffer was prepared (3200 ml of dH20, 800 ml of methanol, 12.1
g of Sigma 7-9 Tris base, 57.7 g Sigma-Aldrich glycine). From the 4 litre Towin Buffer,
1 litre was decanted for soaking the Protran membrane and 15 ml 20% SDS were then
added to give a final concentration of 0.1 % SDS.
The blot was then set-up within a cassette in blotting tank (BioRad) in the following
order:
(negative pole)-Sponge-Whatman Blotting paper-gel-nitrocellulose-Whatman Blotting
paper-sponge-(positive pole). Blotting was performed at 400 mA for 3.5 hours at 4°C.
After transfer, the membrane was rinsed with dH20 and stained with Ponceau-S (0.2%
Ponceau-S in 3% trichloroacetic acid) for 5-10 minutes at room temperature with
shaking. The membrane was rinsed with dH20 with shaking and the position of the
molecular weight markers were marked unambiguously with a needle. The membrane
was stored at 4°C or washed once with PBSTw and used immediately for
immunoblotting.
Immunoblotting
After protein extracts were transferred onto nitrocellulose membranes, membranes
were blocked in PBSTw with 5% skimmed milk powder (Sainsbury) for 1 hour at room
temperature or overnight at 4°C. After washing 3 times for 10 minutes in PBSTw, the
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membranes were incubated with primary antibody in PBSTw or PBSTw with 0.5% milk
for 1 hour at room temperature or overnight at 4°C. After washing 6 times for 5 minutes
each in PBSTw, the membranes were incubated in horseradish peroxidase-linked (HRP)
sencondary antibody for 1 hour at room temperature. Finally, membranes were washed 3
times for 10 minutes each again in PBSTw before processing for detection by incubation
in 10 ml enhanced chemiluminescence solution (ECL, Amersham Biosciences) for
exactly 1 minutes. The nitrocellulose was then exposed to Kodak XAR-5 film for
autoradiography. Films were developed using a Kodak SRX-101A developer.
Stripping of probed nitrocellulose membrane
Membranes were first washed twice with PBSTx for 15 minutes each time and then
incubated in Stripping Solution for 30 minutes at 65°C. After that, membranes were
rinsed twice for 10 minutes each time with PBSTw and then incubated at 4°C overnight
with PBSTw before blocking and probing with another antibody.
Coomassie Brilliant Blue staining of polyacrylamide gels
After protein extracts were resolved by electrophoresis, the gels were stained with
Coomassie Brilliant Blue (0.5% in methanol) diluted 1:5 in Coomassie Blue stain diluent
solution for 1 hour at room temperature. The gels were then destained with Fast Destain
solution for 1 hour at room temperature. Finally the gels were destained further with
Slow Destain solution. The gel was then placed between two cellophanes (IDEA
scientific company) which were clamped together using a plastic square box making sure
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that no bubbles were present. The gel was placed in a fan incubator (BioRad) to dry for
three hours.
Silver staining of gels
After protein extracts resolved by electrophoresis, the gel was fixed 2x15 minutes
in 100 ml 30% EtOH, 10% acetic acid. In order to reduce the background, the gel was
washed in 100 ml 30% EtOH with 0.1 g Na2S203 (0.01% final concentration), and 2.5 ml
4M sodium acetate (0.1 M final concentration, pH 6.8) for 30 minutes. The gel was
washed thoroughly with water until the pH was above 5 (3 x 10 minutes wash was
usually sufficient) before it was incubated in 100 ml 0.1 g silver nitrate (0.1% final
concentration) (AgNCb), 25 pi formaldehyde (0.01% final concentration) (CH2O) for 30
minutes. The gel was then quickly washed with water to remove loose silver ions before
being developed by 2.5g sodium carbonate (NazCCE), 50 pi formaldehyde (0.02% final
concentration) (CH20) in 100 ml dH20 until desired intensity. To stop the reaction, 100
ml 1 % acetic acid was added to the gel. Gels were washed in water before storage.
Immunofluorescence on Drosophila S2 cells
S2 cells were grown on poly-L-lysine treated cover slips. Cells were fixed in 4%
paraformaldehyde dilute from 16% in ampoule (TAAB) in Cytoskeletal Buffer plus 0.5%
TritonX-100 for 10 minutes at room temperature, then rinsed in IX PBS plus 0.1%
TrionX-100 (PBSTx). Cells were then blocked in PBSTx plus 3% BSA for one hour at
room temperature, followed by 3 x 5 minute washes in PBSTx. Primary and secondary
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antibody incubation was carried out in PBSTx plus 0.3% BSA for one hour at room
temperature, followed by 3 x 5 minute washes in PBSTx. The DNA was counterstained
with 0.1 pg/ml DAPI in the second last wash. The coverslips were mounted onto slides
with Mowiol (Calbiochem).
Immunofluorescence staining of larval brains
This protocol has been adapted from Bonaccorsi et al (2000) and is recommended
for analysis ofmitotic spindles in Drosophila neuroblasts.
Third instar larvae were collected from vials and washed in EBR in a dissecting dish
to remove excess food. Individual larvae were transferred to a new well containing EBR
and brains were dissected under a dissecting microscope. Dissected brains were placed
into a new well containing EBR until ready, but never for more than 10 minutes. Brains
were then fixed in 4% paraformadehyde diluted from 16% in ampoule (PFA) in PBS for
30 minutes at room temperature in a dissecting dish. Then the brains were transferred to
a new well containing 45% acetic acid (in dFEO) for 3 minutes, then transferred to a drop
of 60% acetic acid (in dH20) on a siliconised coverslip and squashed gently onto a poly-
L-lysine slide. The slide was flash-frozen in liquid nitrogen and the coverslip was
removed with a razor after breathing on the slide to warm it. The slide was placed in a
coplin jar with pre-chilled 100% ethanol at -20°C for 10 minutes. The brains were then
permeabilised in PBSTx for 10 minutes at room temperature, washed 2x5 minutes in
PBS, blocked in PBS + 3% BSA for 1 hour at room temperature. After blocking, the
slide was washed for 5 minutes in PBSTx and then incubated overnight at 4°C in the
primary antibody diluted in PBS+0.3% BSA. The slide was washed 6 times for 5
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minutes each in PBSTx and the appropriate secondary antibody diluted in PBS+0.3%
BSA was applied for 1-2 hours at room temperature. The slide was then washed 6x5
minutes in PBSTx. The brains were also stained with DAPI (0.1 pg/ml) that was
included in the second last wash. Slides were finally drained and mounted in Mowiol,
allowing 30 minutes for the Mowiol to set before examining by fluorescence microscopy.
Immunostaining for cyclin B in larval brains
This protocol has been adapted from Loupart et al (2000) and is recommended for
detection of cyclin B.
In brief, brains were dissected without imaginal discs in IX EBR, swollen
hypotonically for 3 minutes in 0.25X EBR, fixed for 5 minutes in PFA/HOAc/TX (4%
paraformaldehyde, 10%acetic acid, 0.1% triton X-100, 0.16X EBR), during which time
they were flattened onto polylysine-treated slides under siliconized coverslips. The
coverslip was flicked off after breathing in liquid nitrogen as described before. After that
the slide was immediately washed for 2 minutes in PBS, permeablized 3x10 minutes in
PBSTx, blocked in PBS+3% BSA for 1 hour at room temperature, washed for 5 minutes
in PBSTx. Primary and secondary antibody incubations and washes were performed as
described above.
BrdU incorporation in Drosophila neuroblast
BrdU was weight out 50mg and added in 500mg in instant Drosophila food (Sigma),
rehydrated with 1ml dH20+l drop of food colouring, for a final BrdU concentration of 50
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mg/ml. Larvae with food were selected after being fed for 1 hour. However, since the
mutant larvae are dying, they tend not to eat food, therefore brains were dissected into
fresh Schneider's medium (no FBS), before incubation in BrdU solution at 12 pg/ml in
Schneider's medium for 2 hours.
To co-stain for lamin and BrdU, lamin detection was performed according to the
steps of Tmmunostaining for cyclin B' except that DAPI was omitted. After anti-lamin
detection was complete, slides were post-fixed immediately in 4% PFA in PBS for 1 hour
at room temperature, washed for 5 minutes in PBSTx and then incubated for 15 minutes
in freshly prepared 2N HC1. After 2x5 minute washed in PBSTx, slides were incubated
with rat anti-BrdU antibody (1:2 dilution, Harlan Sera Lab) in PBS + 0.3% BSA at 4 °C
overnight. After 3x5 minute washes, the slides were incubated with Alexa 488 goat
anti-rat conjugate (1:500 dilution, Molecular Probes) in PBSTx + 0.3% BSA for 1.5
hours at room temperature. Finally slides were washed 6x5 minute in PBSTx including
counter-stain with 0.1 pg/ml DAPI at the second last wash. Coverslips were mounted
onto slides with Mowiol.
Mitotic Arrest by Colchicine and DAPI staining of Drosophila
neuroblast squashes
Third instar larvae brains were dissected in IX EBR and incubated in colchicine for
1 hour at 2 mg/ml in Schneider's medium. Brains were transferred to 0.25X EBR for 3
minutes to hypotonically swell the cells, and then fixed in a drop of 45% acetic acid on a
siliconised coverslip for 3 minutes. After that brains were squashed onto a poly-Lysine
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slide before flicking off the coverslip in liquid nitrogen as described before. Slides were
rinsed in PBS and transferred to PBSTx containing 100 ng/ml ofDAPI for 5 minutes.
Finally, the slides were washed 5 minutes in PBSTx before mounting in 35 pi ofMowiol
in glycerol.
Immunofluorescence of HeLa cells
Cells were seeded on round coverslips (13 mm in diameter)in 6-well dishes and
grown under normal conditions using RPMI. The next day, coverslips were fixed in fresh
4% PFA in IX PBS for 3 minutes, the PFA was rinsed off with PBS for 2 minutes,
permeabilised in 0.5% Triton X-100 in PBS for 3 minutes, washed 2x3 minutes in
PBSTx and blocked in 3% BSA in PBS at room temperature for 1 hour. After the
coverslips were washed 5 minutes in PBSTx, the primary antibody incubation was
performed at the appropriate dilution in PBS + 0.3% BSA at 4°C overnight. Then the
coverslips were washed 3x5 minutes in PBSTx before the secondary antibody was
applied at the appropriate dilution in 0.3% BSA, PBS at 37°C for 1 hour. Finally the
coverslips were washed 4x5 minutes in PBSTx (including DAPI at 0.1 pg/ml in the
second last wash) and the coverslips were mounted on slides in Vectashield (Vector
Laboratories) while the edges were sealed with nail varnish.
Drosophila handling
Flies were cultured in bottles or vials contaning "Dundee" maize medium which was
prepared by media staff ofWellcome trust Centre for Cell Biology) using 14 litre of
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water, 150 g of agar, 1100 g of glucose, 620 g of brewer's yeast, 1000 g maize, 80 g of
dried live yeast, 38 g of nipagin (p-hydroxy benzoic acid methyl ester) mixed with 380
ml of absolute alcohol and 45 ml of propionic acid. Files were passed every two week at
room temperature or every month at 18 °C as stock.
Immunofluorescence on Drosophila Embryos
Flies were fed yeast paste for 2 days before transfer to a collection cage containing
grape concentrate agar plate with a dollop of thick yeast paste in the center. The cage
was left undisturbed for the desired laying period at room temperature (22°C) before the
agar plate was exchanged. Embryos were rinsed with water and transferred using a large
paintbrush into a microsieve. The embryos were rinsed with water in the microsieeve to
remove yeast paste and then dechorionated in a freshly prepared 50% hypoclorite bleach
solution in dH20 for 4 minutes with gentle agitation. Bleach was removed by rinsing with
dFEO. Embryos were then transferred to a scintillation vial containing 4.5 ml of PBS.
1.25 ml of 37% formaldehyde (BDH) and 5 ml ofFIeptane were added into the
scintillation vial where embryos were floating between two phases of liquid. The vial
was shaken at room temperature on a shaker for 20 minutes. The lower formaldehyde
phase was removed after shaking without disturbing embryos and replaced with 10 ml of
methanol to remove the vitelline membrane. The vial was shaken vigorously and left to
stand upright for one minute. The devitellinised embryos, which had sedimented to the
bottom, were removed and transferred into a 1.5 ml Eppendorf tube. The embryos were
washed 5 times with fresh methanol with mixing to remove any remaining formaldehyde
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or heptane. Fixed embryos were stored in methanol at -20°C until required for
immunofluorescent.
For immunofluorescence, fixed embryos were rehydrated by performing five minute
washes in a series ofmethanol solutions as follows:
100% methanol





Non specific binding of antibody to embiyos were blocked by incubating in 1% BSA
in PBS for one hour with rotation. Excess BSA in PBS was removed by rinsing the
embryos in PBSTX with rotation 4 times for 15 minutes each. Embryos were then
incubated in primary antibody overnight at 4°C (e.g. VASA antibody 1:500 diluted in
PBSTx). Embryos were washed four times with PBSTx (15 minutes each) before
incubation for 2 hours at room temperature in the desired secondary antibody at a dilution
of 1:500 in PBSTx. After incubation, embryos were washed 4 times with PBSTx, 15
minutes each, including 0.1 pg/ml DAPI in the second last wash. Finally embryos were
transferred to a glass slide and mounted with Vectashield under a coverslip while the
edges were sealed by nail varnish.
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Microscopy
All slides were examined with an Olympus Provis microsope, equipped with
epifluorescence optics. Images were captured with an Orca II CCD camera (Hamamatsu)
and Smart-capture 2 software (Digital Scientific). All images were processed using
Adobe Photoshop software.
In vitro proteolysis of lamin by invadolysin
375 ng of lamin in T7-7 vector, DmIX-14 in pOT2 vector, or GFP control vector
were added to one 24-pl aliquot of the RTS 500 Escherichia coli Circular Template kit
(Roche). Each expression aliquot was incubated in a water bath at 30°C for 1 hour. 10 pi
of synthesized DmIX-14 was mixed with 1 or 4 pi of lamin Dmo or GFP before being
incubated in a water bath at either 29°C or 37 °C for 15 minutes, 50 minutes or 1 hour. In
some cases, the incubation was with ZnCl2 or ZnSCfi, or the zinc chelator 1,10-
phenanthroline. After the reaction, samples were boiled at 100°C for 5 minutes in SDS-
PAGE sample buffer. Lamin was detected after transfer to nitrocelluose and probing
with monoclonal antibody using an mAB gernerated to the Drosophila NFE-terminal
head region (amino acids 22-28) (Paul Fisher, SUNY Stong Brook).
Purification of DmIX-14 recombinant C-terminal fragment
125 ng ofPRSET vector (His tag at N-terminal) containing DmIX-14 C-terminal
fragment (amino acid 401-683) was transfected into 80 pi of BL21 cells. Colonies were
grew overnight on LB agar plate and selected by ampicillin resistant. BL21 cells
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containing this construct were grown to an OD600 of 0.5 before induction with 0.1 mM
IPTG for 3 h at 37°C. Cells were harvested by centrifugation at 2000 x g for 30 minutes
at 4°C. Pellets were washed once with 10 ml ofTEN and once with 5 ml Bugbuster
reagent (Novagen) /g cells containing 1 jj.1 Benzonase/ml. Supernatants were incubated
for 20 minutes at room temperature with shaking before centrifugation at 16,000 x g of
20 minutes at 4 °C. Pellets were resuspended at the same volume of Bugbuster reagent as
used previously with 20 mg/ml lysozyme and incubated for 5 minutes at room
temperature. 6 volumes of 1:10 diluted BugBuster reagent were added to the suspension
and vortexed for 1 minute. The pellet was centrifuged at 16,000 x g as above and washed
with 1/2 the original volume of 1:10 diluted BugBuster for 6 times. Pellets were
resuspended in Ni-NTA Binding buffer (50 mM NaH2P04 pH 8.0, 300 mM NaCl, 10 mM
imidazole) containing Ni-NTA His-Bind Resin at 4 ml lysate per 1 ml Resin. The
mixture were incubated at 4°C for 1 hour before loading onto a Poly-Prep
Chromatography columns (BioRad), then washed with 2 x 4 ml Ni-NTA washing buffer
(50 mM NaH2PC>4 pH 8.0, 300 mM NaCl, 20 mM imidazole). Finally, the protein was
eluted with 4 x 0.5 ml 0.1 mM MOPS, pH 7.5.
Binding of C-terminal fragment of DmIX-14 to Affigel
0.5 ml of each Bio-Rad affi-gel 10 and 15 beads were washed twice in 10 ml cold
dH20 before centrifugation at 600 x g at 4°C and resuspended in 10 ml cold dH20 again.
Beads were centrifuged and resuspended in 100 mM MOPS pH7.5. 1 ml of purified
protein (estimated 50 ug/ml) was added to the beads and incubated with gentle agitation
overnight. The next day, the beads were centrifuged and the supernatant decanted.
60
Beads were resuspended in 1 ml of 1M Ethanolamine, pH 8.0 and agitated for 1 hour at
4°C, before applying onto a Bio-Rad chromatography column. Columns were washed
twice with 5 ml TBS and stored at 4°C.
Affinity purification of antisera
Columns were washed with 5 ml TBS; 5 ml Tris-High Salt (20 mM Tris pH7.5, 500
mM NaCl); 5 ml 100 mM Glycine, pH 2.5; 5 ml 50 mM Tris pH 8.8; 5 ml 100 mM
Ethanolamine and 2 x 5 ml TBS. 1 ml of crude serum from rabbit R1318 (2rd bleed) was
diluted into 4 ml TBS and applied to the gravity fed column. The flow-through was
collected and re-applied to the column 3 more times. Columns were washed with 2x5
ml TBS and 5 ml Tris-High salt sequentially. The antibody was eluted with 0.5 ml
glycine pH 2.5 directly into 5 microfuge tubes containing 42 pi 1M Tris Base (pH 8.8)
and 50 pi 5mg/ml BSA.
Preparation ofAntigen for Injection
E. coli expressed and purified DmIX-14 C-terminal fragment in Ni-NTA Elution
Buffer (50 mM Na^PCU pH 8.0, 300 mM NaCl, 250 mM imidazole) was subjected to
12.5% SDS-PAGE. The gel was rinsed 3x10 minutes with distilled dH20 before
staining with Aqueous Coomassie Blue (0.1% Coomassie Blue in Laemmli running
buffer without SDS) for 1 hour. The gel was destained in 1X Laemmli running buffer
without SDS until a band was seen. The band was excised and ground to a fine powder
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in liquid nitrogen before being sent to Diagnostics Scotland Pentland Science Park for
injection into sheep.
Protein Expression using the Baculovirus system
Constructs to be expressed were cloned into the donor vector of the baculovirus
system (Invitrogen). 500 ng of recombinant construct were transfected into DH1 OBac by
electroporation. After the cells recovered by incubating in SOC medium for 45 minutes
at 37°C, they were spread out on LB plates contain 50 pg/ml Kanamycin, 7 pg/ml
gentamicin, 10 pg/ml tetracycline, 100 pg/ml X-gal, 40 pg/ml 1PTG and grew in 37 °C
incubator until blue and white selection could be performed (Blue is un-recombined
white is recombined). White colonies were selected and inserts were confirmed by single
colony PCR. Confirmed colonies were grown in 100 ml LB medium containing 50
pg/ml Kanamycin, 7 pg/ml gentamicin, 10 pg/ml tetracycline for midiprep. Bacmids
were extracted using the High Purity Plasmid midiprep system (Marligen Biosciences
Inc, Cat no. 11451-028) under manufacturer's instruction. Isolated bacmid was
tranfected into SF9 cells using Cellfectin Reagent (Invitrogen) as follows.
SF9 cells were seeded at 106 cells/ml in a 6-well plate (1 ml per well) in SF-900 II
Medium with L-Glutamine (Gibco) and grown at 27°C for 1 hour. 1 pg of bacmid DNA
was diluted in 100 pi of SF-900 II medium, and 6 pi of Cellfectin was diluted in 100 pi
of SF-900 II medium. Bacmid was combined with Cellfectin and incubated for 30
minutes at room temperature. Cells were washed with 2ml of SF-900 II medium before
the addition of the lipid:DNA in which 0.8 ml of SF-900 II had been added immediately
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before. Cells were incubated for 5 hours at 27°C before washing with 2 ml of SF-900 II
Medium with 10% FBS. Cells were then incubated at 27°C for 5 days when signs of viral
infection (cells became bigger and detached compared to control cells) became apparent.
Cells were harvested at 500 x g using a Biofuge Primo (Heraeus) and 1 ml of virus
containing supernatant was used to infect a larger culture of SF9 cells (20 ml at 106/ml).
When these infections were repeated 3 times, pfu (plaque forming units) were over 10x
pfu/ml. Virus titre was determined by adding 1ml of serially diluted virus into 1ml of
SF9 cells (106 cells /ml). After one week, the most diluted viral concentration causing
cell lysis was regard as pfu. Cells were collected to purified protein. 1 ml virus with pfu
titre greater than 108/ml was used to infect 30 ml SF9 cells at a concentration of 106
cells/ml. Upon signs of infection (2-3 days at 27°C), 10 ml of cells were harvested by
centrifugation at 500 x g. Pellets was resuspended in Lysis Buffer at a concentration of 5
x 106 cells/ml, incubated on ice for 30 minutes before centrifugation at 20,000 x g
(5417R, Eppendorf). The supernatant was incubated with Ni-NTA beads (extract of 5 x
106 cells per 100 pi) for 1 hour at 4°C and the resin mixture was loaded into a Poly-Prep
Chromatography Column (BioRad Cat. 731 -1550). The flow through was allowed to
bind 3 times. The column was washed with Washing Buffer (2 volume of flow through)
before elution by Elution Buffer (half volume of flow through). Elutions were collected 4
times. Beads were boiled in IX SDS-PAGE Sample Buffer (half volume of flow
through). All fractions were analysed by Immunoblotting and Coomassie Blue staining.
Lysis Buffer Washing Buffer Elution Buffer
Condition 1 50 mM Tris-HCl pH8.0,400
mM NaCl, 0.5% Deoxychola
1 x Lysis buffer. 1 x with washing buff
1: 50 mM Tris-HCL pH 8.0, 400 mM
10 mM Tris-HCl pH 7.5
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acid, 1%NP40, 1 pM/rnl
PMSF, lmg/CLAP, 1.7 pg/n
aprotinin
NaCl, 0.1%NP40, 1 pM/ml PMSF, 1
mg/ml CLAP, 1.7 pg/ml aprotinin. 1 x
with washing buffer 2: 10 mM Tris-HC]
pH 7.5, 150 mM NaCl, 0.1 pM/ml PMS
150 mM NaCl, 0.1 pg/n
PMSF, 250 mM Imidaz
Condition 2 10 mM Tris-HCl pH 8.0; 30C
mM NaCl; 10 mM NaF; 10
mM Na2HP04; 10 mM
NaH2P04; 1% Tnon X-100;
mg/ml CLAP; 1 mg/ml
aprotinin; 1.74 mg/ml PMSF
40 mM Tris-HCl pH 8.0; 260 mM NaCl
2% Triton-X 100; 10% glycerol
40 mM Tris-HCl pH 8.0
260 mM Nacl; 2% Trito
X 100; 10% Glycerol; 1
mM immidazole
Condition 3 50 mM Na2HP04 pH 8 0; 10
mM immidazole; 300 mM
NaCl; 1% Trion-X 100; 1 ml
DTT; 10 mM PMSF, 1 mg/n
CLAP; 1 mg/ml aprotinin
Washing buffer 1: 50 mM Na2HP04 pH
8.0; 300 mM NaCl; 1 mM DTT; 10 mM
lmmidazole. Washing buffer 2: 50 mM
Na2HP04 pH 8.0; 300 mM NaCl; 1 mM
DTT; 20 mM immidazole
50 mM Na2HP04 pH 8.1
300 mM NaCl; 1 mM
DTT; 200 mM
immidazole
Condition 4 50 mM NaH2P04, pH 8.0; 30
mM NaCl; 10 mM immidazo
1%NP40, 1 mg/ml CLAP; 1
mg/ml aprotinin; 1.74 mg/ml
PMSF
50 mM NaH2P04, pH 8.0; 300 mM NaC
20 mM immidazole
50m M NaH2P04, pH 8.




100 mM NaFI2P04, 10 mM
Tris-HCl, 8 M Urea; final pF
8.0
100 mM NaH2P04, 10 mM Tris-HCl, 8
Urea; final pH 6.3
Elution buffer 1: 100 ml
NaH2P04, 10 mM Tris-
Hcl, 8 M Urea; final pH
5.9. Elution buffer 2: 1(
mM NaH2P04, 10 mM
Tris-Hcl, 8 M Urea, lint
pH 4.5.
Purification of Recombinant DmIX-14 from SF9 cells
0.5 ml of chelating Sepharose Fast Flow (Amersham) was washed 5 times in 2.5 ml
of dH20 by centrifugation at 500 x g for 5 minutes. Beads were resuspended in 0.25 ml
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0.1 M Z11SO4 and incubated for 5 minutes with shaking at room temperature. Beads were
then washed 3 times with 2.5 ml dH20 each before incubation with 0.5 ml SF9 cells in
Lysis Buffer described above at a concentration 5 x 106 cells/ ml for 30 minutes at room
temperature. Beads were washed 3 times with 2.5 ml PBS pH 7.4 before elution with 1
ml Elution Buffer (PBS pH7.4, 50 mM EDTA ) passed over the beads 4 times.
Pichia Pastoris Genomic DNA Extraction
Fresh (just after grown in the incubator, had not stored in fridge) single yeast colony
was inoculated into 2 ml YPDA and grown overnight at 30°C with shaking. The next
day, 1.5 ml of culture was pelleted in an Eppendorf tube by spinning at 13,000 rpm for 1
minute in a bench centrifuge Biofuge 13 (Heraeus Instruments) at room temperature. (All
the following spins were done at this speed and temperature.) Each yeast pellet was then
resuspended in 200 pi of Lysis Buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10
mM Tris, pH 8.0, 1 mM EDTA) with 200 pi ofglass beads. Then 200 pi of
Phenol/CHCft/IAA (25 : 24 : 1) was added before vortexing the tube for 5 minutes. The
tube was then centrifuged for 5 minutes and the upper phase was transfer into a new tube.
100 pi of Chloroform was added before vortexing the tube for 30 seconds. The tube was
then spun for 2 minutes and the upper phase was transferred to a new tube. 2.5 volumes
of 100% ethanol was added to precipitate the DNA before the tube was spun for 5
minutes. 300 pi of 70% ethanol was added to wash the DNA and DNA was pelleted
again by spinning for 3 minutes. The pellet was dried for 5 minutes at room temperature
before being resuspended in 50 pi TE.
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Chemical transformation into Pichia pastoris
Pichia pastoris strain KM71H was inoculated into 10 ml ofYPDA medium and
grown overnight at 30°C with shaking. A 100 ml logarithmic growing culture derived
from this culture were harvested at an OD600 of 1.0 by 800 x g 5 minutes, washed once
in 10 ml water, and once in 1.5 ml 100 mM CH3COOLi (Lithium acetate) before
resuspending in 250 pi 100 mM LiAc. 50 pi of cell suspension was incubated with 10 pi
linearised plasmid (1.5 pg), 240 pi 50% PEG3350 and water to give a final volume of
360pl. The mixture was incubated at 30°C for 30 minutes before a 15 minute 42°C heat
shock. Cells were centrifuged in a microfuge (Picofuge, Stratagen) for 5 seconds. Cells
were then resuspended in 200 pi ofYPDA medium and grown for 2 hours at 30°C to give
enough time for the cells to express antibiotic resistance gene. Then a serial dilution of
cells was spread onto YPDA plate with appropriate antibiotic and incubated for 2-3 days
at 30°C when large colonies could be observed.
Electroporation Transformation into Pichia pastoris
Pichiapastoris cells (100 ml) were grown to an OD600 between 0.25 and 0.5
(between 5 x 106/ml and lx 107 cells/ml). They were harvested by spinning at 4000 rpm
(800 x g) for 5 minutes at room temperature in a Megafuge 1 .OR centrifuge (Heraeus).
The pellet was resuspended in 20 ml of ice cold 1.2 M sorbitol and transferred to a 50 ml
falcon tube. The cells were harvested by centrifugation as above. The pellet was
resuspended in 10 ml ice cold 1.2 M sorbitol and harvested by centrifugation as above.
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The resuspension steps were repeated twice. After centrifugation, the pellet was
resuspended in 1.2 M sorbitol to give a concentration of lx 109/ml. The cells were
divided into 200 pi aliquots and mixed with 50 ng ofDNA per aliquot. After mixing
with DNA, the cells were immediately electroporated, using settings of 2.25 kilovolts,
200 Ohms and 25 pF. 1 ml ofYPDA medium was added after electroporation. Cultures
were grown for two hours to allow expression of antibiotic before different dilutions of
cells were spread on selective medium plates. Plates were incubated at 30°C for 2-5 days
before transformants appeared.
Expression of Recombinant Pichia pastoris strains
After the appropriate construct had been transfected into KM71H Pichia strain,
recombinant colonies was validated by PCR from yeast genomic DNA. Confirmed
recombinant colonies or control colonies were inoculated into 100 ml ofBMG or BMGY
in a 1 litre flask and grown at 30°C in a shaking incubator (250 lpm) until the culture
reached an OD6oo between 2 and 6. Cells were harvested by centrifuging at 1800 x g for
5 minutes at room temperature using a Megafuge 1 .OR centrifuge (Heraeus). To induce
expression, the cell pellet was resuspended in methanol inducing medium BMM or
BMMY in 1/5 of the original culture volume. The culture was then grown at the
conditions as above in a 100 ml flask. At time points (0, 12, 24, 48, 72, 96 hours), 1 ml
of culture was taken and centrifuged at 10,000 x g to separately save the supernatant and
pellet in -80°C. Methanol was added every 24 hours to maintain a final concentration of
0.5% for keeping induction. To test the expression level, the supernatant from each time
point was directly loaded on a SDS-PAGE gel or after concentration for Coomassie
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staining or immunoblotting. On the other hand, the pellets from each time point were
processed as below:
Cell pellets were quickly thawed and placed on ice. 100 pi of Breaking Buffer (50
mM sodium phosphate, pH 7.4, 1 mM EDTA, 5% glycerol, 1 mM PMSF, 1 pg/ml CLAP,
1.7 pg/ml aprotinin) per 1 ml sample was added to resuspend the pellet. The equal
volume of acid-washed glass beads (size 0.5 mm) was added. The mixture was then
vortexed for 30 seconds, then incubated on ice for 30 seconds (This was repeated 8 times
more). The tube was then centrifuged at 13,000 rpm for 10 minutes at 4°C using a bench
centrifuge Biofuge 13 (Heraeus). The supernatant was loaded on a SDS-PAGE gel for
Coomassie staining or immunoblotting. The debris was loaded on a SDS-PAGE gel after
the boiling and sonicating in SDS-PAGE sample buffer.
68
2.4 Table ofOligonucleotide primers
1. Primers for HsIX-14
Figure 2.4, panel A






2. Primers for DmIX-14
Figure 2.4, panel B
Primer name Primer Sequence































Figure 2.4A: Primer placement in human and Drosophila IX-14.
A: The primers for HsIX-14 and their relevant placements to HsIX-14 ORF.
B: The primers for DmIX-14 and primers around 37 amino acid insertion and
their relevant placements to DmIX-14 cDNA. The orange block shows the
ORF ofDmIX-14. All the arrows show the direction of the primers and the




3. Primers around 37 amino acid insertion to perform RT-PCR
Figure 2.4A, Panel B






4. Primers to construct Donor vectors containing DmIX-14 fragments
for Baculovirus system expression
Primer Name Primer sequence





IX-140RFXbaI lower 5' -GCTCTAGATTTGTGCGAAGTGGATACGA-3'
IX-140RFXbaIlower 5' -AATCTAGACGGTAAATATCCGAGGACACACT-3'











5. Primers for baculovirus system
Primer name Primer sequecne
PFastBacTMHTAseq 5' -AGTGGTTCGCATCCTCGGTTTTCT-3'
Ml3 Forward 5'-CGTTGTAAAACGACGGCCAGT-3'
Ml3 Reverse 5' -TTTCACACAGGAAACAGCTATCAC-3'
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6. Primers to construct Pichia expression vector containing DmIX-14
fragments.
Primer name Primer sequence
PichiaPsec 16upper 5' -ACCCAGACACTCGACAAACC-3'




Chapter 3: Characterisation of the Invadolysin
phenotype
3.1 Mitotic arrest reveals a chromosome structure defect
in IX-14 mutant neuroblasts.
Colchicine is a well-known microtubule-depolymerizing drug that inhibits the
assembly of the spindle, and consequently activates the mitotic spindle checkpoint that
arrests cell division at metaphase (Rieder and Palazzo 1992). There is no report claim
that colchicines have direct effect on chromosome condensation or chromosome
structure.
I first tested the effect of colchicine by examining the microtubules of wild type cells
with and without colchicine treatment. As shown in Figure 3.1 A, microtubules in the
colchicine treated cells were depolymerized compared to the control microtubules.
Comparing the chromosomes ofwild type neuroblasts (with and without colchicine
treatment), to mutant neuroblasts (with and without colchicine treatment), it is evident
that mitotic arrest gives the wild type chromosomes the chance to hypercondense (Figure
3.IB). But it is different from the appearance that the IX-14 mutant gives, since although
the chromosomes of the IX-14 mutant are also hypercondensed in length, chromosomes
appear 'loosely' condensed at the edge of hypercondensed mitotic chromosomes (Figure
3.1C). Moreover, colchicine can not make the mutant chromosomes condense further, in







Comparison of the microtubules ofwild type neuroblasts treated with and
without colchicine. Green is tubulin, red is P~H3 and blue is DAPI. The
microtubules obviously depolymerized (no individual filament could be seen)



















Figure 3.1B: Comparison of wild type and IX-14 mutant
neuroblasts with and without colchicine treatment.
Colchicine gives wild type cells a hyper-condensation phenotype (compare -
col and +col columns) and can not condense the mutant further (compare -col
and +col columns). The phenotype given by colchicine is different from that
given by the IX-14 mutant, since there is loosely condensed chromatin
surrounding the hypercondensed chromosomes in the IX-14 mutant, but not in
wild type cells (compare wild type +col column and mutant -col columns).
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Figure 3.1C: Enlarged view of loosely condensed chromatin.
These are enlarged images ofwild type and mutant with or without colchicine
treatment to highlight the loosely condensed chromatin present in mitotic
mutant cells.
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mutants have an intrinsic chromosome structure defect that can not be rescued by simply
spending more time in mitosis.
Mitotic arrest was confirmed in the mutant by determining the percentage in each of
the five stages (late G2, prophase, prometaphase/metaphase, anaphase and telophase)
included in P~H3 positive cells in wild type and mutant neuroblasts. Since no anaphase
or telophase figures were found in the mutant neuroblasts, and the percentage of
metaphase figures in the mutant is higher than in wild type, we suggest a mitotic arrest in
the mutant (Figure 3.ID).
3.2 Lamin DmO, otefin and lamin A/C increase in IX-14
mutant neuroblasts.
The nuclear envelope is composed ofnuclear membranes, nuclear pore complex, and
the nuclear lamina. The nuclear membranes are divided into three morphologically
distinct but interconnected domains: outer nuclear membrane, inner nuclear membrane
and nuclear pore membranes. Pore membranes connect the inner and outer nuclear
membranes at numerous points and are associated with nuclear pore complex (Worman
and Courvalin 2005). The nuclear lamina was first described as a fibrous structure
underlying the inner nuclear membrane in vertebrate cells, taking observed by electron
microscopy (Fawcett 1966). Interphase lamina is associated with nuclear pore complexes
and three major bands had been isolated from the pore complex-lamina fraction which are
components of the lamina (Dwyer and Blobel 1976). These components were further
confirmed by raising antibodies against them and observing their localizations (Gerace,
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Percentage of P~H3 positive cells in indicated phases
G1 S G2 Mitosis
Wild type 45.1% 39% 13.4% 2.5%
mutant 77.3% 11.5% 5.4% 5.8%

























Late G2 Prophase Prom®taPhase / Anaphase Telophasemetaphase
Figure 3.1 D: Quantitation of different stages in cell cycle in
wild type and IX-14 mutant neuroblasts.
IX-14 mutant cells are arrested in metaphase since a higher percentage of
prometaphase/metaphase cells appeared in the IX-14 mutant and no anaphase
or telophase were observed.
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Blum et al. 1978) and named lamin A, lamin B and lamin C (Gerace and Blobel 1980).
The nuclear lamina undergoes reversible depolymerization during cell division, a process
that is believed to result from reversible enzymatic phosphorylation (Gerace and Blobel
1980). A decade later, accompanying papers were published to describe specific mitotic
phosphorylation sites that are associated with lamina disassembly. Cdc2 kinase was
reported to phosphorylate lamin B at its N-terminus which result in its depolymerization
during mitosis (Peter, Nakagawa et al. 1990). Lamin C was shown to have
phosphorylation sites in its N-terminal and C-terminal, which are conserved in different
organisms. S6 kinase II phosphorylates lamin C at Ser-404 (Ward and Kirschner 1990).
Mutation of two conserved phosphorylation sites (Ser-22 and Ser 392) in lamin A blocks
the disassembly of lamina in an overwhelming majority ofmitotic cells (Heald and
McKeon 1990). Lamin proteins were shown to belong to the intermediated filament
family by both morphological (Aebi, Cohn et al. 1986) and biochemical evidence
(Goldman, Maul et al. 1986). The complete nucleotide sequence of the coding region of
the A and C lamins shows striking homology with the entire family of cytoplasmic
intermediate filament protein (McKeon, Kirschner et al. 1986) which further verifies this
hypothesis. Lamins contain head and tail domains of variable structure and conserved
alpha-helical central rod domain and polymerise to form filaments approximately 10 nm
in diameter, like other cytoplasmic intermediate filaments (Herrmann and Aebi 2004).
Lamins have orthologs in several eukaryotic species, but not in yeast. In human, there
are three genes encode nuclear lamins which is LMNA (Lin and Worman 1993) , LMNB1
(Lin and Worman 1995) and LMB2 (Biamonti, Giacca et al. 1992). Lamin A and C are
raised by alternative splicing ofmRNA encoded by LMNA while lamin B1 and lamin B2
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are encoded by LMNB1 and LMNB2 individually. Except for lamin C, lamins contain
CAAX boxes in which A is an aliphatic-hydrophobic residue and X is generally S, M, C,
A, or Q. Lamin B post-translational modification includes farnesylation of the cysteine
residue in CAAX box, removal of the AAX tripeptide and subsequent methylation of the
now carboxyl-terminal cysteine (Farnsworth, Wolda et al. 1989). Lamin A maturation
also has the three sequential post-translational modifications as lamin B, but differ in that
the C-terminus (the farnesylated, methylated cysteine) of the prelamin A molecule is
removed from the mature protein (Sinensky, Fentle et al. 1994) (Weber, Plessmann et al.
1989). This molecular difference between mature lamins A and B might account for the
observation that all cells express lamin B, while lamin A expression to be reserved to
cells of differentiated tissues (Lehner, Stick et al. 1987) (Stewart and Burke 1987). Two
lamin genes appear in Drosophila: one encodes a B-type lamin, termed Lamin DmO and
the other encodes an A-type lamin, termed lamin C (Gruenbaum, Landesman et al. 1988)
(Bossie and Sanders 1993).
Brian McHugh discovered a novel phenotype of IX-14 mutants, that being an
increase in lamin DmO levels in some mitotic cells (McHugh, Krause et al. 2004). This
may be because lamin DmO is a substrate of IX-14. In the null mutant of IX-14, where
there is no detectable IX-14 metalloprotease activity, lamin DmO protein accumulates.
Figure 3.2A shows the co-staining of lamin DmO and P~H3 in wild type and IX-144Y7
neuroblasts. Compared to interphase cells, lamin DmO disperses in mitotic cells in wild
type but increases in some mitotic cells in mutant neuroblasts.
Extracts were prepared from brains dissected from 3rd instar larvae ofwild type and
IX-14 mutants. Two wild type brains or 6 mutant brains (since the mutant brains are
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Figure 3.2A: Co-stain lamin DmO with P~H3 on neuroblasts.
Analysis of the level of lamin DmO in mitosis by co-staining lamin DmO with
P~H3. While lamin DmO seems to disperse (yellow arrow) in mitosis in wild
type (A column), it increases dramatically (yellow arrowhead) in IX-14 mutant
mitotic cells (B column). The lamin DmO increase was also found in some
mutant cells which are P~H3 negative, indicating interphase cell (C column).
DNA (DAPI) is in blue, P~H3 is in red and lamin DmO is in green.
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much smaller than wild type brains) were loaded per lane for SDS-PAGE analysis. The
gel was transferred to nitrocellulose membrane and probed for Lamin DmO antibody.
Lamin DmO was found to be increased in the mutant brain extracts compared to wild
type. Tubulin was used as a loading control (Figure 3.2B, Panel A and B). Figure 3.2C
shows the densitometric analysi of lamin using Image J. Sample loading difference was
compensate by comparing the Integrated Density ofwild type lamin band divided by
tubulin band with Integrated Density ofmutant lamin band divided by tubulin band. It
shows that lamin increase in invadolysin mutant 1.88, 1.6 and 2.22 times than in wild
type in three individual experiments.
To rule out the possibility that the lamin DmO increase was due simply to a mitotic
arrest, wild type brains were incubated in Schneider's medium with colchicine at 2 mg/ml
for 2 hours before preparing protein extract. Control brains were incubated in
Schneider's medium for 2 hours with no colchicine. Then proteins in the control and
colchicine-treated brain extracts were resolved by SDS-PAGE and protein was
transferred to nitrocellulose. Lamin DmO was detected by immunoblotting. As shown in
Figure 3.2B (Panel C), lamin DmO did not increase in colchicine-treated wild type brain
extracts compared to control brain extracts. Some brains, both -col and +col, were
prepared for immunofluorescence with DAPI staining to examine the mitotic arrest. The
mitotic index in control neuroblasts was 1% compare to 3.2% in colchicine-treated
brains. Therefore the lamin DmO increase was due to the 1X-14 mutation, not solely
mitotic arrest.
I was interested to see whether other nuclear envelope proteins might increase in IX-






























Figure 3.2B: Immunoblotting shows lamin DmO increases in
IX-14 neuroblasts and it is not due solely to mitotic arrest.
A: Immunoblotting for lamin DmO on wild type and mutant brain extracts. An
expected 71 kDa (size of lamin DmO) band can be seen in both the wild type
and the mutant. However, the band in the wild type is obviously weaker than
in the mutant. B: Using a-tubulin as a loading control for A. C: Lamin DmO
does not increase in wild type Drosophila neuroblasts treated with colchicine.
In colchicine treated brains (+col), lamin DmO signal is the same density to




lamin-wt 1087320 837165 19635
lamin-mut 1604460 1444830 58905
tubulin-wt 1365270 1198245 1495830
tubulin-mut 1078905 1292340 2016795
lamin mut/wt 1.4756 1.7285 3
tubulin mut/wt 0.7902 1.0785 1.3483
mut(lamin/tubulin) 1.4871 1.118 0.0292






otefin-mut 622455 13005 |
tubulin-wt 1635825 51765
tubulin-mut 1336710 57375
otefin mut/wt 7.7987 6.375










Figure 3.2C: Densitometric analysi of lamin and otefin increase.
Panal A shows the Integrated Density (the sum of the values of the pixels in the
selected band) of tubulin, lamin or otefin band (both wild type and mutant) from
immunoblotting film. The analysis was done using Image J and a threshold has
been set for the calculated pixels to segment the image into features of interested
and background. Lamin increase was analysed in 3 individual experiment and
otefin increase was analysed in 2 individual experiments. Panel B left shows the
graph of Integrated Density of lamin/tubulin in wild type and mutant. Panel B
right shows the graph of Integrated Density otefin/tubulin ofwild type and
mutant.
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mutant neuroblasts. Otefin is a nuclear envelope protein localized to the periphery of the
nucleus (Harel, Zlotkin et al. 1989), and co-localizes with lamin DmO in situ. It is present
in all somatic cells during Drosophila development. It plays an essential role in
Drosophila nuclear envelope assembly and is phosphorylated by cdc2 kinase at serine 36
(Ashery-Padan, Ulitzur et al. 1997). Otefin was shown to interact with lamin DmO in a
two hybrid screen (Goldberg, Lu et al. 1998). Figure 3.2D shows that otefin, like lamin
DmO, disperses during mitosis in wild type, whereas some IX-14 mutant mitotic cells
show an increase in otefin.
To discern whether the otefin increase happens in the same cells as the observed
DmO increase, co-staining for otefin and lamin DmO was performed in wild type and
mutant neuroblasts. As shown in Figure 3.2E, otefin and lamin DmO significantly
accumulate in the same mutant cells. Immuoblotting of neuroblasts shows an otefin
increase in IX-14 mutant compared to wild type neuroblasts (Figure 3.2F). Figure 3.2C
shows the densitometric analysi using the same method as analysis lamin increase. From
2 indivitual experiments, it shows otefin level increase 9.88 and 5.75 times in invadolysin
mutant than in wild type.
In addition to the B-type lamin, lamin DmO, Drosophila also has an A-type (lamin
C). I was interested to see whether it also was elevated in level in IX-14 mutant
neuroblasts. Figure 3.2F showed the immunoblot of lamin A/C antibody on wild type
and mutant neuroblasts. Lamin A/C increased in the mutant in the same manner as



































Figure 3.2D: Otefin increases in IX-14 mutant neuroblasts.
Co-staining of otefin and P~H3 in wild type and mutant neuroblasts.
Otefin disperses like lamin DmO in mitosis in wild type cells








Figure 3.2E: Otefin increases in the same cells that lamin
DmO increases in.
Co-staining of lamin DmO and otefin. When lamin DmO disperses in a
mitotic wild type cell, otefin disperses as well (arrowheads). When
lamin DmO increases in a mutant cell, otefin increases as well (arrows).
Wild type IX-144Y7
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Figure 3.2F: Otefin and lamin C accumulate in IX-14 mutant
neuroblast.
A: Immunoblotting for otefin on wild type and mutant brain extracts. An
expected 46 kDa band (size of otefin) was seen in IX-14 mutant. In the same
way as for lamin DmO, the band in the wild type is much weaker (hardly see
anything) than in the mutant. B: Using a-tubulin as a loading control for A,
indicating sample are equally loaded. Two wild type brains or 6 mutant
brains were loaded in each lane. C: Wild type and IX-14 mutant neuroblasts
were probed for antibody against lamin C. Lamin C increased in mutant
brains compare to wild type. D: The a-tubulin loading control for lamin C
probed in panel C.
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3.3 Lamin increase is not cell cycle dependent.
I found that lamin DmO was increased in some mutant cells that are P~H3 negative,
which indicates they are not in G2 or mitosis (Figure 3.2A). Compared with the 5.8 % of
P~H3 positive cells in the whole population of IX-14 mutant neuroblasts (Figure 3.3A),
in neuroblasts showing lamin DmO increase, 37.9% of them were P~H3 positive while
62.1% of them were P~H3 negative (Figure 3.3B). This resemble a significant
accumulation of lamin in mitosis
It is logical to ask when might the lamin DmO increase happens? To answer this
question, 1 co-stained wild type and IX-14 mutant neuroblasts for lamin DmO and
incorporated BrdU or cyclin B. BrdU is a thymidine analogue incorporated into DNA
during replication that can be detected with an antibody, used it as an S-phase indicator.
Cyclin B is synthesized in S/G2 phase and destroyed following the completion of
chromosome attachment to the spindle. Since I can distinguish cells in G2 from those in
mitosis using DAPI staining, I used Cyclin B as a G2 and early mitosis indicator. What I
found was that 7.8% ofwild type cells were BrdU positive after 2 hour BrdU
incorporation, while only 2.3% ofmutant cells were BrdU positive (Figure 3.3A). The
lower percentage of BrdU incorporation indicates a cell cycle delay (other than S phase)
in terms of pulse versus postion. But, replication defect could not be claimed in the IX-14
mutant neuroblasts since it is possible that less cell enter into S phase due to the cell cycle
delay. Lamin has been reported involved in DNA replication but at which stage of
replication lamin play a role remains controversial. Ellis has reported lamin filament
assembly is required for the formation but not for the maintenece of replication center
(Ellis, Jenkins et al. 1997). On the other hand Spann and Goldman argue that the factors
90








Brdll P~H3 Cyclin B
Figure 3.3A: Overall percentage of BrdU, P~H3 and Cyclin B
in total population of wild type and mutant neuroblasts.
In the total population ofwild type and IX-14 mutant neuroblasts, a higher
percentage ofmutant cells (5.8% out of 1112) were in mitosis than in wild
type (2.5% out of 627). A lower percentage ofmutant cells (2.3% out of
1430) were in S phase than in wild type (7.8% out 2365). Mutant cells has








BrdU P~H3 Cyclin B
Figure 3.3B: When does the increase in lamin DmO occur.
Lamin DmO was co-stained with cell cycle markers such as P-H3, BrdU or
Cyclin B on IX-14 mutant neuroblasts to elucidate when the lamin DmO
increase occurred. Out of all the cells sharing elevated levels of lamin
DmO in IX-14 mutant, 37.9% are P-H3 positive, 0% are BrdU positive,
22.2% are cyclin B positive.
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necessary for initiation phase ofDNA replication such as DNA polymerase and ORC was
not affect when lamin organization was disrupted but factor necessary for DNA
elongation like PCNA and RFC were affected instead (Spann, Moir et al. 1997). Figure
3.3C-D showed the BrdU and lamin DmO co-staining in wild type (3.2C) and mutant
(3.2D) neuroblasts. And of all 33 BrdU-positive cells in the mutant, none of them had
elevated lamin DmO, and 2 lamin DmO elevated cells were BrdU-negative. Figure 3.2D
shows images of lamin DmO and Cyclin B co-staining. Eighteen lamin DmO elevated
cells were found, 4 ofwhich were cyclin B-positive (22.2%) (Figure 3.3E). IX-14 mutant
neuroblasts have less Cyclin-B signal compare to wild type (Figure 3.3A and Brian
McHugh, personal communication). So, the lamin DmO increase seems to take place
after replication. Cyclin B negative cells with lamin accumulation could be in early G2, if
not in G1 nor S phase.
3.4 Summary.
The first part of this chapter has reported the mitotic chromosome structure defect of
IX-14 mutants, the appearance differs from colchicine treated mitotic arrest in wild type
cells. A periphery of loosely or poorly condensed chromatin is surrounding the
hypercondensed chromosome in IX-14 mutant. In the following part of this chapter, three
nuclear envelope protein (lamin DmO, otefin and lamin A/C) were seen to be elevated in
level by both immunoblotting and immunofluorescence. Lamin DmO was further
characterized by its increasing time. However, lamin increase does not seem to correlate
with a particular stage in the cell cycle. Thus it is worthy to do histology to address




Figure 3.3C: Co-staining of BrdU with lamin DmO on wild type
neuroblasts.
The arrow head indicates cells which are BrdU positive. DNA is in blue, BrdU
is in red and lamin DmO is in green. I found 184 out of 2365 cells (7.8%) were
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Figure 3.3D: Co-staining of BrdU and lamin DmO in IX-144Y7
neuroblasts.
The arrow indicates cell which has increased lamin DmO staining and are BrdU
negative while the arrowhead indicate cells positive for BrdU (have the normal
level of lamin DmO). I found 33 out of 1430 cells (2.3%) which had normal
level of lamin DmO were BrdU positive. In this experiment, 1 only found two
cells which had elevated lamin DmO levels, both ofwhich were BrdU
negative.
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Merge Cyclin B Lamin DmO DAPI
IX-14
Mutant
Figure 3.3E: Co-staining for Cyclin B with lamin DmO in wild
type and mutant neuroblasts.
The arrowhead indicates lamin DmO elevated cells in the mutant. In the IX-14
mutant images, the top panel shows lamin DmO increase cell in early mitosis
indicated by the positive cyclin B signal and already condensed chromosome.
The middle panel shows Lamin DmO increase cell in early G2 indicated by the
positive cyclin B signal and interphase chromosome. The bottom panel shows
lamin DmO increase cell in phase other than early G2 and mitosis indicated by
the negative cyclin B signal. 22.2% (4/18) of lamin DmO increased cells were
cyclin B positive. The percentage of cyclin B positive cells in the overall
mutant neuroblasts was 5.4% (29 of 539).
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larvar brain comprises cellular cortex that surrounds a central neuropile. The glials
sheaths envelope the cortex surface that include surface glial, cortex glial and neuropile
glial. The central neuropile is formed by two structural elements: long axon tracts and
terminal axon tracts (Younossi-Hartenstein, Salvaterra et al. 2003). It would be interested
to know whether lamin increase was limit to any of those histological cells.
However, there are limitations of using immunofuluorescence for studies of lamin
level. 32 lamin proteins were in cross-section of lamin intermediate filament that
assembly together under nuclear envelope. Not all epitopes are exposed to antibody.
Lamin increase could be observed without actual increased in lamin level when 1) an
increase of percentage of phosphorylated lamin (for example by CDKl-cyclinB or by
protein kinase C) resulted in disaseembling of lamin from filaments which in turn
exposing more epitopes to the antibody. 2) a lamin partner protein (such as LBR) is
degraded that also result in increasing lamin epitope accessibility. The second
possibility is less likely since the lamin staining was also more diffuse, which would be
more consistent with the first possibility. Thus the immunoblot data is the only clear
data to support lamin increase in this chapter.
Cyclin B was used to distinguish cell in G2 phase, interestingly I found its level is
decrease in IX-14 mutant.
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Chapter 4: Germ Cell Migration defect
4.1 Vasa staining of IX-14 heterozygous embryos to exam
germ cells.
IX-14 has a cytoplasmic localization pattern indicated by antibody staining as ring¬
like structures in HeLa cells. In migrating macrophages stained with the IX-14 antibody,
the majority of the protein was observed at the leading edge ofmigrating macrophages.
This indicates that IX-14 might have a role in cell migration in addition to its role in
mitosis. In order to verify this hypothesis, migrating cells in developing Drosophila
embryos was examined. The best candidate migrating cells in Drosophila embryos are
the pole cells, the precursor cells of the gonads. Furthermore, gonads were previously not
observed in third instar larvae of IX-141/IX-14' and IX-144Y7/IX-144Y7 which may indicate
a defect in germ cell migration. Pole cells, the progenitors of the germ line, form at the
posterior end ofDrosophila embryo from a region of specialized cytoplasm rich in
ribonucleoprotein particles termed polar granules (Mahowald 1968). The posterior polar
plasm, germinal plasm, is essential for pole cell formation since transferring this
particular kind of cytoplasm to a new region of the embryo results in an induction of cells
functioning as primordial germ cells in these regions (Illmensee, Mahowald et al. 1974).
The Vasa protein is localized to the posterior pole of the Drosophila embryo and is a
component of the polar granules. The sequence of the Vasa protein suggests that it may
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be an RNA binding helicase involved in the function of the posterior determinant system.
Vasa protein is present in Drosophila germ cells throughout development (Hay,
Ackerman et al. 1988a) (Hay, Jan et al. 1988b), thus have been widely used in many
animals as germ cell markers (Matova and Cooley 2001). Absence ofVasa during
embryogenesis leads to abdominal defects and the failure to form pole cells (Schupbach
and Wieschaus 1986). A rabbit polyclonal antibody has been raised against amino acid
16-433 of the Vasa protein (Lasko and Ashbumer 1990).
Drosophila embryo development could be divided into 16 stages according to their
morphology (Roberts, Grigliatti et al. 1986) (Hartenstein 1993). Canton S (wild type),
IX-144Y7/TM6B flies were collected overnight to obtain all stages ofembiyonic
development. Figure 4.1A-4.1E shows wild type and IX-14 mutant embryos from stage 1
to stage 14 stained with DAPI and the Vasa antibody. All the timings mentioned below
are the approximate time of growth taken to reach each stage at room temperature (22°C).
In stage one (0-15 min), the embryo has just been freshly laid and the cytoplasm of the
embryo is homogeneous. In stage two (15 min to 1 h and 20 min), more nuclei were
visible by DAPI staining with the early rounds of syncytial divisions occur. A cap of
clear cytoplasm becomes visible at the posterior pole. In stage three (1 h 20 min to 1 h 30
min), more nuclei are present from further divisions, and the nuclei migrate to the cortex
of the embryo. Then the pole cells stand out from the surface of the posterior pole of the
embryo. In stage four (1 h 30 min to 2 h 30 min), syncytial division is continuous and the
cortical cytoplasm become thicker and distinct from the underlying yolk. In stage five (2
h 30 min to 3 h 15 min), the syncytial rounds of division finish. The nuclei elongate and












Figure 4.1A: Image of wild type and IX-14 homozygous mutant
embryos (Stage 1 to Stage 3)
Wild type and IX-14 mutant embryos from stage 1- stage 3 stained with DAPI
and VASA. Germ cells labelled by VASA are initially formed during stage 3 at












Figure 4.1 B: Image of wild type and IX-14 homozygous
mutant embryos (Stage 4 to Stage 6)
Wild type and IX-14 mutant embryos from stage 4- stage 6 stained with
DAPI and VASA. Germ cells labelled by VASA forming an obvious cluster
of 34-37 cells by stage 5. From stage 6, germ cells move with the midgut
invagination.
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embryo. In stage six (3 h 15 min to 3 h 35 min), gastrulation begins as soon as the cells
on the ventral side of the embryo complete cellularization. A ventral furrow forms as a
longitudinal cleft along the ventral midline of embryo. Pole cells migrate dorsally at this
stage. In stage seven (3 h 35 min to 3 h 45 min), the posterior midgut is parallel to the
long axis of the embiyo and the pole cells are migrated to the dorsal side of the embryo.
In stage eight (3 h 45 min to 4 h 30 min), the posterior midgut invagination is still at the
posterior dorsal region of the embryo, carrying poles cells into the lumen of the midgut.
In stage nine (4h 30 min to 5 h 10 min), the gut opening has reached the head region
about two-thirds of the embryo length. Pole cells were still stayed in the lumen of the
posterior midgut rudiment. In stage ten (5 h 10 min to 6 h 50 min), foregut invagination
occurs, and invagination moves posteriorly. Pole cells are still associated with the
posterior midgut invagination. In stage 11 (6 h 50 min to 9 h), the defined segments of
the developing embryo are visible, the anterior midgut has flattened and grown along the
ventral germ band. The posterior midgut moves along the dorsal side of the germ band.
Pole cells begin to pass through the posterior midgut and become located between the
dorsal surface of the posterior midgut rudiment and the mesoderm. In stage 12 ( 9 h to 10
h 30 min), the germ band contracts, and the posterior gut opening moves posteriorly. The
pole cells begin to form clusters on either side of the embryo. This cluster is in close to a
set ofmesoderm cells that will later give rise to the gonad sheath. In stage 13 (10 h 30
min to 11 h 30 min), the germ band is completely retracted. Three Thoracic (T) segments
and nine Abdominal (A) segments can be observed easily. The pole cells form as two












Figure 4.1C: Image of wild type and IX-14 homozygous
mutant embryos (Stage 7 to Stage 9)
Wild type and IX-14 mutant embryos from stage 7- stage 9 stained with
DAPI and VASA. Germ cells labelled with VASA antibody migrate into the















Figure 4.1D: Image of wild type and IX-14 homozygous
mutant embryos (Stage 9 to Stage 12)
Wild type and IX-14 mutant embryos from stage 10- stage 12 stained with
DAPI and VASA. In stage 10, germ cells begin to migrate out of the
midgut rudiment while in stage 11 they migrate dorsally. At stage 12 and,










Figure 4. IE: Image of wild type and IX-14 homozygous mutant
embryos (Stage 13 to Stage 14)
Wild type and IX-14 mutant embryos from stage 13- stage 14 stained with
DAPI and VASA. At stage stage 13, the pole cells form an elongated cluster
on either side of the embryo. Finally germ cells and surrounding mesodermal
sheath cells form the gonads at stage 14.
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involution can be observed and the pole cells and surrounding mesodermal sheath cells
form the gonads.
Embryos laid by IX-144Y7/TM6B heterozygotes will be a mixture of the following
genotypes: IX-144Y7/IX-144Y7 (3rd instar lethal), IX-144Y7/TM6B (viable), TM6B/TM6B
(embryonic lethal). These embryos were still normal compared to wild type until some
embryos show defects in pole cells migration at stage 12-13, the time when the pole cells
had passed through the midgut rudiment and on their way to assemble as clusters on each
side of the embryos. IX-14 mutant embryos could form very small gonads finally (Figure
4.1A-4.1E).
In order to obtain an enriched population of the developmental stage when the IX-
14/TM6B embryos show a defect, the embryos ofwild type and IX-144) 7/TM6B
heterozygous flies were collected at room temperature for 3 hours. The adult files were
removed and embryos were then aged for 9-12 hours. Thus allowed more specific
characterisation of the defect at stage 12-13. As shown in Figure 4.IF, all the stage 12-13
wild type embryos (242 in total) form clusters of pole cells on each side of the embryos.
On the other hand, 7 out of 139 (5%) embryos laid by IX-14'/TM6B heterozygous flies
and 7 out of 80 (8.75%) embryos laid by IX-144i7/TM6B heterozygous flies fail to form
the cluster of pole cells. Poles cells were diffusely spread in the embryo without forming
any characteristic clusters. This is an indication that homozygous IX-14 mutant embryos
may have a pole cell migration defect. To rule out the possibility that the defect is due to
a mutation on the balancer chromosome TM6B, embryos from Poly/TM6B were collected
under the same conditions as above and stained with Vasa antibody and DAPI. As
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Figure 4.1F: Migration defect of embryos of two heterozygous
IX-14 alleles.
Images shown are lateral or dorsal views of stage 12-13 embryos. In wild type,
germ cells form two clusters on either side of the embryo. In the original IX-14
heterozygous allele and the P element IX-14 heterozygous allele, there is a
noticeably higher percentage of embryos with abnormal germ cell migration.
These cells do not form two clusters as observed in wild type. As a control,
another mutant over TM6B balancer Poly/TM6B does not have this germ cell
migration defect which indicates that the defect is specific to the IX-14
mutation.
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expected, the pole cells in all the 35 Poly/TM6B embryos migrate efficiently to form the
two clusters.
4.2 Migration defect of homozygous IX-14 embryos.
To specifically select homozygous IX-14 mutant embryos, IX-144Y7/TM6B was
crossed to D/TM3p [KrGFP] (D stand for Dichaete) to establish a IX-144Y7/ TM3p
• A77 AV7
[KrGFP] line. IX-14 /IX-14 homozygous mutant embryos can be selected by
absence of a GFP signal using a fluorescence stereo microscope.
Crosses were performed at room temperature. In order to rebalance IX-14 lines
with a fluorescent balancer chromosome, virgin female IX-14 allele flies collected as




72f-74y/TM3,Kr-GFP IX-141/D TM6B/TM3-KrGFP D/TM6B
Virgin female and male of IX-14VTM3,Kr-GFP were selected using dominant
banlancer markers to establish lines
^ ZV-74y/TM3,Kr-GFP X IX-141ITM3, Kr-GFP c?
IX-144' '/TM3,Kr-GFP was created following the same scheme. Homozygous IX-
141/IX-141 and IX-144Y7/IX-144)' embryos were isolated based on a lack ofGFP signal
and hence absence of balancer. Homozygous embryos collected, fixed and stained with
Vasa antibody and DAPI after. No migration defects were observed in the 24 GFP
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positive embryos (1X-144Y7/ TM3p [KrGFP] and TM3p [KrGFP] / TM3p [KrGFP])
while 6 out of 23 (26%) GFP negative embryos (IX-144Y7/IX-144Y7) showed pole cell
migration defects (Figure 4.2 A). Figure 4.2 B is the dorsal view of embryos showing the
defect from a developmental perspective view. Compared to wild type, homozygous
mutant embryos are still normal at stage 10-11 when germ cells are passing through the
midgut, but germ cells failing to migrate and form clusters at either side of the embryo
are observed in stage 13.
4.3 Examination of the somatic cells of the gonad.
In Drosophila gonadal development, the mesodermal origin SGP cells (somatic
gonadal precursor cells) begin to associate with germ cells when the germ cells are
passing through the midgut and mesoderm until they together form the gonad (Brookman,
Toosy et al. 1992) (Boyle and DiNardo 1995). In order to rule out that the gonad forming
defect was due to the SGP cells instead of the germ cells themselves, SGP cells were
observed labelling by EYA antibody. In Drosophila, EYA is encoded by the Drosophila
eyes absent gene which is required to promote the differentiation or survival of eye
progenitor cells anterior to the morphogenetic furrow. Moreover, EYA biologically
synergizes ectopic eye formation in conjunction with eyeless (Bonini, Bui et al. 1997). In
addition to its role in eye development, EYA plays a role in the formation of the gonad in
the developing embryos. An additional allele of eyes absent, clift, is an embryonic lethal
mutation with defects in head development. (Boyle, Bonini et al. 1997). Two versions of
EYA cDNAs are present in Drosophila which differ at the N-termini (-450 bp in type I










Figure 4.2A: Migration defect of 4Y7/4Y7 embryos.
IX-14 mutant files were crossed to a GFP balancer line to allow selection of
homozygous embryos. Germ cell migration was normal in all stage 12-13
heterozygotes, however, a higher percentage (26%) of selected homozygous
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Figure 4.2B: Migration defect of 4Y7/4Y7embryos in stage 11
and stage 13.
Embryos are viewed from the top and stained for DNA, VASA and shown in
conjunction with the phase image. In wild type embryos, germ cells were
observed passing through the midgut in stage 11. By stage 13, they have
formed two clusters on either side of the embryo. In the selected homozygous
IX-14 mutant, the germ cells show no defect in migrating out of the midgut in
stage 11, but they fail to form distinct clusters on either side of the embryo by
stage 13.
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The EYA antibody is a mouse polyclonal anitserum raised against the carboxy-terminal
551 amno acids of the cDNA that is common to both type I and type II cDNAs (Bonini,
Leiserson et al. 1993).
The images shown in figure 4.3A are embryos double stained with EYA and Vasa.
Wild type embryos form gonads on both lateral sides by stage 14. and the tight
association between somatic cells and germ cells inside the gonad can be observed under
high magnification. Conversely, IX-14477/ 1X-144Y7 homozygous mutant embryos fail to
form proper gonads by the same stage. Embryos viewed at higher magnification show
that the SGP cells still form a sheath around the gonads, but there are no germ cells
associated with them. This is consistent the previous observation that showed SGP cells
can cluster into a gonad normally in the absence of germ cells (Brookman, Toosy et al.
1992).
4.4 Summury.
Consistent with a role for IX-14 in migration in human macrophages, its
Drosophila homologue plays a role in migration as well. This was verified by examining
migrating germ cells in Drosophila embryos. Some IX-14 homozygous mutant embryos
fail to form clusters on both sides of the embryos in stage 12-13, instead germ cells lose
their way and become dispersed in embryos. This migration defect had not been
observed in wild type embryos nor in embryos from other mutations over TM6B, such as
Poly/TM6M. The reason not all homozygous embryos exhibit germ cell migration defect
could because that I categorise some gonad of the homozygous mutant with lagging germ
cells (Figure 4.1, stage 13 4Y7/4Y7) as normal since it does happen in wild type. Our
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Figure 4.3A: Gonad defect in 4Y7/4Y7 was not due to somatic
cells in gonad.
Dorsal view of stage 14 embryos stained for DNA, VASA and EYA. The top
panel shows a wild type embryo which formed gonads on both sides. Higher
magnification image shows the germ cells labelled by VASA antibody were
tightly associated with the surrounding somatic cells labelled by EYA antibody.
The bottom panel shows a IX-14 mutant embryo with germ cell migration
defects and with no gonads on either side. Higher magnification image shows
that the surrounding somatic cells are still able to form a sheath around the
gonads but there was no germ cells associated with the structure.
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coordinator, Dr Ivan Clerk, has made a movie confirmed this germ cell migration defect.
In his movie, there are some lagging germ cells appear in wild type gonad, but it finally
assemble into the gonad. This is different from the homozygous mutant while the lagging
germ cells could never assemble into the gonad. The possibility that gonads fail to form
because of abnormality in somatic cells around the gonad has been eliminated since the
somatic cells can still form the gonad sheaths even without germ cells associated with
them. Mutants ofAbdominalA, Abdominal B and clift affect somatic gonadal precursor
cells formation from mesoderm and affect germ cells migration (Boyle and DiNardo
1995; Boyle, Bonini et al. 1997). The possibility that germ cells failing to migrate to
gonad is due to the interaction defect between somatic cells is less likely. E-cadherin is
presenct in both somatic cells and germ cells and is essential for proper germ cell-soma
interaction during gonad morphogenesis. E-cadherin mutant shows different germ cell
migration defect from invadolysin mutant since the germ cells still migrate to the gonad
but do not associate with somatic cells in E-cadherin mutant while germ cells were
completely lost in invadolysin mutant (Jenkins, McCaffery et al. 2003). Although germ
cells travel a long way, they finally fail to migrate to the right place during the last stages
ofmigration. Invadolysin could passively affect germ cell migration by affecting germ
cells response to the migration signal during stage 12/13. Mutants such as trel (trapped
in endoderm), wunen and wunen 2 were all defined as mutantion affecting germ cell
migration while the germ cells migrate a long way but fail to target to the right place
(Santos and Lehmann 2004). Therefore, we can conclude that IX-14 have a migration
role in Drosophila in addition to its mitotic role. Being a good model for visualizing cell
migration in vivo, C. elegans bear the advantage of limited morphological variability and
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a translucent body. There is no experimental report that the C. elegans homologue of
invadolysin, Y43F4A.la, is involved in cell migration. Thus, this is the first time
invadolysin homologous protein was reported involved in cell migration.
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Chapter 5: Protease analysis
5.1 DmlX-14 cleaves Lamin DmO in vitro.
Several nuclear envelope proteins including lamin DmO, lamin A/C and otefin were
increased in the neuroblasts of 3rd instar larval extracts of1X-14 homozygous animals as
seen by immunoblotting and immunofluorescence. Since the IX-14 gene encodes a
protease, these experiments suggest that lamin DmO or other nuclear envelope proteins
might be substrates ofDmIX-14. Previous work demonstrated the protease activity of
DmIX-14 using an zymogram gel in protease assay (McHugh, Krause et al. 2004). Brain
extracts from DmIX-14 mutant flies were unable to cleave the substrate casein in this
system. Therefore, an in vitro protease assay was developed to test this hypothesis that
lamin DmO might be a substrate ofDmIX-14.
The RTS 500 E.coli Circular Template in vitro transcription and translation kit
(Roche) (Circular template kit) was used to express proteins. Reactions were set up with
the following cloned gene vectors: DmIX-14 in pOT2 vector, lamin DmO in T7-7 vector,
GFP in pIVEX vector or C-terminal HsIX-14 (amino acid: 331-665) in pRSET
(containing the his-tag). The transcription and translation extracts were then incubated at
30°C for one hour to express the proteins. An aliquot with no added vector was incubated
at the same condition as a control. In vitro expressed GFP, lamin DmO and C-terminal
DmIX-14 proteins were eletrophoresed on 4%-12% gradient protein gels and transferred
to nitrocelluose membranes. The membranes were then incubate with the appropriate
GFP, lamin DmO or FTis antibodies. All proteins (lamin DmO, DmIX-14 and GFP) were
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expressed at the predicted size (Figure 5.1 A). These protein bands were not observed in
control no vector lanes.
Protease analysis was performed when DmIX-14 and lamin DmO were mixed in vitro
and incubated under the following different conditions. DmIX-14 (10 pi) and lamin DmO
(5 pi) expressed in vitro were incubated together at 29°C for 15 minutes. In some cases,
the incubation included ZnCl2, ZnS04 or the zinc chelator 1,10-phenanthroline (OPA).
After the incubation, sample were boiled at 100°C for 5 minutes in SDS-PAGE sample
buffer. Samples were loaded on a 12% protein gel to better separate smaller molecular
weight proteins. Then the gels were transferred to nitrocelluose membranes which were
blotted with monoclonal antibody against the N-terminal region of lamin DmO (Figure
5. IB). Although high background was present in this blot, no band of the expected size
for lamin DmO (lane 2) was observed in the DmIX-14 lane only (lane 1) which indicates
specificity of the anti-lamin antibody. Adding DmIX-14 to lamin DmO only (lane 3) did
not induce change in lamin DmO. However, protease activity was appear when ZnCF
was added to a final concentration of 1 mM (lane 4) or 10 mM (lane 5), or ZnS04 was
added to a final concentration of 1 mM (lane 6) or 10 mM (lane 7). OPA is a general
chelator iron of zinc and other divalent cations. It was previously reported to inhibit the
cleavage of synthetic peptide substrates of gp63, the paralogue of IX-14, at millimolar
concentrations (Bouvier, Schneider et al. 1990). OPA was added with ZnCl2 or ZnS04 to
determine if it could inhibit the activity ofDmIX-14. As expected, lamin DmO cleavage
by DmIX-14 was inhibited by the addition of OPA to a final concentration of 1 mM,
indicated by the strong signal of lamin DmO observed in lane 8. In attempt to enhance
the cleavage of
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Figure 5.1A: Lamin, C-terminal HsIX-14 and GFP was able to
be expressed by Circular kit.
In vitro transcript kit was used to express proteins. Reactions were set up
with the following cloned gene vectors: DmIX-14 in pOT2 vector, lamin
DmO in T7-7 vector, GFP in pIVEX vector or C-terminal HsIX-14 (amino
acid: 331-665) in pRSET (contain his-tag) in each aliquot. An aliquot with
no added vector was incubated at the same condition as a control. A: The
membrane was probed with a monoclonal antibody against the N-terminal
22-28 amino acid of lamin DmO. The red asterisk shows the in vitro
expressed lamin DmO band which does not appear in the control. B: The
membrane was probed with anti-his antibody. The yellow asterisk shows the
expressed his tagged C-terminal ElsIX-14 band which did not appear in the
control. C: The membrane was probed by an anti GFP antibody. Expressed













E - ZnCI2 ZnS04 1mM
q 2 4 ZnCI2
1mM
1mM 10mM 1mM 10mM OPA
Figure 5.1 B: DmIX-14 expressed by Circular kit cleave lamin.
In vitro expressed lamin DmO (5 pi) and DmIX-14 (10 pi) were incubated
together at 29°C for 15 minutes. The gel was blotted with a monoclonal
antibody against the N-terminal 22-28 amino acid of lamin DmO. The predicted
band size of lamin DmO (red asterisk) was absent in lane 1. No obvious
cleavage of lamin DmO was observed when it was mixed with DmlX-14 (lane
3). Both ZnCf, and ZnS04 at final concentration of 1 mM and 10 mM increased
DmIX-14 cleavage of lamin DmO (lane 4-7) When the zinc chelator
orthophenanthroline (OPA) was added (lane 8) the cleavage was inhibited to
levels seen in lanes 2 and 3.
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lamin DmO by DmIX-14, a higher incubation temperature and a longer incubation time
were applied. Similar to the previous experiment, in vitro expressed lamin DmO (5 pi)
and in vitro expressed DmIX-14 (10 pi) were removed from a freshly translated aliquot
and incubated together. Instead of 29°C for 15 minutes, they were incubated at 37°C for
50 minutes. The membrane was blotted with antibody against the N-terminal region of
lamin DmO. Under these conditions, lamin DmO cleavage by DmIX-14 was apparent
even in the absence ofZnCh (Figure 5.1C, Panel A, lane 3). Adding ZnCfi to a final
concentration of 1 mM (lane4), or 10 mM (lane 5) or ZnSCb to a final concentration of 10
mM (lane 6) showed almost completely cleavage of lamin DmO by DmIX-14. The
cleavage of lamin DmO was inhibited when OPA (1 mM final concentration) was
incubated with ZnCL, DmIX-14 and lamin DmO (lane 7). The cleavage ofGFP by
DmIX-14 was used as a control. GFP was not cleaved by DmIX-14 when they were
incubated at 37°C for 50 minutes without ZnCl2 and with ZnCl2.
Due to high background of the N-terminal (amino acid: 22-28) antibody of lamin
DmO, a monoclonal antibody against the C-terminal (amino acid: 548-620) lamin DmO
was used. Although 37°C enhanced cleavage of lamin DmO, it is not a physiologically
relevant condition for Drosophila. Therefore, 3 pi of in vitro expressed lamin DmO and
10 pi of in vitro expressed DmIX-14 were removed immediately from their respective in
vitro expressed aliquots and incubated together at 29°C for 1 hour. As shown in Figure
5. ID, DmIX-14 alone can not cleave lamin DmO without the addition ofZnCL. Lamin
DmO cleavages were apparent when ZnSCfi were added at different final concentrations
to reactions containing DmIX-14 and lamin DmO (lane 4, 6 and 8). Cleavage was
inhibited when OPA was added to a final concentration of 1 mM (lane 5,7 and 9).
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Figure 5.1C: DmIX-14 expressed by Circular kit cleave lamin but
not GFP.
A: In vitro expressed lamin DmO (5 pi) and DmIX-14 (10 pi) were incubated
together at 37°C for 50 minutes. The gel was blotted with a monoclonal antibody
against the N-terminal 22-28 amino acid of lamin DmO. The predicted band size
of lamin DmO (red asterisk) was absent in lane 1. Cleavage of lamin DmO was
obvious under this condition in the absence ofZnCl2. Adding ZnCUto a final
concentration of 1 mM, or ZnCl2 or ZnS04 to a final concentration of 10 mM
with DmIX-14 almost completely cleaved lamin DmO. The cleavage of lamin
DmO was inhibited to about the same extent as without ZnCb when OPA was
incubated ZnCl2. B: GFP (yellow asterisk) was not degraded when it was




















Figure 5.1 D: Detect lamin cleavage by antibody against N-
terminal lamin.
In vitro expressed lamin DmO (3pl) and DmIX-14 (lOpl) were incubated
together at 29°C for 1 hour. The gel was blotted with a monoclonal antibody
against the C-terminal 548-620 amino acid of lamin DmO. The predicted size
band of lamin DmO (red asterisk) was absent in lane 1. Cleavage of lamin
DmO by DmIX-14 was not obvious under this conditions in the absence of
ZnS04. Adding ZnS04 to a final concentration of2mM, 5mM and lOmM
together with DmIX-14 can result in cleavage of lamin DmO and the cleavage
was inhibited when OPA was added together with ZnS04.
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An alternative polyclonal antibody raised against full length lamin DmO was used to
blot the same membrane. This antibody has reduced the background without altering the
ability to detect lamin DmO (Figure 5.IE).
Lamin DmO could not be cleaved by ZnS04 alone (Figure 5.IF, lane 3) or with an
aliquot of the in vitro expression kit containing no vector in the presence and absence of
ZnS04 (lane 4-lane8).
The paralogue ofDmIX-14, gp63 cleaves a potential substrate MARCKS
(Myristoylated alanine-rich C kinase substrate) related protein (MRP) in its effector
domain (ED), Ser92 Pffe93 Lys94. (Corradin, Ransijn et al. 1999). MARCKS and MRP
are both belongs to the MARCKS family and play roles in brain development and
regulation ofmembrane-cytoskletal interactions. MARCKS and MRP have different
localization and share the almost identical ED which exhibit membrane binding, Ca2+-
calmodulin and actin binding activity. These bindings could be reversed by PKC-
dependent phosphorylation in ED (Arbuzova, Schmitz et al. 2002). This cleavage
sequence, Ser Phe Lys, was found in ED of both MARCKS and MRP, also in lamin
DmO. If cleaved at that site, lamin DmO would be divided into two fragments with the
resultant sizes of 25 kDa and 46 kDa. No obvious homology was observed between
MRP, MARCKS and its Drosophila homologue (DAKAP200) and any of the
accumulated proteins (lamin DmO, lamin C and otefm) in Drosophila except the common


















Figure 5.1E: Detect lamin cleavage by antibody against C-
terminal lamin.
The gel in Figure 5.ID was stripped and probed with the polyclonal lamin DmO
antibody. Lamin DmO cleavage by DmlX-14 in the presence ofZnS04 can still
be observed (red asterisk) while the background was reduced.
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Figure 5.1F: Circular kits lysate with no vector could not cleave
lamin.
In vitro expressed lamin DmO (3pl) and in vitro expression kit containing no
vector (lOpI) were incubated together at 29°C for 1 hour. The gel was blotted
with a monoclonal antibody against the C-terminal 548-620 amino acid of
lamin DmO. The predicted size band of lamin DmO (red asterisk) was absent
in lane 1. Cleavage of lamin DmO was not observed under this conditions in
the presence or absence ofZnS04 (lane 4-8). Tamin could not be cleaved by
ZnS04 (lane 3) or OPA itself (lane 9).
125
5.2 Use of radio-labelled lamin DmO to identify cleavage
products.
In order to identify the cleavage products of lamin DmO, lamin DmO was synthesised
by TNT® T7 Coupled Reticulocyte Lysate System (Promega) (Reticulocyte kit) in the
presence of 35S. Full length DmIX-14 (77 kDa, 12 methionines) and lamin DmO (71 kDa,
7 methionines) were radio-labelled during synthesis using this system. Radio-labelled
luciferase was used as a positive control of the efficiency of this system (Figure 5.2A lane
1). The band of radio-labelled DmIX-14 migrated at a size very close to the band of
radio-labelled lamin DmO (Figure 5.2A lane 3&4). This generated a potentially
confusing signal when the two were used together. To overcome this problem, DmIX-14
without a radioactive label was synthesized using the RTS 500 ProteoMaster E. coli HY
Kit from Roche (ProMaster kit) since the "Circular template kit" was no length available
from Roche. The expression was performed by adding DmIX-14 in pOT2 vector (1 pi)
in a 50 pi aliquot of the kit and incubated at 30°C for 2 hours. A cleavage band of lamin
DmO was observed above 51 kDa when DmIX-14 was added (lane 5). This band become
more obvious when ImM ZnCl2 was added together with DmIX-14 and was less apparent
when 9mM OPA was added (Figure 5.2A, lane 6 & 7).
Figure 5.2B demonstrated that DmIX-14 synthesised by ProteoMaster kit could not
cleave GFP, an nonspecific substrate, in the presence or absence ofZnCF under the same
condition as used in Figure 5.2A. Radio-labelled luciferase was used as a positive control
for this radioactive label system (lane 1) while non-radioactively labelled DmIX-14
synthesised by RTS 500 ProteoMaster E.coli HY Kit served as a negative control for this
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Figure 5.2A: Lamin cleavage band was observed when lamin was
expressed by reticulocyte kit and IX-14 was expressed by
Proteomaster kit.
Luciferase in pUC (1 pg), DmlX-14 in pOT2 (1 pg) and lamin DmO in T7-7 (1
pg) were added to an aliquot of reticulocyte lysate kit to synthesise S35-
methionine-labelled protein. Lane 1 contains radio-labelled luciferase. Non
radio-labelled DmlX-14 (lane 2) was synthesised by ProteoMaster kit and shows
no signal. Green asterisk indicates the signal of radioactive DmlX-14 while red
asterisk shows the signal of radioactive lamin DmO. A potential cleavage band
of lamin DmO (blue asterisk) appeared when 10 pi of non-radioactive DmlX-14
was incubated with 4 pi of radioactive lamin DmO at 29°C for 1 hour. This band
became more obvious when ZnCl2 was added to a final concentration of 1 mM.













Figure 5.2B: DmIX-14 expressed by reticulocyte kit was not
able to cleave GFP.
Luciferase in pUC (1 pg), DmIX-14 in pOT2 (1 pg) and GFP in piVEX (1
pg) were added to an aliquot of reticulocyte lysate kit to synthesise-S35-
methionine labelled protein. Lane 1 contains the radio-labelled luciferase.
Non radio-labelled DmIX-14 was synthesised by ProteoMaster kit and
shows no signal (lane 2). Red asterisk indicates the signal of radioactive
DmIX-14 while blue asterisk shows the signal of radioactive GFP. While 10
pi of non radio-labelled DmIX-14 was incubated with 4 pi of radioactive
GFP at 29°C for 1 hour, no GFP degradation band can be observed in the
presence or absence ofZnCl2.
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radioactive label system (lane 2). Another control was performed by mixing radio-
labelled lamin DmO with non-radio-labelled GFP synthesised by ProteoMaster. Lamin
DmO was cleaved when incubated in the presence or absence of zinc at 29°C for 1 hour
with freshly expressed GFP from ProteoMaster Kit (Figure 5.2C). This result was
puzzling. To get to the bottom of this problem, 10 pi ProteoMaster kit was added to
express protein without the addition of vector. This was added to 4 pi radio-labelled
lamin DmO and incubated at 29°C for 1 hour. Lamin DmO cleavage was still observed
(lane 9) which meant the cleavage was due to the mixture of extracts from the two kits
(ProteoMaster kit and reticulocyte kit). The possibility that lamin DmO was cleaved by
each kit alone was ruled out because lamin DmO expressed by each kit was not cleaved
by adding the mock expressed exact from the same kit (Figure 5.IF and Figure 5.2D). It
appeared that mixture of the two kits activated some endogenous protein which cleaved
lamin DmO. The original cleavage of lamin DmO must due to IX-14 itself.
DmIX-14 was then synthesised by reticulocyte kit with no l5S methionine and
incubated with ^S-labelled lamin DmO expressed from the same kit. No cleavage of
lamin DmO was observed (Figure 5.2D). When DmIX-14 and lamin DmO were both
expressed by ProteoMaster kit, no lamin DmO cleavage was observed in the presence or
absence ofZnCl2 when incubated at 29°C for 1 hour (Figure 5.2E). Higher ZnCl2
concentrations were also tried, but no lamin DmO cleavage was observed (Figure 5.2F).
Expressway HTP Cell-Free E. coli expression kit from Invitrogen (HTP kit) was
used to express DmIX-14 and lamin DmO. DmIX-14 in pOT2 (0.5 pg) and lamin DmO in
T7-7 (0.5 pg) were added to a 25 pi aliquot ofE.coli lysate from Invitrogen and






Figure 5.2C: Mixture of reticulocyte kit and Proteomaster kit
cleaves lamin.
DmIX-14 in pOT2 (1 p.g) and GFP in pIVEX (1 pg) were added to an aliquot of
reticulocyte lysate kit to synthesise 35S-methionine-labelled protein. Lane 1
shows radio-labelled GFP. Red asterisk shows the signal of radioactive lamin
DmO (lane 2) while the blue asterisk shows the cleavage bands. This cleavage
band was observed even when mock expressed protein from ProteoMaster kit
(underwent the expression without the addition of vector) was added to
radioactive lamin DmO (lane 9). Expression from the reticulocyte lysate kit
without the addition of vector shows no expressed protein in the exposure (lane
8).
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Figure 5.2D: DmIX-14 expressed by reticulocyte kit was not
active.
Lamin DmO was synthesised by reticulocyte kit and radioactive labelled by
35S. IX-14 was synthesised by reticulocyte kit too but with no radioactive
label which give no signal on this exposure (lane 1). 10 pi ofDmIX-14 was
incubated with 4 pi of lamin DmO at 29°C for 1 hour. Lamin DmO (red
asterisk) was not cleaved by IX-14 in the presence and absence ofZnS04 (lane






Figure 5.2E: DmIX-14 expressed by Proteomaster kit was not
active.
DmlX-14 in pOT2 (1 pg) and lamin DmO in T7-7 (1 pg) were added to an
aliquot of ProteoMaster kit. The gel was blotted with an monoclonal antibody
against the N-terminal 22-28 amino acid of lamin DmO. No lamin DmO
cleavage (red asterisk) was observed when 4 pi ofDmIX-14 was incubated
with 5 jiil of 1:5 diluted lamin DmO at 29 °C for 1 hour in the presence or
absence ofZnS04.
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Figure 5.2F: DmIX-14 expressed by Proteomaster kit was not
active.
DmIX-14 in pOT2 (1 pg) and lamin DmO in T7-7 (1 pg) were added to an
aliquot of ProteoMaster kit. The gel was blotted with an monoclonal antibody
against the N-terminal 22-28 amino acid of lamin DmO. No lamin DmO
cleavage (red asterisk) was observed when 4 pi ofDmIX-14 was incubated
with 5 pi of 1:5 diluted lamin DmO at 29 °C for 1 hour in the presence or
absence ofZnS04.
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14 were mixed and incubated at 29°C for 1 hour. Lamin DmO was not cleaved by DmlX-
14 in the presence or absence of ZnCl2 (Figure 5.2G).
5.3 Summary
DmIX-14 expressed by Circular template kit can cleave lamin DmO in vitro in the
presence of ZnCl2 or ZnSCU, this cleavage can be inhibited by the chelator, OPA. Lamin
DmO was almost completely cleaved when incubated with DmIX-14 at 37°C in the
presence of ZnCl2. DmIX-14 cleaved lamin DmO under these conditions even in the
absence ofZnCl2. However, since the cleavage bands were not observed, there are
possibilities that lamin cleavage (not detected by lamin antibody) was due to reasons
other than invadolysin directly cleavage. 1) Invadolysin could induce lamin precipitation
then reduce the possibility lamin epitopes being recognized by antibody. 2) Invadolysin
could cleave chaperon protein which keep lamin soluble. This would result in lamin
precipitation indirectly. 3) Invadolysin cleaved and activated a baterial enzyme in the E.
coli lysate which cleaved lamin subsequently. 4) Invasolysin absorbs the protease
inhibitors of the in vitro expression system and in turn lamin was degraded by protease.
5) Epitopes recognised by lamin antibody was cleaved off into small fragment and run
out of the gel. The other potential problem of this analysis is that OPA was reported to
cause protein cross-linking in the presence ofCu, in turn change the structure of active
and inactive state of protein (Hamdan, Ward et al. 2002). It is still possible that the
protease inhibition activity ofOPA was not due to its chelating property, but was due to
its crosslinking activity in the presence of copper in the E.coli lysate instead. Invadolysin


















Figure 5.2G: DmIX-14 expressed by HTP kit was not active.
DmIX-14 in pOT2 (0.5 pg) and lamin DmO in T7-7 (0.5 jag) were added to an
aliquot ofHTP kit and incubated at 23°C for 2 hours with shaking (300 rpm).
The membrane was blotted with monoclonal antibody against N-terminal 22-28
amino acid of lamin DmO. No lamin DmO cleavage (red asterisk) was observed
when 6 pi of DmIX-14 was incubated with 2 pi of lamin DmO at 29 °C for 1
hour in the presence or absence ofZnS04.
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lamin DmO in the presence or absence ofZnCh. One possible explanation is that protein
expression.in the "Circular template kit" may have been significantly slower than the
other three kits. This could provide DmIX-14 enough time to finish all the required
proper folding. Another possibility is that the Circular template kit contained factors that
activated DmIX-14 or possibly induced the self-cleavage and activation ofDmIX-14. I
predict these factors are not present in the other 3 kits. Actually, the paralogue ofDmIX-
14, GP63, needs to undergo an auto-processing event (cysteine switch) for activation.
This removes Cys48 from the pro-region, releasing blockage by abolishing protease
inhibitory coordination between Cys48 and active-site zinc (Figure 1.3C). Full protease
activity was exhibited after activation with HgCF (Macdonald, Morrison et al. 1995).
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Condition used for protease essay
Kit used Conditions Cleavage
Circular kit for lamin DmO and DmlX- 29°C for 15 minutes
lamin DmO: DmIX-14 (5:10
Depend on ZnCb,
inhibited by OPA
Circular kit for lamin DmO and DmlX- 37°C for 50 minutes
lamin DmO: DmIX-14 (5:10
Depend on ZnCf,
Inhibit by OPA
Circular kit for lamin DmO and DmlX- 29°C for 1 hour
lamin DmO: DmIX-14 (3:10
Depend on ZnCl2,
Inhibit by OPA
Proteomaster kit for DmIX-14
Reticulocyte kit for 33S lamin DmO
29°C for 1 hour
lamin DmO: DmIX-14 (4: 10
Artificial cleavage
Reticulocyt kit for DmIX-14
Reticulocyte kit for 33S lamin DmO
29°C for 1 hour
lamin DmO: DmIX-14 (4: 10
No cleavage
Proteomaster kit for DmIX-14
Proteomaster kit for lamin DmO
29°C for 1 hour
lamin DmO: DmIX-14 (1:4)
No cleavage
HTP kit for DmIX-14
HTP kit for lamin DmO
29°C for 1 hour
lamin DmO: DmIX-14 (2:6)
No cleavage
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Chapter 6: In Vitro Expression of DmIX-14
6.1 Expression of DmIX-14 using the Baculovirus system.
Further characterization ofDmIX-14 protease activity would require large amounts
of active DmIX-14. The available in vitro transcription and translation systems
mentioned in Chapter 5 did not give reliable protease activity, were expensive, and on
very small scale. E. coli expression was not further explored as it lack post-translation
modifications and Brian McHugh had previously that it failed to express full-length
DmIX-14 (perhaps due to toxicity).
We therefore decided to use Bac-to-Bac baculovirus expression system from
Invitrogen to express DmIX-14. This system can express high levels of protein, typically
larger proteins than other systems and is suitable for expression of proteins cytotoxic on
other systems. It also can support eukaryotic post translational modifications. Figure
6.1A shows a schematic of the Bac-to-Bac baculovirus system (Invitrogen). The DmIX-
14 ORF was cloned into a donor vector, pFastBacHT A which contains a miniTn7
transposons to recombine the inserted gene with a bacmid and a his-tag fused to the
inserted protein at the N-terminus. This construct was then transformed into E.coli
DHlOBac, which contains a baculovirus shuttle vector (bacmid) with a mini attTn7 target
site and a helper plasmid. After transforming the construct, transposition occurs between
the min-Tn7 element on the pFastBacHT A vector and the min-attTn7 target site on the
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Figure 6.1A: Schematic of the Bac-to-Bac baculovirus system.
DmIX-14 ORF was cloned into pFastBacHTA vector which has a his-tag fused
to the inserted protein on the N-terminus. The construct was then transformed
into DHIOBac where DmIX-14 recombined with bacmid and was selected by
antibody and blue/white colour. Recombinant bacmid was isolated by
midiprep and used to infect SF9 insect cells. After infection, SF9 cells were
centrifuged to collect expressed protein while supernatant was stored as virus
stock.
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supplied by the helper plasmid. The recombination was selected by kanamycin (carried
by the bacmid), tetracycline (carried by the helper vector) and gentamicin (inside the mini
Tn7 transposon in pFastBacHT A). Recombination disrupts expression of the flanking
lacZ gene, allowing identification of recombinant by blue and white selection
(recombinant colonies are white, non-recombinant colonies are blue). A pair ofMl3
primers flanking the mini attTn7 on the shuttle vector can be used to verify the
recombination by PCR (Figure 6.IB, panel A). Several white colonies (cell with
recombined bacmid) were picked to perform colony PCR and compared to
nonrecombinant bacmid. All the PCR products from white colonies gave a band of the
expected size, approximately 4500 bp (2430 bp from vector + 2052 bp for DmIX-14
ORF). One of these colonies was selected and grown to isolate bacmid by midiprep
(Figure 6.IB, panel B-red arrow). SF9 cells (derived from the parental Spodoptera
frugiperda ovary cell line) were infected with this recombinant bacmid. Cells were
collected and centrifuged when signs of infection were observed (cells became bigger,
stopped dividing and detached from the bottom of the flask) (Figure 6.1B, panel C).
Figure 6.1C shows the purification ofDmlX-14. An aliquot of cells in media was saved
as T (total). The rest of the culture was centrifuged, saving the virus-containing
supernatant as SI (supernatant 1) and cell pellet was lysed in lysis buffer as PI (Pellet 1).
The lysate was centrifuged and the supernatant was saved as S2 (supernatant 2, this
should contain any soluble DmlX-14). The pellet was resuspended in IX SDS-PAGE
sample buffer as P2 (pellet 2). S2 was incubated with Ni-NTA agarose beads and the
beads were washed with washing buffer (wl-w3). DmIX-14 was eluted from the beads
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Figure 6.1B: Bacmid recombination and infection.
A: DmIX-14 ORF cloned in pFastBacHT A vector that could recombine with
bacmid by the mini-attTn7 Transposon. M13 forward and reverse sequences
were beside the mini-attTn7 sequence. B: Using M13 primer pairs to verily
recombination. Nonrecombinant bacmid served as a positive control. After
transformation, white colonies were used as a PCR template. All PCR
reactions show the expected size band for DmIX-14 (blue asterisk). The red
asterisk indicates the colony picked for expression. C: Demonstration of the
difference between noninfected and infected SF9 cells with baculovirus. Cells
stop dividing, increase in size and detach from the flask.
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Incubate with Ni-NTA beads
Wash beads with lysis buffer 2 times, once with
washing buffer 1 and once with washing buffer 2
elution buffer was applied 4 times to beads and then beads were
boiled in 1X SDS-PAGE sample buffer
Figure 6.1C: Steps of fractionation and purification
After infection, cells in an aliquot of medium were collected and saved as
Total (T). Then, cells were centrifuged and resuspended in lysis buffer as PI,
the supernatant containing virus was saved as SI. Resuspended PI was
centrifuged again and the supernatant was collected as S2. S2 should contain
the soluble protein. The pellet was resuspended in IX sample buffer and
saved as P2. S2 was incubated with Ni-NTA agarose beads. The beads were
washed with lysis buffer and subsequent washing buffers. Elution buffer was
applied to the beads before beads were boiled in IX SDS-PAGE sample
buffer.
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with elution buffer as (el-e3) The beads were boiled in IX SDS-PAGE sample buffer
prior to loading on gel.
Figure 6.ID shows the characterisation ofDmIX-14 antibody which would be used
for expression detection. R747 gives several bands near the predict size on S2 extracts.
On immunofluorescence, R747 2nd bleed staining was limit to cytoplasm of S2 cells.
Since the anbibody is not purified, the immunoflurorescence data is meaningless. This
R747 bleed was used to immunoblot on SF9 cells for the expressed protein detection.
Under condition 1 (see material and methods), a band near expected size for DmlX-14
appeared in all the fractions of T, SI, PI, S2, P2 indicating that some DmIX-14 was
secreted into the medium and finally the pellet was not totally solubilized (Figure 6.IE).
To help in initial characterization, I used constructs of his-Borealin as a control and the
band for DmIX-14 was not observed in Borealin infection. DmIX-14 did not appear to
bind to the Ni-NTA beads, as seen by the same amount of the DmIX-14 band in the input
and flow through from the beads. In addition, no bands appeared in any of the wash or
elution fractions, or the final sample buffer eluate. TCA precipitation was used to
concentrate the original elution and bead fractions to rule out the possibility that protein
was not observed due to its low concentration. These precipitations allowed all of the
remaining sample to be run in one lane each. No band was detected in the elution and
boiled beads fraction (Figure 6.1F). Other conditions such as using different
concentration of salt or different detergent or adding reducing reagent have been tried to
help solubilization (see material and method, condition 2-4). However, I found no
DmIX-14 binding to the Ni-NTA beads in any of these conditions. Denaturing




Figure 6.1 D: Characterise the DmIX-14 antibody used for
expression detection.
A: The immunoblotting of three DmIX-14 antibody (R738, R747, R759),
using the pre-immune bleed (PI), immune second bleed (2nd) and immune
third bleed (3rd) on S2 cells extract (all in 1:1000 dilution of the serum).
Only R747 give bands in immune serum relatively close to predict size
(77kDa). R738 antibody was shown in a much less exposure time than
R747 and R759. B: Using R747 2nd to immunostain on S2 cells. In both
mitosis and interphase, the protein is limit to the cytoplasm. But since the
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Figure 6.1E: Expression of N-terminally his-tagged DmIX-14.
A: All the membranes were blotted with polyclonal antibody to DmIX-14
(R747). Fractions T, SI, PI, S2, P2 were loaded into each lane of 2 x 104
infected cells, while fractions IN, FL, wl-w3, el-e3, beads were loaded at 10
more concentrated of infected cells into each lane. DmIX-14 was expressed in
all the fractions ofT, SI, PI, S2, P2. DmIX-14 was unable to bind Ni-NTA
beads indicated by the same signal intensity between input (IN) and flow
through (FL) and the absence of a signal at the elutions (el-e3) and beads (red
















Figure 6.1F: Concentrated fraction of N-terminally his-tagged
DmIX-14.
All the membranes were blotted with polyclonal antibody to DmIX-14 (R747).
A: Fractions IN, FL were loaded at 2 x 105 each lane while fractions wl-w4,
el-e4 and beads were loaded ate 1.35 x 107 per lane. DmIX-14 was still
unable to bind Ni-NTA beads indicated by the same signal intensity between
input (IN) and flow through (FL) and the absence of a signal at the elutions
(el-e4) and beads (red asterisk). B: As expected, no DmIX-14 signal was
detected in any of the Borealin infection fractions.
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(see material and method). As shown in Figure 6.1G, DmIX-14 did not bind Ni-NTA
beads. These results suggest that the his-tag has been lost from DmIX-14. Actually,
when antibody to his-tag was used to immunoblot infected cells (fraction T), there was a
loss of the N-terminal his-tag from DmIX-14 (Figure 6.1H). No his-tag signal was
observed in the cells infected by DmIX-14 recombinant bacmid during the specific time
course. A band of the expected size for his-borealin was observed in cells infected by
Borealin recombinant bacmid. This indicated that the his-tag on DmIX-14 was cleaved
in the baculovirus system.
An alternative vector (pFastBacl) was used to engineered a his-tag on the C-
terminus ofDmIX-14. Unlike pFastBacHT A which contains a his-tag at N-terminus,
pFastBacl does not have any additional tag fused to the inserted protein. DmIX-14
expression and purification procedures were followed as described earlier (see material
and method, condition 1). Similar to previous results, C-terminally his-tagged DmIX-14
also failed to bind to Ni-NTA beads suggesting that the his-tag was lost from this tagged
fusion as well (Figure 6.11). Analysing the sequence ofDmIX-14 has identified a signal
sequence near the N-terminus and a GPI anchor site near the C-terminus. Both of them
might be processed during protein production. This may explain why the his-tag appears
to be lost during protein expression. SF9 cells infected by bacmid recombined with
Borealin underwent the same expression and purification steps as a positive control.
Borealin was not secreted into the medium (S1) but appeared in other fractions, T, PI, S2,
P2 (Figure 6.1 J). N-terminally his-tagged Borealin bound Ni-NTA beads, as indicated by
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Figure 6.1G: DmIX-14 expression and purification under
denaturing conditions.
A: All the membranes were immunoblotted with polyclonal antibody to
DmIX-14 (R747). Fractions T, SI, PI, S2, P2 were loaded into each lane of 2
x 104 infected cells, while fractions IN, FL, wl-w3, el-e3, beads were loaded
at 10 more concentrated of infected cells into each lane. DmIX-14 was
observed in all the fractions ofT, SI, PI, S2, P2. DmIX-14 was unable to bind
Ni-NTA beads under denaturing conditions (red asterisk). B: As expected, no
DmIX-14 signal was detected in any of the fractions from Borealin infection.
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Figure 6.1H: The N-terminal his-tag was lost from DmlX-14.
A: SF9 cells infected by his-tag DmlX-14 were immunoblotted with his
antibody during infection time course. Each fraction was loaded into each lane
of 2 x 104 infected cells. The predict DmlX-14 size signal was not observed
(blue asterisk). SF9 cells infected with his-tag Borealin were used as a positive
control and the predicted size signal (red asterisk) was observed. B: loading
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Figure 6.11: C-terminally his-tagged DmIX-14.
A: All the membranes were immunoblotted with polyclonal antibody to
DmIX-14 (R747). Fractions T, SI, PI, S2, P2 were loaded into each lane of 2
x 104 infected cells, while fractions IN, FL, wl-w4, el-4, beads were loaded at
10 more concentrated of infected cells into each lane. DmlX-14 appeared in
all the fractions ofT, SI, PI, S2, P2. DmlX-14 was unable to bind Ni-NTA
beads with its C-terminal his-tag (red asterisk). DmIX-14 signal was not






















Figure 6.1J: Borealin expression and purification
All the membranes were blotted with anti-Borealin antibody. Fractions T, SI,
PI, S2, P2 were loaded into each lane of 2 x 104 infected cells, while fractions
IN, FL, wl-w4, el-4, beads were loaded at 10 more concentrated of infected
cells into each lane. A: Borealin (about 40 kDa) was expressed in the T, PI,
S2, P2. Fractions. However, it was not secreted into the medium that
contained the virus (SI). B: Some Borealin bound Ni-NTA beads through its
N-terminal his-tag. However his-tagged Borealin could not be eluted from the
beads using elution buffer and the protein remains on the beads (red asterisk).
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difference was very obvious) but could not be eluted off from the beads indicated by the
absence ofDmIX-14 band in elution fraction and presence of protein in boiled beads.
The bound borealin demonstrated that the procedure of protein expression and
purification did not affect protein binding to the beads. I believe that DmIX-14 did not
bind to the beads because its his-tag was lost in the baculovirus system. His-tagged
borealin could not be eluted off from the beads might due to their high affinity.
Unfortunately, DmIX-14 could not be purified using his-tags at the N and C-termini
in the baculovirus system. Instead, I attempted to use metal sepharose to purify this
protein, hoping to take of advantage DmIX-14 being a metalloprotein. After the binding
ofmetal sepharose to ZnS04, the S2 Baculovirus fraction was incubated with this ZnS04
: sepharose complex. DmIX-14 should bind to the sepharose beads through the
interaction at the HEXXH metalloprotease motif. The beads were washed with PBS and
DmIX-14 was eluted from the beads by EDTA, a metal chelator that competes with
DmIX-14 for ZnS04. DmIX-14 bound the sepharose beads and could be eluted off by
EDTA, although some protein remained on the beads (Figure 6.IK). Sepharose
incubated with dH20 instead of ZnS04 was used as a negative control. DmIX-14 could
not bind to plain sepharose beads as expected in the absence of zinc ion.
In order to check whether the expressed DmIX-14 from baculovirus has activity,
protease assays were performed. The elution fraction (el) (500 pi) was concentrated
using a Biomax-5 column (Millipore) and washed several times with PBS to attempt to
separate DmIX-14 from EDTA (which could potentially inhibit protease activity of
DmIX-14). The el fraction was concentrated to 50 pi from an original amount of 3 x 106
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Figure 6.1K: DmIX-14 purification by metal sepharose
All membranes were blotted with polyclonal antibody to DmIX-14 (R747).
Fractions were loaded in each lane at 2 x 105 of infected cells. A: DmIX-14
(red asterisk) bound the zinc ion : sepharose complex and was not washed off
by PBS, but was eluted off by EDTA. B: little DmIX-14 binds to plain
sepharose that was not incubated with zinc beforehand.
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lamin Dmo expressed from ProteoMaster kit as described in chapter 5. Lamin DmO was
completely cleaved by DmIX-14 in the presence or absence of ZnSCfi. OPA completely
blocked lamin Dm0 cleavage by DmIX-14 el. However, el fraction from Borealin
control also cleave lamin Dm0 but not completely. A little lamin Dm0 was left
undegraded under the same condition (Figure 6.1L). The el fraction from uninfected SF9
cell could also degrade lamin Dm0 to a lesser extent under the same conditions (Figure
6.1L). This could be due to the presence of other metalloproteases co-purified from SF9
cells by the metal sepharose beads. These metalloprotease may also cleave lamin Dm0.
The lamin Dm0 cleavage difference between uninfected SF9 cells and borealin
recombinant bacmid infected SF9 cells might be due to some protease that are over
expressed during infection. The lamin Dmo cleavage difference between borealin
recombinant bacmid infected SF9 cells and DmIX-14 recombinant infected SF9 cells
might be due to activity ofDmIX-14.
In summary, both N and C-termini his-tags fusion was lost in baculovirus system
during of after protein production. Metal sepharose could not purify DmIX-14
specifically. There are a lot of other metalloprotease was purified as well, some ofwhich
could cleave lamin DmO.
6.2 Expression ofDmIX-14 using Pichia pastoris.
Since the his tags ofDmIX-14 keep losing in baculovirus system and it takes months
for the whole procedure from cloning to purification, Pichia pastoris was used as an
alternative system to express DmIX-14. Yeast expression systems bears the advantage of
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Figure 6.1L: Protease activity of elution fractions.
All the membranes were blotted with polyclonal antibody against full length
lamin DmO (lamin DmO signal was indicated by red asterisk). Elution one (el)
fraction from Zn++ : sepharose beads was incubated with lamin DmO expressed
from ProteoMaster kit described in Chapter 5. A: lamin DmO cleavage using
the el fraction from DmIX-14 infection. DmIX-14 elution fraction alone does
not show any signal by this antibody (lane 1). Lamin DmO was almost
completely cleaved when it was mixed with el from DmIX-14 infection in the
presence (lane 4) or absence (lane 3) of ZnSO4. Addition ofOPA inhibited
lamin DmO cleavage (lane 5). Panel B: lamin DmO cleavage was also
observed when the el from Borealin infection was assayed. Panel C: lamin
DmO cleavage was observed when el from control SF9 cell extracts with no
infection was assayed although the cleavage was in a far less extend.
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machinery for potentially post-translational protein modifications of eukaryotic cells.
Pichia pastoris is a methylotrophic yeast, which use methanol as its sole carbon source.
The first step of utilization ofmethanol is the oxidation ofmethanol to formaldehyde
using oxygen by the enzyme alcohol oxidase (Invitrogen). There are two genes coding
for alcohol oxidase in Pichiapastoris, AOX1 and AOX2. These genes share 97%
homology in their coding sequence but no homology outside the protein coding
sequences. AOX1 accounts for the majority of alcohol oxidase activity in the cell while
AOX2 metabolizes methanol slower than AOX1. The difference sequence located 5' of
the protein coding region of the genes might account for this activity difference. This
slow growth allows isolation ofMuts (Methanol utilisation Slow) strains such as
KM71H, which has a mutated form ofAOX1 gene (substitute 0.6 kb ofAOX1 from the
5'-most site by a 3.0-kb gragment containing the S. cerevisiae ARG4 gene) (Cregg,
Madden et al. 1989) (Koutz, Davis et al. 1989).
I cloned the DmIX-14 ORF into the pPICZalpha A vector. This vector fused a
protein alpha-factor sequence at the N-terminus ofDmIX-14 and c-myc and his-tags at
the C-terminus. After being linearised, recombinant plasmid was transformed into the
KM71H stain where it integrates within the Pichia genome. Transformed yeast were
plated on zeocin selective YEPD plates. Recombination of the yeast genome was
confirmed by PGR, using the isolated yeast genome as template. As Figure 6.2A shows,
one of the yeast colonies was verified by PCR to have the right construct. This colony
was selected together with a colony from KM71H yeast transformed with the pPICZalpha
A vector (excluding the insertion) and a colony from KM71FI yeast that was not
transformed. All colonies were grown in BMG medium. When the OD600 reached 2.5,
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Figure 6.2A: Verification that DmIX-14 recombined into the
Pichia genome.
A: Schematic graph of linear DmIX-14 ORF in pPICZalpha A used to be
transformed into the KM71H stain. B: PCR confirmation of recombined
construct into the Pichia genome. Eleven colonies were picked for PCR analysis
using the pairs of primers indicated in panel A. Only one (lane 1) had the
appropriately sized band for both PCR reactions. This clone was used for
protein purification.
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the cultures were induced by the addition ofmethanol (BMM medium, 1/10 of the
original volume). Aliquots of sample cultures (1 ml) were removed for analysis at the
time points: Oh, 9h, 12h. Figure 6.2B is a schematic of the fractionation and
solubilization of expressed DmIX-14. In brief, sample cultures were centrifuged, the
supernatant was saved as S1 (supernatant 1) and the pellet was resuspended in breaking
buffer (see material and method) as PI (pellet 1). Resuspended PI was vortexed on ice
with glass beads in a centrifuge tube, followed by centrifugation. The new supernatant
was saved as S2 while the pellet (P2) was resuspended with IX SDS-PAGE sample
buffer and boiled. Although alpha-factor is fused to the N-terminus of DmIX-14, and
should be processed to allow protein secretion into the medium, no DmIX-14 was
detected in the medium, SI (Figure 6.2C Panel A). DmIX-14 was induced by methanol
at the time points 9h and 12h in yeast by the vector containing the DmIX-14 insert, but
not the vector only (Figure 6.2C, arrow). Flowever, DmIX-14 was not solublized in the
supernatant fractions under these conditions. DmIX-14 was observed in the PI (panel B)
and P2 (panel D) blots, but not in SI (panel A) and S2 (panel C).
Alternative approaches are now being explored in the laboratory to identify the best
lysis conditions to allow protein purification. These include using several
different lysis buffers and mechanical lysis methods such as grinding cells with glass
beads in a larger volume container (perhaps appropriate cell lysis was not achieved with
glass beads in the centrifuge tube) or grinding cells in liquid nitrogen or lyse cells using
French Press. Under these new conditions, other lab members have been able to partially
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Figure 6.2B: Schematic graph of the fractionation and
solubilization of expressed DmIX-14.
The recombinant colony was grown in BMG medium and induced by changing
the medium to BMM medium. Aliquots were removed from the BMM
medium at different time points (0, 9, 12 hrs). Cultures were centrifuged and
the initial supernatant was saved as SI and pellet as PL PI was resuspended in
lysis buffer and vortexed after glass beads were added. Another centrifugation
was performed to separate soluble protein in the second supernatant (S2). P2
was resuspended in IX sample buffer.
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Figure 6.2C: DmlX-14 was not solublized from the pellet
fractions.
All blots were probed with the anti-myc antibody. A: No band of expected
size ofDmIX-14 was observed in SI. B: A band of the expected size for
DmlX-14 appeared in Pichia after 9 and 12 hrs inductions (arrow). This band
was not observed in Pichia cells transformed with vector only. C: The DmlX-
14 band did not appear in the S2 fraction ofDmIX-14 or vector. D: The




During the three years research on IX-14/Invadolysin, I get the conclusion that three
nuclear envelope proteins were accumulated in IX-14 mutant; IX-14 could cleave lamin
DmO in vitro; there is a germ cell migration defect in IX-14 mutant; His-tags at N and C
terminal ofDrosophila IX-14 were cleaved in baculovirus system. These results suggest
that lamin DmO, lamin A/C, otefin was potential substrates ofDrosophila IX-14; IX-14 is
involved in cell migration in Drosophila; Drosophila IX-14 might went through
translation and post-translation modification to cleave off its signal sequence near N-
terminus and GPI replacement signal near C-terminus.
7.1 Role of Invadolysin.
Invadolysin is a metalloprotease which links the cell cycle with cell migration. The
Drosophila Invadolysin mutants have defects in spindle formation, centrosome
separation, cell cycle progression, chromosome structure and condensation, abnormal
accumulation of nuclear envelope proteins, and germ cell migration.
It is possible that the spindle defects may be due to an upstream defect of some other
cell cycle defect and not due to abnormal centrosome separation. This assumption is
based on the observation that almost normal-looking bipolar spindles were observed in
the background of asterless, a mutant which abolishes centrosome formation, in
Drosophila neuroblasts and ganglion mother cells (Bonaccorsi, Giansanti et al. 2000). In
addition, the checkpoint protein BubRl remains on chromosome and maybe important
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for cell cycle arrest in metaphase. A metaphase arrest was also confirmed by the higher
percentage of P-H3 positive cells in this mutant compared to wild type and a complete
absence of anaphase and telophase cells in the Invcidolysin mutant. It is not surprising to
see the chromosome passenger protein INCENP did not display the dynamic localisation
pattern but instead was only limited to the centromeres since there is no anaphase cells.
Whether this change affects other passenger proteins like Survivin (which is a member of
the inhibitor of apoptosis protein (IAP) family) and in turn may be responsible for the
high apoptosis rate observed in Invadolysin mutants would be an interesting hypothesis to
test. Currently, there is no evidence for a direct role for Invadolysin in centrosome
separation or spindle assembly. However, Invadolysin might affect centrosome
separation through its substrates.
Mask (multiple ankyrin repeats single KH domain) and tankyrase, which are
structural constituents of the cytoskeleton, were identified as potential interactors of
Invadolysin in a genome-wide two-hybrid screen (Giot, Bader et al. 2003). They both
contain ankyrin repeats which bind actin. Actin has been shown to participate in
centrosome separation during the G2/M transition and works in synergy with the
microtubules to accelerate centrosome separation during mitosis (Uzbekov, Kireyev et al.
2002). Spindle formation can occur independently of the centrosomes as described
above, but it could still be affected by actin. Actin has been reported to regulate spindle
orientation (Hwang, Kusch et al. 2003). This may suggest a different pathway that
involves actin regulation of centrosome separation and spindle formation.
Invadolysin mutants also have unusually hypercondensed chromosomes with loose
edges in metaphase which suggests a chromosome structure or condensation defect. This
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could be due partly to the cell cycle arrest at metaphase which would allow more time for
chromosome condensation. Alternatively, Invadolysin could have a direct role on
components such as topoisomerase II or condensin, or be a result of disruption of a novel
pathway in which proteolysis plays a role in chromosome condensation. However,
loosely condensed chromatin was found around the periphery of hypercondensed
chromosomes in this mutant which may argue a structural role for this protein in
chromosome condensation. Invadolysin might affect chromosome scaffold binding to
SARs ofDNA. This may make the edge of the chromosomes fuzzy even though the
overall level of condensation was increased. This loosely condensed chromatin could not
be condensed normally by colchicine treatment which delays cells in metaphase. This
indicated again the loosely condensed chromatin was due to a distinct pathway separate
from overall chromosome condensation. Invadolysin also appears to have a role in
chromosome architecture during interphase because mutations exhibit poorly structured
polytene chromosomes in salivary gland and have compromised heterochromatin, as
assayed by position effect variegation.
The other phenotype of the Invadolysin mutant is the accumulation of several nuclear
envelope proteins (lamin DmO, lamin A/C and otefin) in neuroblasts. This funding
suggests that Invadolysin or one of its downstream targets normally promotes the
turnover of these nuclear envelope proteins. In fact, cleavage may be due to Invadolysin
itself, as the Drosophila Invadolysin can cleave Drosophila lamin DmO in vitro in a zinc-
dependent manner. Lamina dynamics in mitosis are regulated by reversible
phosphorylation ofCdKl :cyclin B and are reused at nuclear envelope reformation during
telophase (Gant and Wilson 1997). Cyclin B was used as a marker to distinguish G2
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cells, interestingly I have observed low levels of cyclin B in the lnvadolysin mutant.
Whether a low level of cyclin B in Drosophila Invadolysin mutants act upstream the
lamin accumulation directly or indirectly remains unclear. This is because lamin
accumulation is not cell cycle dependent (while the CdKl :cyclin B remains at low level
consistently throughout interphase). The low level of cyclin B could due to the fact that
invadolysin could alter the activity of a phosphatase. Cdc25 phosphatase was well know
to regulate cyclin B/Cdkl acticity (Strausfeld, Labbe et al. 1991). Recently, it was
reported that cyclin B translation was suppressed by protein phosphatase 1 (PP1) until
break down of nuclear envelope, when a potent translational activator (most like the PP1
inhibitor) was delivered to the cytoplasm (Lapasset, Pradet-Balade et al. 2005).
Invadolysin does play a role to prevent nuclear envelope broke down during mitosis, it
might prevent releasing the PP1 inhibitor and keep suppressing cyclin B translation.
GP63, the Leishmania protease, can cleave its potential substrate MRP between the
consensus cleavage site in its effector domain, Ser92 / Phe93 Lys94. Intriguingly, this
cleavage sequence was also found in lamin DmO. If utilized, the resultant cleavage
products should be 25 and 46 kDa. However no cleavage bands of this size could be
detected by immunoblotting in the protease assay with lamin antibodies. Radioactive
labelled lamin was needed to identify the cleavage band. Investigation of lamin or otefin
sequence showed that ser / phe lys was not present in either lamin A/C or otefin. This
cleavage site was not present in Drosophila lamin A/C or otefin. Whether Invadolysin
cleaves lamin DmO at the same cleavage site as GP63 cleaves MRP remains unknown. If
Invadolysin uses the same cleavage site as gp63, lamin A/C and otefin accumulation must
be a downstream event of lamin DmO cleavage as they could not be cleaved themselves.
164
No obvious homology was observed between MRP and any of the accumulated proteins
(lamin DmO, lamin A/C and otefin) in Drosophila, except the common cleavage site
between lamin DmO and MRP. However, although the mechanism and timing of the
Invadolysin-dependent nuclear envelope turnover has yet to be determined, the
phenomenon is important because it reveals previously unsuspected complexity of
nuclear envelope dynamics during the cell cycle. Significantly, lamin is reported to be
involved in a wide range of diseases known collectively as "laminopathies". These
include striated-muscular dystrophy, partial lipodystrophy, peripheral neuropathy and
premature aging syndromes eg. progeria (Worman and Courvalin 2005). Further research
on Invadolysin may shed light on the intricate molecular mechanism of lamin turnover,
and may in turn lead to information into these diseases.
Beside Invadolysin, there must be other proteases which can cleave lamin as
indicated by cleavage of lamin in the un-trans formed SF9 cell extracts in baculovirus
expression system. Whether those as yet unidentified proteases interact with Invadolysin
might be an interesting question to be answered. How the nuclear envelope protein
defects coordinate with the chromosome condensation and architecture defects is an
interesting issue. One possibility is that Invadolysin might regulate interactions between
chromatin and the nuclear envelope that are important for gene expression and/or mitotic
chromosome condensation.
Although a nuclear pool of Invadolysin is detectable in human cells, the protein is
also localized to the cytoplasm, where it is concentrated in unusual ring-like structures in
human cells. These structures are observed during interphase in a number of transformed
human cultured cells, but become dispersed during mitosis, when the protein adopts a
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more diffuse distribution. These ring-like structures resemble invadopodia, cytoplasmic
structures that have been proposed to have an important role in cell migration and cancer
metastasis. Like invadopodia, the ring-like structures containing Invadolysin are
localized to the lower third of the cell close to the substratum. This finding led us to test
the migration role of Invadolysin in both human and Drosophila cells. When migrating
human macrophages were labelled with the Invadolysin antibody, the Invadolysin protein
was strikingly localized to leading edge of the cells. In Drosophila mutants, I observed a
germ cell migration defect in embyros. These results suggested strongly that Invadolysin
is involved in cell migration. Ching-Wen Chang, a Ph.D. student in the Heck laboratory
has performed wound healing experiments to further analyse a role for Invadolysin in cell
migration. When HeLa cells were "wounded" by a pipette tip, Invadolysin localize to the
wound edge within 3 hours. GP63, the ortholog of Invadolysin has been shown to
enhance migration of Leishmania through the extracellular matrix (ECM) (McGwire,
Chang et al. 2003). This activity might be due to the fact that GP63 can degrade ECM
components. Invadolysin might affect cell migration by degrading the ECM to clear a
pathway for cells, hence the localisation at the leading edge or invadopodia. It is reported
that cell migration is driven by the protrusive activity at the leading edge of the cell,
where continuous remodelling of actin and adhesive contacts are required (de Curtis
2001). The potential interactors of Invadolysin, mask and tankyrase, which possess actin
binding activity, may present a possible explanation for the migratory role of Invadolysin.
It is also possible that Invadolysin is involved in cell migration by regulating some
signaling proteins such as cell surface receptors. Actually, it was report that EGF
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(epidermal growth factor) and EGF receptor signalling are necessary for invadopodia
formation (Yamaguchi, Lorenz et al. 2005).
Intriguingly, dynamin 2, which is also found in invadopodia, has been shown to play
a role in centrosome cohesion (Thompson, Cao et al. 2004). This connection ties in well
with our results linking migration with mitosis.
7.2 Why Invadolysin has diverse functions.
Invadolysin has been shown to play diverse roles in the cell cycle and cell migration.
How these different roles are coordinated by Invadolysin raises a very interesting
question. Invadolysin might perform its diverse role through its interactors. As mention
above, mask and tankyrase, which were found as interactors of Invadolysin in a genome-
wide two hybrid screen, might affect cell migration through their actin binding activity.
A Ph.D. student in the Heck laboratory, Shubha G. Rao, has found a genetic interactor for
Invadolysin, non-stop. Non-stop is a ubiquitin-specific protease that is involved in glial
cell migration and affects the target layer selection in the visual system ofDrosophila
(Poeck, Fischer et al. 2001). S. Rao has also shown that the non-stop mutant has
hypercondensed chromosomes in metaphase neuroblasts cells similar to those observed in
the Invadolysin mutant. In addition, both Invadolysin and non-stop mutants show
accumulation of ubiquitinated proteins in larval extracts. When S. Rao compared the
immunoblotting pattern of ubiquitinated proteins and histone F12B in larval extracts, she
observed similar patterns. This may indicate that the ubiquitinated proteins might in fact
be ubiquitinated histone H2B. The yeast homologue of non-stop, ubp8 (ubiquitin specific
protease 8), exhibits the ability to deubiquitylate histone H2B and regulate transcriptional
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activity (Henry, Wyce et al. 2003). Whether ubiquitinated histone H2B is associated with
the defects in chromosome condensation has not yet been clearly determined.
Invadolysin might be involved in protein degradation pathways directly or through
interaction with non-stop, which may in turn regulate many other cell cycle or cell
migration events.
The other way in which Invadolysin may carry out roles in such diverse functions is
through the presence of different variants. In human, there are current four variants.
Four variants were described in Chapter 1. They differ in with or without a 37 amino
acid insertion and with or without a N-terminal signal sequence as described previously.
The variants that bears N-terminal signal sequences would be targeted to the ER and GPI
anchored on the cell membrane, thus might be involved in cell migration. The other
variants that lack the N-terminal signal sequences would not be targeted to ER and thus
likely not GPI anchored on the cell membrane, and possibly involved in the cell cycle. In
Drosophila, only one variant has been found to date (include N-terminal signal sequence,
GPI-anchored and the 37 amino acid insertion), but the existence of alternative splice
forms of Invadolysin in flies is still possible. Identification of such forms would help us
to understand more about the diverse functions of Invadolysin.
7.3 How to activate Invadolysin.
In order to further characterise the in vitro activity of Dmlnvadolysin, it is necessary
to express the protein in a large scale. However this has proved to be very difficult.
Perhaps this is because the protease requires a "cysteine switch" to be activated. The
presence of signal sequence near the N-terminus and the GPI anchor signal near the C-
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terminus also make its difficult to tag and purify this protein as they would be potentially
cleaved during translation and post-translational modification. Tagging the protein in the
middle may run the risk of altering the tertiary structure and thus altering the protein's
function. It is possible that the cleavage observed with the first ivTnTkit, (Circular
template kit), was due to its slower expression allowing the protease enough time to fold
properly or to perform auto-cleavage, or to be activated by other proteases. An
alternative method utilising Pichia (allowing slow induction by methanol) was also
initiated to express the protein. However, whether Pichia expression could result in a
large enough quantity of active protein remains unknown.
7.4 Future Direction.
Invadolysin is an interesting and dynamic protein involved in a wide range of
activities from cell cycle to cell migration. The potential for this protein to be involved in
many fundamentally crucial pathways is enormous, and warrants a great deal more
investigation.
Large quantity expression of active Invadolysin would provide a platfonn for many
other aspects of research on Invadolysin. Tagging the protein at a site where surface
insertions occur (based on comparison with the GP63 sequence) would be a potential way
to try to purify Invadolysin. Treating the inactive Invadolysin ivTnT expressed from
Reticulocyte kit, ProteoMaster Kit and HTP kit with HgCL might make GP63 active by
abolishing the protease inhibitory coordination between Cysteine and the active-site zinc.
This might activate Invadolysin based on the hypothesis that homologues would use the
same mechanism to be activated.
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Finding alternative splice forms and substrates of Invadolysin would be an important
way to understand the link between this protein and its activities. RT-PCR on different
tissues or cell lines from both human and Drosophila could be performed to examine the
tissue or cell specific distribution of alternatively spliced forms of Invadolysin. Although
genome-wide two-hybrid screen has been performed in Drosophila, a more specific two-
hybrid screen performed in the laboratory may be able to identify more relevant or
stronger interactors. Other biochemical methods such as immuno-precipitation or
multiple tag pull downs could be performed to "fish out" further interactors of
Invadolysin. A genetic screen using a deficiency library that covers about 50 percent of
the whole Drosophila genome has been performed to identify genetic interactors of
Invadolyisin. With the availability ofmore deficiency lines, a whole genome-wide
genetic screen could be performed for Invadolysin. Further characterization of some of
already identified interactors of Invadolysin such as lamin DmO, nonstop and mask
should also be performed.
IX-14 mutant was originally characterised as a mutation affecting imaginal disc
formation and chromosome condensation, but it was found involving in a much wider
range of biological process than original findings such as cell cycle and cell migration. In
turn, IX-14/Invadolysin was implicated in some important medical roles, for example,
cancer metastasis and laminopathies. Further characterisation of Invadolysin would shed
light on understanding of cancer and laminopathies and finally make them more treatable.
Among the 27 interactor of invadolysin, three has been found to connect with human
disease in their human homologues in OMIM. Henna (CG7399) is a phenylalanine
hydroxylase whose human homologue is connected to Huntington's disease (HD) that
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results from genetically programmed degeneration of neurons in certain areas of the
brain. CGI2789 poses scavenger receptor activity, its human homologue is connected to
Carotid Intimal-Medial Thickness. CG6508 have cathepsin D activity, its human
homologue is connected to Huntington Disease, Ceroid Lipofuscinosis (CL) (a metabolic
disease which affects the nerve cells of the body), and Alzheimer disease (AD)
(neurodegenerative disease). Explore interactor of invadolysin and their interaction will
give more information about these diseases.
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Invadolysin: a novel, conserved metalloprotease
links mitotic structural rearrangements with
cell migration
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The cell cycle is widely known to be regulated bynetworks of phosphorylation and ubiquitin-directedproteolysis. Here, we describe IX-14/invadolysin, a
novel metalloprotease present only in metazoa, whose
activity appears to be essential for mitotic progression.
Mitotic neuroblasts of Drosophila melanogaster IX-14
mutant larvae exhibit increased levels of nuclear enve¬
lope proteins, monopolar and asymmetric spindles, and
chromosomes that appear hypercondensed in length with
a surrounding halo of loosely condensed chromatin. Zy-
mography reveals that a protease activity, present in
wild-type larval brains, is missing from homozygous tis¬
sue, and we show that IX-14/invadolysin cleaves lamin
in vitro. The IX-14/invadolysin protein is predominantly
found in cytoplasmic structures resembling invadopodia
in fly and human cells, but is dramatically relocalized to
the leading edge of migrating cells. Strikingly, we find
that the directed migration of germ cells is affected in
Drosophila IX-14 mutant embryos. Thus, invadolysin
identifies a new family of conserved metalloproteases
whose activity appears to be essential for the coordina¬
tion of mitotic progression, but which also plays an unex¬








Recent years have witnessed remarkable strides in our under¬
standing of the control of cell cycle progression. It is now
clear that cell cycle progression is driven by the successive
activation and inactivation of the Cdks, and that abrupt transi¬
tions are often enforced by the cleavage of key targets by the
proteasome after their ubiquitination by various E3 ubiquitin
ligases (for review see Murray, 2004). Cdk phosphorylation
of key components regulates the entry of cells into S phase
and choreographs the subsequent firing of replication origins.
Entry into mitosis is also determined by Cdks, and Cdk phos¬
phorylation of the nuclear lamins drives the cycle of nuclear
envelope disassembly and reassembly that is characteristic of
mitosis in metazoa. The exit from mitosis is triggered not
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only by proteolysis of mitotic cyclins but also of securin lead¬
ing to the activation of separase, a CD clan protease that
cleaves the rad21/Sccl non-structural maintenance of chro¬
mosomes cohesin subunit, thereby triggering the separation
of sister chromatids.
One aspect of mitosis about which we still know rela¬
tively little is the process of mitotic chromosome formation.
The compaction of chromatin into mitotic chromosomes is es¬
sential to avoid sister chromatid entanglement and cleavage
of chromatin at cytokinesis. Recent breakthroughs, such as
the discovery of the structural maintenance of chromosomes-
containing condensin complex, at first appeared to provide
the key, but recent analyses of condensin mutations and
RNAi depletions have revealed that mitotic chromosomes
form even in the absence of condensin subunits (Bhat et al.,
1996; Steffensen et al., 2001; Coelho et al., 2003; Hudson et
al., 2003). Further evidence suggests that correct mitotic
chromosome condensation is linked to replication timing and
checkpoint control (Louparl et al., 2000; Krause et al., 2001;
Pflumm and Botchan, 2001). Thus, the search for factors that
give the mitotic chromosome its characteristic form and in¬
tegrity is still very much on.
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This work began as part or our ongoing characterization
ofDrosophila melanogaster mutations that are defective in mi¬
totic chromosome condensation. Mitotic events are particularly
amenable to study in Drosophila as many mutations affecting
mitosis are lethal only at the late larval stages due to the mater¬
nal store of proteins in the embryo and the fact that larvae do
not require mitotic activity for growth and development. This
allows the use ofmitotically active tissues such as larval brains
and imaginal discs for studying proliferation in wild-type and
mutant states (Gatti and Baker, 1989; Theurkauf and Heck,
1999). As a result, Drosophila has proven useful both for the
characterization of known cell cycle regulators (O'Farrell et
al., 1989; Edgar and Lehner, 1996; Fogarty et al., 1997; Sibon
et al., 1997; Jager et al., 2001) and for the identification of
novel factors, such as the polo and aurora kinases that have
subsequently proven to be important for cell cycle regulation in
diverse organisms (Sunkel and Glover, 1988; Llamazares et al.,
1991; Glover et al., 1995).
We examined the 1(3)1X-14 mutation because of its dra¬
matic effects on mitotic chromosome formation, distinct from
other mitotic mutations. Our detailed analyses have revealed
the gene to be important for other aspects of mitosis, includ¬
ing spindle assembly and nuclear envelope dynamics. Fur¬
thermore, the identification of the gene and characterization
of its higher eukaryotic counterparts led to several surprises.
The IX-14 gene encodes a metalloprotease that is concen¬
trated in cytoplasmic structures resembling invadopodia. In¬
vasive tumor cells have the ability to elaborate invadopodia
that facilitate extracellular matrix degradation, thus aiding
metastasis (Bowden et al.. 2001; Buccione et al., 2004). The
IX-14 protein is structurally related to leishmanolysin, a ma¬
jor surface protease from Leishmania protozoa, which is
thought to have a significant role in the pathogenesis of leish¬
maniasis (Yao et al., 2003). As a result of the subcellular lo¬
calization and the sequence homology, we have termed the
protein product of the IX-14 gene "invadolysin." We have
discovered that invadolysin is highly concentrated at the lead¬
ing edge of migrating macrophages. Consistent with a role in
cell migration, we observe that the active migration of pri¬
mordial germ cells is affected in mutant fly embryos. Thus,
IX-14/invadolysin, a member of a new class of metallopro-
teases, links mitosis with cell migration.
Results
Chromosome structure is disrupted in
the IX-14 mutation
l(3)IX-14' is a late larval lethal mutation on the right arm of the
third chromosome, generated in an ICR-170 chemical mu¬
tagenesis screen for imaginal disc mutations (Shearn et al.,
1971). Preliminary analysis reported that the mutation was
characterized by metaphase arrest and hypercondensed mitotic
chromosomes (Gatti and Baker, 1989). We generated a trans-
poson insertion allele of the gene, I(3)1X-144Y7, by local hop¬
ping of a nearby P-element insertion. Here, we report a detailed
phenotypic analysis of both alleles, investigating not only chro¬
mosome morphology but also other aspects of cell division.
Whole mount preparations of IX-14 third instar larval
brains and imaginal discs showed that mutant tissues had
proliferation defects resulting in much-reduced brain size and
missing imaginal discs (unpublished data). Fig. 1 shows typi¬
cal DAPI-stained mitotic figures observed in wild-type (Fig.
1 A) and in IX-14 mutant (Fig. 1 C) neuroblasts. The IX-14
neuroblasts show the length-wise hypercondensation of mi¬
totic chromosomes initially observed after orcein staining,
but additionally demonstrate that the mutant chromosomes
appear loosely condensed with a ragged periphery. This phe-
notype differs from the extreme hypercondensation in other
mutations that produce a mitotic arrest phenotype (Heck et
al., 1993) or treatment of wild-type cells with microtubule
poisons such as colchicine (Fig. 1 B). Allowing more time in
mitosis with colchicine does not rescue the lateral condensa¬
tion defect in IX-14 mutant neuroblasts (Fig. 1 D), thus we
believe the phenotype represents a specific condensation de¬
fect rather than "conventional" hypercondensation in re¬
sponse to mitotic delay.
The IX-14 mutation affects interphase polytene chromo¬
somes as well as mitotic chromosomes. Polytene chromosomes o
from salivary glands of wild-type third instar larvae are dis- §
tinctively banded along the chromosome arms, and the cen- §
tromeres of the endo-reduplicated chromosomes are clustered g.
at the chromocenter (Fig. 1 E). This characteristic banding pat- 3
tern is abolished in IX-14 mutant polytenes and the chromo- |
some arms appear twisted and frayed (Fig. 1 F). In many nuclei |
it is difficult to identify an obvious chromocenter. Addition- 'g
ally, mutant polytenes were approximately half the size seen in o
wild type. This reduction in size may be due to under-replica- o
tion, as BrdU incorporation is clearly reduced in IX-14 mutant -n
neuroblasts, though the structural defects are not merely expli- 5"
cable by reduced replication. Ji
To further investigate an effect of the IX-14 mutation ^
on interphase chromatin structure suggested by the polytene w
phenotype, we addressed whether or not this mutation might °
act as a modifier in a position effect variegation assay. We
examined the effect of one copy of each IX-14 allele on ex¬
pression of the white gene in a white mottled 4 {wm4) back¬
ground. In wm4, inversion of much of the X chromosome
places the white gene (expression of which is responsible for
normal red eye color) adjacent to heterochromatin, thereby
reducing its expression. Mutations that enhance variegation,
E(var)s, further reduce expression of the white gene (whiter
eyes) potentially by increasing the "spreading" of hetero¬
chromatin. Suppressors of variegation, Su(var)s, result in
greater expression of the white gene (redder eyes) by de¬
creasing the heterochromatic environment of the reporter
gene. Fig. 1 G shows a pronounced increase in the redness of
flies' eyes with one copy of each IX-14 allele in a wm4 back¬
ground, indicating that IX-14 alleles are acting as Su(var)s
and "opening" heterochromatin. By inference, one role of
wild-type IX-14 may be to promote chromatin compaction or
heterochromatin formation, which is consistent with the ob¬
served mitotic defects. Therefore, we conclude that IX-14 is
required for chromosome architecture during both mitosis
and interphase.
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IX-14 Figure I. Chromosome defects in l(3)IX-14.
(A-D) Mitotic chromosome spreads from wild-
type (wt) and homozygous l(3)IX-14 mutant [IX-
14) third instar larval brains. "+ col" denotes
images from the representative genotype after
treatment with colchicine for 90 min. Note that
even with colchicine treatment, the IX-14 chro¬
mosomes are unable to condense as tightly as
the wild-type chromosomes. Bar, 5 fxm. (E and
F) Polytene chromosome spreads from wild-type
and IX-14 homozygous mutant third instar lar¬
val salivary glands. Banding and a chro-
mocenter are not as obvious in the mutant chro¬
mosomes. Bar, 10 (jum. (G) Position effect
variegation assay using "white" as a reporter
gene [W"4). Flies were sorted into categories
based on redness of the adult eyes (white bars,
0-25% redness; yellow bars, 26-50% red¬
ness; orange bars, 51 -75% redness; red bars,
76-100% redness). The distribution of eye
color is shown for the original W"4 stock as well
as for w™4 stocks containing one copy of each
of the two mutant l(3)IX-14 alleles. The majority
of W4;I(3)IX-14 (both alleles) flies grouped to¬
ward the red end of the spectrum, implying that
the mutant alleles act as suppressors of variega¬
tion (enhancing expression of the reporter
gene) and, conversely, that the wild-type gene
product acts to compact chromatin.
m""> IX-141 !X-144Y7
Spindle and centrosomal abnormalities
are common in IX-14 mutants
The over-shortened mitotic chromosomes suggested that IX-14
mutants may experience a metaphase delay possibly caused by
aberrant spindles. Neuroblasts of IX-14 mutants indeed exhibited
abnormal spindle morphology (Fig. 2, B-D and F), and in fact
only 2% of mitotic cells had a normal bipolar spindle. Spindle
abnormalities included monopolar spindles (37%; Fig. 2 B, inset
1), disorganized spindles (34%; Fig. 2 B, insets 2 and 3), and mi¬
totic figures where the spindle appeared bipolar, but asymmetric
(27%, Fig. 2 C, inset 4). Mutant spindles also appeared to have
thicker bundles of microtubules, compared with the finer fibers
observed in wild type (Fig. 2 A). Almost no anaphase figures
were observed in DAPI-stained neuroblasts from IX-14 mutant
larvae, which is consistent with a metaphase delay or arrest.
Nearly 70% of mitotic figures in IX-14 neuroblasts ap¬
peared to have only one focus of centrosomal staining, as judged
by CP190 localization (Fig. 2, B-D and F). Cells with monopo¬
lar spindles always had a single centrosome, whereas 75% of the
asymmetric bipolar spindles also had only one CP 190 "spot"
(Fig. 2 G). This single centrosome phenotype was also verified
with another mitotic centrosomal marker, centrosomin (unpub¬
lished data). In many cases, centrosomes appeared to have a
dumbbell shape (Fig. 2 F, arrow), suggesting that centrosomes
had duplicated but not separated. Although CP190 normally has
a nuclear localization during interphase (binding to specific loci
on polytenes), the protein dissociates from chromosomes in mi¬
tosis (Whitfield et al., 1995). Mitotic chromosomes from IX-14
homozygous cells curiously appeared to have higher levels of
CP190 than wild-type chromosomes (Fig. 2 F).
The aberrant spindles in the IX-14 mutation afford an ex¬
planation for the length-wise hypercondensation of chromo¬
somes, as spindle defects would be expected to arrest cells in
mitosis. However, the loose compaction and ragged edges of
the chromosomes cannot be accounted for by spindle abnor¬
malities as this is not observed when cells are arrested in mito¬
sis in response to microtubule poisons or other spindle defects
(Heck et al., 1993). Thus, IX-14 has essential roles both in
chromosome and spindle architecture in Drosophila cells.
IX-14 mutant: mitotic cells accumulate
abnormally high levels of nuclear
envelope proteins
As higher eukaryolic cells enter mitosis, chromosome condensa¬
tion and spindle assembly are accompanied by the disassembly
of the nuclear envelope. Surprisingly, the majority of IX-14 mi¬
totic cells showed dramatically increased levels of lamin DmO
(a B-type lamin), compared with wild-type mitotic cells (Fig. 3,
A and B). Strikingly, the level of another Drosophila nuclear
envelope protein, otefin, also appeared elevated in IX-14 mitotic
cells (Fig. 3, C and D). When double immunofluorescence was
performed, we observed a simultaneous increase of lamin and
otefin in the same cells (unpublished data). We believe this ele¬
vation occurs before mitosis as late G2 cells (those positive for
mitosis-specific phosphorylation of Serine 10 on histone H3)
also exhibited increased lamin and otefin fluorescence.
The increase in immunofluorescence corresponds to an
actual increase in protein level. Immunoblotting for lamin DmO
and otefin very clearly showed that these proteins accumulated
to unusually high levels in IX-14 larval brains (compare with
the a-tubulin loading control in Fig. 3 [E and F]). We addition¬
ally detected an increase in the level of Drosophila lamin C
(unpublished data). We only detected increase of full-length
forms by immunoblotting, with no evidence for accumulation
of alternative forms. Merely arresting wild-type cells in mitosis
with colchicine did not elevate lamin levels (unpublished data).






Figure 2. Centrosome and spindle pheno-
types of l(3)IX-14. (A) Wild-type larval neuro¬
blasts stained for a-tubulin (green), CP190
(red), and DAPI (blue). Wild-type metaphase
figures contain normal bipolar spindles with
two centrosomes. (B-D) IX-14 larval neuro¬
blasts labeled as in A show extreme spindle
abnormalitios. Boxod mitotic figures in IX 14
mutant panels are enlarged in D to highlight
mutant phenotypes of monopolar (1), disorga¬
nized (2 and 3), and asymmetric (4) spindles.
Bar, 5 pm. (E) Wild-type larval neuroblasts
stained for CP 190 (green) and DAPI (red),
showing duplicated and separated cen¬
trosomes at metaphase. (F) IX-14 larval neuro¬
blast stained as in E, showing chromosome
condensation and centrosome separation de¬
fects (arrow) in mitosis. Additionally, CP 190
appears to persist on IX-14 mutant chromo¬
somes longer than in wild-type cells. Bar, 5
p,m. (G) Quantitation of centrosome number in
the wild-type and IX-14 mitotic cells. Nearly
70% of mitotic figures in the IX-14 mutation
appeared to have only one focus of centroso-
mal staining.
merged a-tubulin CP190 DNA
We conclude that the IX-14 mutation appears to affect multiple
aspects of structural rearrangement as cells enter mitosis.
The IX-14 gene encodes a novel
metal loprotease
We mapped the original IX-14 allele to the 85E10-F16 region by
crossing to deficiency lines with known breakpoints. We then
generated a P-element insertion allele by local hopping a nearby
P-element, 1(3)04017. The P-element allele allowed cloning of
adjacent genomic DNA by inverse PCR; hybridization of this
fragment to a Drosophila PI array refined our mapping to
85F14-15. A candidate IX-14 gene was cloned by identifying a
3.6-kb full-length Drosophila adult head library EST whose se¬
quence overlapped with the ^700-bp genomic fragment flank¬
ing the P-element. The gene was composed of nine exons, with
the first exon separated from the remaining eight by a large
(~8.6 kb) intron (Fig. 4 A, asterisk). This gene has been desig¬
nated CG3953 in the Drosophila genome annotation database.
We mapped the P-element insertion site to 40 bp up¬
stream of the start of transcription of the IX-14 gene. Precise
excision of this P-element was shown to revert the mutant phe-
notype and restore viability. The insertion appeared to disrupt
the IX-14 promoter, resulting in a strong hypomorphic or null
mutation. To determine whether or not expression of this gene
was affected in IX-14 alleles, Northern blot analysis was per¬
formed on total RNA from third instar larvae. This showed that
the predicted 3.6-kb mRNA was indeed missing in larval ex¬
tracts prepared from both IX-14 alleles (Fig. 4 B).
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tify orthologues in all higher eukaryotes examined, but con¬
spicuously not in bacteria or yeasts, suggesting that the IX-14
gene product may only be required in metazoa.
The worm, human, mouse, and lly orthologues are shown
in the alignment of Fig. 4 C, but other more divergent ortho¬
logues (e.g., Arabidopsis thaliana and Dictyostelium discoi-
deum) are not included. Although the most obvious homology
with leishmanolysin is centered on the conserved zinc-metallo-
protease motif (Fig. 4 C, boxes) and immediate surrounding re¬
gions, the NH2- and COOH-terminal regions are considerably
more divergent. A potential signal sequence is present near the
NH2 terminus of all orthologues, although whether or not this
sequence acts to target the protein is currently unknown. In-
tnguingly, there are at least nine blocks (Fig. 4 C, numbered
double-headed arrows) shared among the worm, human,
mouse, and fly orthologues that are absent from the leish¬
manolysin sequence. Despite this finding, the positions of 14
cysteines are remarkably conserved between leishmanolysin
and the higher eukaryotic proteins (Fig. 4 C, asterisks). This re¬
sult suggests strongly that the "core" of the IX-14 protease
should resemble that of leishmanolysin (Schlagenhauf et al.,
1998), and furthermore predicts that the indicated "insertions"
should lie at the surface of this structure. Indeed, the sites of
these insertions all map to the surface of the leishmanolysin
structure (Fig. 4 D, black numbered spheres; the internal zinc
ion essential for catalysis is represented by a magenta sphere).
Therefore, we conclude that IX-14 is a member of a subgroup
of the leishmanolysin protease group.
RNAi depletion of IX-14 in cultured cells
phenocopies neuroblast defects
As further evidence that the gene we identified is responsible
for the defects observed in IX-14 larval tissues, we per¬
formed dsRNA-mediated interference of IX-14 in Drosophila
Schneider 2 (S2) cells. The abnormal spindle phenotypes seen
in the mutant alleles, typically monopolar or disorganized,
were phenocopied in roughly 25% of the IX-14 RNAi mitotic
cells (Fig. 5 A). In addition, mitotic figures front RNAi cultures
were frequently observed to have single centrosomes or what
appeared to be two closely apposed centrosomes (Fig. 5 B). Al¬
though control S2 cells have a low level of aneuploidy and oc¬
casional abnormal numbers of centrosomes, neither the aber¬
rant spindles nor unseparatcd centrosomes were observed in
control cells (Fig. 5, -dsRNA panels). Therefore, we are con¬





Figure 3. Abnormal levels of nuclear envelope proteins in l(3)IX-14 mutant
cells. Larval brains from wild-type and IX-14 homozygous mutant animals
were processed for lamin and otefin detection. (A) Wild-type mitotic cells
(arrow) show homogeneous lamin staining as the nuclear lamina becomes
dispersed during mitosis. (B) In contrast, both IX-14 alleles have greatly in¬
creased lamin staining during mitosis (arrowhead). Bar, 5 p-m. (C) Wild-
type neuroblasts show distinct nuclear envelope staining similar to lamin.
(D) Both IX-14 alleles also show greatly increased otefin staining during
mitosis. Protein extracts from wild-type and IX-14 larval brains were probed
for DmO lamin (E) and otefin (F). a-tubulin (bottom) served as a loading con¬
trol, and confirmed that the samples were similarly loaded. The levels of
both lamin and otefin detectable by immunoblotting was significantly
greater in the mutant tissues than in wild-type brains.
merged lamin DmO DNA
The 2,052 nucleotide ORF in the IX-14 cDNA encodes a
683 amino acid protein (predicted Mr = 71 kD) with homology
to proteins in the M8 class of zinc-metalloproteases focused on
the characteristic "HEXXHXXG[X]NH" catalytic motif. The
founding member of this family is the leishmanolysin cell sur¬
face protein (also called GP63) from the pathogen Leishmania
major. In vitro mutagenesis of leishmanolysin has determined
that the glutamic acid and three histidine residues are essential
for protease activity (McMaster el al., 1994; Macdonald et al.,
1995; McGwire and Chang, 1996). We have been able to iden-
IX-1 4 cleaves lamin in vitro
To examine whether or not IX-14 has protease activity, sug¬
gested by its homology to the catalytic motif of leishmanolysin.
we performed two complementary approaches. In the first, pro¬
tein extracts prepared from wild-type and IX-14 mutant larval
brains were examined for protease activity (Fig. 6 A). Protease
activity was assayed in zymogram gels containing casein as
substrate. Whole larvae harbor a high level of protease activity
at numerous molecular masses when assessed by zymography
(unpublished data). Therefore, we prepared protein extracts
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Figure 4. Molecular characterization of l(3)IX-14. (A) Map of the DmlX-14 gene (CG3953), with exons depicted as black boxes and 5' and 3' UTRs as
hatched boxes. The position of the P element insertion in I(3)IX-144Y7 is 40 bp upstream of the transcription start site (gray triangle). The first intron (8.6 kb,
asterisk) is not shown to scale in this figure. (B) Northern blot of wild type and IX-]4 heterozygous (+/—) and homozygous {—/—) total larval RNA probed
with IX-14 full-length cDNA. The same blot probed for ribosomal protein RP49 mRNA is shown as a control. The IX-14 mRNA is undetectable in RNA
obtained from homozygous IX-14 alleles. (C) T-COFFEE alignment showing homology between Drosophila melanogoster IX-14, metazoan orthologues,
and Leishmanolysin, with the conserved HEXXHXXG (and third required H) zinc-metalloprotease motif boxed. Sequences shown are as follows: Ce, Cae-
norhabditis elegans (CAB16471); Hs, Homo sapiens (CAC42882); Mm, Mus musculus (NP 76641 l); Dm, Drosophila melanogaster (NP 652072); Lm,
Leishmania major (AF039721). Although the homology between leishmanolysin and the other proteins appears to be largely limited to regions surround¬
ing the metalloprotease motif, the placement of 14 cysteines (asterisks) is strikingly conserved. Nine regions shared among the higher eukaryotic ortho-
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A merged a-tubulin P~H3 DNA Figure 5. dsRNAmediated interference of IX-14 inDrosophila S2 cells phenocopies the mutation. (A] Spin¬
dles of S2 cells: control (top) and 72 h after dsRNA
treatment (bottom). Cells are stained for a-tubulin
(green), P-H3 (red), and DAPI (blue). The normal bi¬
polar spindle in the control S2 cell is to be contrasted
with the disorganized spindle shown in the treated
cell. This is similar to that observed in IX-14 homozy¬
gous mutant alleles. Bar, 5 pm. (B) Centrosomes of
S2 cells: control (top) and 72 h after dsRNA treatment
(bottom). Cells are stained for CP 190 (green) and
DAPI (red). The treated cells show the centrosome sep¬
aration defect (arrow) similar to that observed in




from larval brains only, as the phenotypes were clearly appar¬
ent in this proliferating tissue. Wild-type brain lysates had two
visible bands of protease activity, migrating at ~120 and 135
kD (Fig. 6 A, asterisks). Remarkably, these two bands of activ¬
ity were almost completely absent in IX-14 brains, indicating
that mutant extracts were indeed missing proteolytic activity. A
separate stained gel documents that wild-type and mutant lanes
were equivalently loaded (Fig. 6 B). As these zymogram gels
are nondenaturing, the molecular mass of the observed activity
is not necessarily related to predicted molecular mass, but may
suggest that IX-14 migrates as a multimer or part of a complex.
The lack of protease activity in mutant brains further suggests
that the IX-14 gene product is responsible not only for the mu¬
tant phenotypes but also for the protease activity observed un¬
der these conditions (either directly or potentially through the
activation of other proteases).
The increase in nuclear envelope proteins observed by
immunofluorescence and immunoblotting in mutant brains
suggested that lamin (or otefin) might be a substrate of the IX-
14 meialloprotease. As shown in F'ig. 6 C, in vitro synthesized
DmO lamin is cleaved by in vitro synthesized IX-14. Further¬
more, the cleavage of lamin can be inhibited by the inclusion of
ortho-phenanthroline, a chelator of zinc (Fig. 6 C, asterisks).
Although full-length lamin was detected by immunoblotting in
this experiment (Fig. 6 C, arrowhead), we failed to detect any
cleavage products (they may not be recognized by the antibody
used). Thus, IX-14 is a novel essential protease capable of
cleaving at least one component of the nuclear envelope.
IX-14 localizes to distinct structures
in the cytoplasm of Drosophila and
human cells
Several approaches were used to determine the subcellular lo¬
calization of the IX-14 protein. Drosophila S2 cells tran¬
siently transfected with expression plasmids tagging either
the NH2 or COOH terminus with EGFP showed cytoplasmic
localization, whereas vector alone localized to both the nu¬
cleus and cytoplasm (Fig. 7 A). The human genome contains
a single IX-14 gene, which we have shown by preliminary
siRNA analysis to be essential for viability (unpublished
data). Due to the limit of resolution with the relatively small
and generally nonadherent S2 cells, we turned to examining
IX-14 localization in human cells. A COOH-terminal EGFP
fusion construct of HsIX-14 in HeLa cells was also localized
logues (absent from leishmanolysin) are indicated by double-headed arrows. The gray triangles delimit the region of the leishmanolysin protein that is
shown in D. (D) Stereo pair of the three-dimensional structure of leishmanolysin is shown (PDB accession code is 1LML). The black numbered spheres rep¬
resent the higher eukaryotic "insertions" (relative to leishmanolysin), which all map to the surface of the leishmanolysin structure. The internal magenta
sphere represents the zinc ion required for catalysis.
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M wt IX-14
Figure 6. The IX-14 protein exhibits protease activity. (A) Colloidal
Coomassie blue-stained nondenaturing casein zymogram gel showing
one brain equivalent of wild type (+/+) versus three brain equivalents of
homozygous (IX-14) third instar larval brain extract. A doublet of protease
activity is observed in wild-type extracts (asterisks), but is greatly depleted
in mutant extracts. A band of protease activity is also present in the
prestained molecular mass markers (arrowhead), which serves as an inter¬
nal control in these experiments. (B) Coomassie blue-stained denaturing
polyacrylamide gel showing equivalent loading of larval brain extracts
(three mutant brains are a roughly equivalent amount to one wild-type
brain). (C) Drosophila IX-14 cleaves Drosophila DmO lamin in vitro. In
vitro transcribed and translated proteins were mixed and incubated for
60 min at 29°C (IX-14 and lamin alone are in the first two lanes). The
cleavage of lamin was detected by immunoblotting with a mAb generated
against the NF^-terminal head region (arrowhead). The addition of zinc at
2, 5, or 10 mM enhanced the cleavage reaction, whereas the addition of
the 1,10-phenanthroline zinc chelator inhibited the cleavage of lamin by
the IX-14 protease (asterisks).
in the cytoplasm, often as unusual ring-like structures (Fig. 7
B). A control transfection with EGFP alone localized through¬
out both the nucleus and cytoplasm. From these experiments
we concluded that the IX-14 protein localized predominantly
in the cytoplasm of fly and human cells.
Two protein sequences for the human orthologue possi¬
bly representing alternatively spliced forms have been submit¬
ted: CAC42883-version 1 and CAC42882-version 2 (Fig. 4
B). These forms differ in their NH2-terminal regions (upstream
of the residues VINK) and by the presence of a 37 amino acid
sequence in the COOH-terminal half of version 2 found in all
the other eukaryotic orthologues so far (between the residues
EDTG:RQME). We generated an antibody to amino acids 327
to 629 of HsIX-14.vl (downstream of the catalytic motif). As
this region is fully present in both predicted human versions,
the antibody should recognize the two forms if they indeed
both exist. Fig. 8 A shows a typical staining pattern observed
with the HsIX-14327"629 antibody in HeLa cells. We observed
unusual ring-like structures similar to those seen with the
EGFP-tagged protein. These striking structures were also ob¬
served in two other human transformed cell lines, Jurkat and
CF-PAC (unpublished data). These structures were observed in
all interphase cells, and although their size remained fairly con¬
stant (< 1 p,m in diameter), the number of the structures varied
on a cell to cell basis. Z-series of sections through cells showed
that these structures were located in the lower third of the cells.
Because the ring-like structures were dispersed in mitosis in all
cell types examined, we believe that the localization (and/or ac¬
tivity) of IX-14 may be regulated during the cell cycle.
Although proteases are found in diverse structures within
cells, this particular localization did not resemble any of the
usual protease-containing complexes, e.g., 26S proteasome,
the related COP9-signalosome complex, lysosomes, or aggre-
somes. Nonetheless, we performed colocalization immunofluo¬
rescence with antibodies to IX-14 and proteasome core sub-
units a5 and |35i, signalosome subunit Cgn3, chaperone protein
Hsc70, and markers for Golgi, mitochondria, and lysosomes.
We observed no significant colocalization between IX-14 and
any of these proteins (unpublished data). However, numerous
transformed cells contain invadopodia, which are believed to
be important for extracellular matrix degradation and cellular
migration (Bowden et al., 1999, 2001; Baldassarre et al., 2003;
Buccione et al., 2004). Invadopodia resemble in size and distri¬
bution the structures labeled by the IX-14 antibody. As no pro¬
teins exclusive to invadopodia have yet been identified, defini¬
tive colocalization was not possible. However, we detected
limited colocalization with markers shown to label invadopo¬
dia (e.g., phosphotyrosine, cortactin, and Dynamin 2), suggest¬
ing that these cytoplasmic ring-like structures very likely are
invadopodia.
A role for IX-14 in cell migration
If IX-14 were involved in cell migration, as suggested by the
invadopodia-like localization, one might predict that the pro¬
tein should localize to regions of cells actively involved in mi¬
gration. Thus, we examined the localization in stationary and
migrating human macrophages (Fig. 8, B and C). Fig. 8 B
showed that punctate, at times ring-like, cytoplasmic IX-14
structures were observed in cultured human macrophages (in
the example shown, the cell is stationary). The morphology of
macrophages is dramatically altered as they migrate. In the two
examples shown, the IX-14 protein is strikingly mobilized
from internal structures to the leading edge of cells (Fig. 8 C).
This extraordinary relocalization of IX-14 protein suggests a
very intimate involvement of this protein in cell migration.
Given a possible role for this protein in cell migration, we
examined primordial germ cell migration in wild-type and IX-
14 mutant Drosophila embryos (for review see Santos and Leh-
mann, 2004). After being the first cells to form very early in
embryogenesis, primordial germ cells are passively carried
along the dorsal side of the embryo in close association with
the posterior midgut primordium. As this primordium invagi-
nates, the germ cells are carried to the interior of the embryo.
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merged Figure 7. Localization of GFP-tagged IX-14 in Drosophila
S2 and HeLa cells. (A) Drosophila S2 cells transiently trans-
fected with constructs expressing EGFP vector only (top) and
DmlX-14 tagged at the NH2 (middle) and COOH termini
(bottom). EGFP, green; DAPI, red. DmlX-14 tagged with
EGFP at either end appears to be concentrated in cytoplasmic
foci, in contrast to EGFP alone, which shows diffuse localiza¬
tion throughout the cytoplasm and nucleus. Bar, 5 |xm. (B)
HeLa cells transiently transfected with constructs expressing
EGFP vector only (left) or HslX-14 tagged at the COOH termi¬
nus (right). EGFP alone is localized diffusely throughout both
nucleus and cytoplasm, HslX-14~EGFP is localized to cyto¬




the adjacent mesoderm where they associate with somatic go¬
nadal precursor cells. These clusters of cells further migrate
and coalesce into gonads later in embryogenesis. Using Vasa as
a marker for primordial germ cells, we examined embryos both
before and after the migration phases. As shown in Fig. 9, germ
cells in both wild-type (Fig. 9 A, top) and mutant (Fig. 9 B,
top) embryos are similarly dispersed at the stage before active
migration. However, a dramatic difference is seen in embryos
at the later stage of gonad coalescence, with gonads visible in
wild type (Fig. 9 A, bottom), but not in the mutation (Fig. 9 B,
bottom). Mutant larvae then lack gonads (unpublished data).
Therefore, the IX-14 protease is playing a role in cell migra¬
tion, as well as in mitosis, in Drosophila.
Discussion
Drosophila IX-14 mutations cause a variety of defects in chro¬
mosome, spindle, and nuclear envelope structure during mito¬
sis. Here, we have shown that the IX-14 gene encodes a novel
metalloprotease that is highly conserved in metazoa. Because
of its homology to leishmanolysin, we suggest that the core of
the IX-14 protease should structurally resemble that of leish¬
manolysin. In both Drosophila and human cells, the metallo¬
protease is concentrated in cytoplasmic organelles that we
believe correspond to invadopodia. In recognition of the
homology and intracellular distribution, we have termed the
IX-14 enzyme invadolysin.
Three lines of evidence point to invadolysin activity as
being crucially involved in the mitotic structural defects ob¬
served in Drosophila IX-14 neuroblasts: (1) The mRNA for the
IX-14 gene is absent from larval tissues of two independently
generated mutations, both of which have identical phenotypes;
(2) dsRNA-mediated depletion of the IX-14 protein in cultured
cells mimics the specific spindle and centrosome defects ini¬
tially observed in the animal; and (3) in zymography experi¬
ments, mutant larval brains lack protease activity that is present
in wild-type tissues.
Our analysis of the phenotype of IX-14 mutant alleles of
Drosophila revealed that lamin (both DmO and C) and otefin
proteins are present in elevated amounts in mutant neuroblasts.
This finding suggests that invadolysin or one of its downstream
targets normally promotes the turnover of these nuclear enve¬
lope proteins. In fact, cleavage may be due to invadolysin it¬
self, as we have shown that the enzyme can cleave Drosophila
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B merged invadolysin actin DNA












Figure 8. Localization of IX-14/invadolysin in human cells. (A) HslX-14 localization in HeLa cells, detected with a rabbit antibody generated to HslX-14
(amino acids 327-629). HslX-14, green; a-tubulin, red; DAPI, blue. The HslX-14 staining is seen as discrete ring-like structures in the cytoplasm of inter¬
phase cells, in addition to a nuclear pool of the protein. This staining pattern becomes more diffuse in mitosis, and is similar in Jurkat and CF-PAC cells
(not depicted). Bar, 5 (cm. (B) HslX-14 localization in normal stationary human macrophages cultured in vitro. HslX-14, green; rhodamine-phalloidin/
actin, red; DAPI blue. Bar, 5 rem. (C) HslX-14 localization in normal migrating human macrophages cultured in vitro. HslX-14, green; rhodamine-phalloidin/
actin, red; DAPI, blue. Note that all of the IX-14/invadolysin has now strikingly relocalized to the leading edge of the cells.
lamin DmO in vitro. Many previous papers have demonstrated
that lamina dynamics in mitosis are regulated by reversible
phosphorylation by Cdklxyclin B and that the proteins are re¬
used at nuclear envelope reformation during telophase (Gant
and Wilson, 1997). Thus, although the mechanism and timing
of the invadolysin-dependent nuclear envelope turnover has yet
to be determined, the phenomenon is important because it re¬
veals previously unsuspected complexities of nuclear envelope
dynamics during the cell cycle. Identification of other invado¬
lysin substrates, e.g., ones essential for chromosome condensa¬
tion and spindle assembly, will also illuminate further details of
these mitotic rearrangements.
The IX-14 gene encodes a novel
metalloprotease
Sequence analysis of the IX-14 gene suggested that it encodes a
novel conserved zinc-metalloprotease with sequence homology
to leishmanolysin and to orthologues that we have identified in
a range of metazoan species. Leishmanolysin is a major cell
surface protease that is required for Leishmania 's parasitic ac¬
tivity. It has been extensively studied due to its pathogenic role
in leishmaniasis (Russell and Wilhelm, 1986; Yang et al.,
1990; Connell et al., 1993; Xu and Liew, 1995; McGwire and
Chang, 1996; Yao et al., 2003), and has also recently been
shown to enhance migration of Leishmania through extracellu¬
lar matrix (McGwire et al., 2003).
Like leishmanolysin, invadolysin has the conserved resi¬
dues of the metzincin protease "HEXXHXXG[X]NH" motif.
This motif has been characterized in detail by mutational anal¬
ysis of the three conserved histidine (which coordinate the zinc
ion) and glutamic acid residues, which are absolutely required
for catalytic activity (McMaster et al., 1994; Macdonald et al.,
1995; McGwire and Chang, 1996). We additionally noted the
conserved spacing of 14 cysteines among leishmanolysin and
the orthologues described in this paper. Molecular modeling
studies revealed that the framework of the higher eukaryotic
form of this protein is likely to closely resemble that of leish¬
manolysin, with differences being confined to surface features
that likely mediate interactions with substrates, regulators, and/
or other binding partners.
None of the identified invadolysin orthologues has had any
functions ascribed to them. Therefore, we propose that the IX-14/
invadolysin family is required for cell cycle structural rearrange¬
ments, a novel activity for this class of proteases. The Zmpste24
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B IX-14/IX-14
Figure 9. Germ cell migration defects in II3/IX-14 embryos. All panels are dorsal views of Drosophila embryos. Left panels are phase-contrast images, middle
panels show DAPI labeling of DNA, right panels show germ cells detected by Vasa antibody. (A) Wild-type Canton S embryos, (topj Stage 10/11, when germ
cells are in the middle of passing through the midgut and migrating dorsally. (bottom) Stage 13, when germ cells form two elongated clusters on either side of
the embryo. (B) IX-14 homozygous embryos selected for absence of the Kr-GFP balancer chromosome, (top) Stage 10/11, germ cells appear as in wild-type
embryos, [bottom) Stage 13, when the abnormal germ cell migration phenotype is apparent. The germ cells fail to migrate and coalesce into gonads.
metalloprotease in mice (a member of the M48 family of zinc-
metalloproteases) has a role in prelamin A cleavage (Pendas et
al., 2002). Matrix metalloproteases (MMPs) have been impli¬
cated in remodeling of the extracellular matrix (Ishizuya-Oka et
al.. 2000) and in release of growth factors (Levi et al., 1996).
MMPs have been shown to act in some cancers to digest the sur¬
rounding extracellular matrix and aid the process of metastasis
(Ellerbroek and Stack, 1999; Horikawa et al., 2000; Johansson et
al., 2000). Whereas the human genome encodes 24 MMPs, Dro¬
sophila has only two MMP genes: Dml-MMP is expressed more
specifically during embryonic stages and Dm2-MMP apparently
throughout development (Llano et al., 2000, 2002). Few muta¬
tions are available to study metalloproteases in a developing or¬
ganism, although a study on double mutants of the two Drosoph¬
ila MMPs has shown that whereas tissue remodeling is disrupted,
embryonic development and larval mitosis are unaffected (Page-
McCaw et al., 2003). Thus, no other metalloprotease affects cell
proliferation as IX-14/invadolysin does.
Intracellular localization of IX-14 to
invadopodia
Although a nuclear pool of invadolysin is detectable in human
cells, protein is also localized to the cytoplasm in both fly and
human cells, where it is concentrated in unusual ring-like struc¬
tures. These structures are observed during interphase in all hu¬
man cultured cells examined, but become dispersed during mi¬
tosis, when the protein adopts a more diffuse distribution. We
believe the ring-like structures represent invadopodia, cyto¬
plasmic structures that have been proposed to have an impor¬
tant role in cell migration and metastasis. Like invadopodia, the
ring-like structures containing invadolysin are localized to the
lower third of the cell close to the substratum. They also con¬
tain cortactin, paxillin, and dynamin 2, previously shown to be
enriched in invadopodia. Inlriguingly, dynamin 2, which is also
found in invadopodia, has been recently shown to play a role in
centrosome cohesion (Thompson et al., 2004), thus tying in
with our results linking migration with mitosis.
Strikingly, although invadolysin has a punctate cyto¬
plasmic localization in stationary macrophages, when actively
migrating macrophages are visualized, invadolysin becomes
strongly concentrated at the leading edge of the cell. How this
relocalization occurs will be investigated in living cells, cou¬
pled with an analysis of extracellular matrix degradation. Inva¬
dolysin appears to be the first specific marker for invadopodia
as a discrete cytoplasmic compartment, and, as such, will be a
key potential target for drugs designed to limit cell migration.
Analysis of invadolysin mutants identifies
a previously unsuspected role for
metalloproteases in cell division and
development
The IX-14 mutation in Drosophila causes cells to arrest in mi¬
tosis with hypercondensed mitotic chromosomes surrounded
by poorly condensed chromatin, a phenotype that is clearly dis-
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tinct from the chromosome hypercondensation commonly ob¬
served in mutations exhibiting mitotic delay (Heck et al., 1993;
Theurkauf and Heck, 1999). Invadolysin also appears to have a
role in chromosome architecture during interphase because
mutations exhibit poorly structured polytene chromosomes and
have compromised heterochromatin, as assayed by position ef¬
fect variegation. The levels of nuclear lamin and otefin proteins
are dramatically increased in mutant mitotic cells. One possi¬
bility suggested by these results is that invadolysin might regu¬
late interactions between chromatin and the nuclear envelope
that are important for gene expression and/or mitotic chromo¬
some condensation. Invadolysin could have a direct role on
components such as topoisomerase II or condensin, or the ef¬
fects we have observed could result from disruption of a novel
pathway in which proteolysis plays a role.
In addition, invadolysin has nonchromosomal roles, as
both centrosome duplication and/or separation and mitotic
spindle formation are aberrant in mutant neuroblasts. Thus, the
phenotypes resulting from loss of invadolysin are novel and
distinct from other previously described mitotic defects. We
have presented evidence that the protein is involved in migra¬
tion of human macrophages and fly primordial germ cells.
Thus the identification and study of this gene has provocatively
linked mitosis with cell migration.
A simplistic hypothesis is that different forms of the pro¬
tein may be important for structural rearrangements during the
cell cycle and for cellular migration. Clearly, the generation of
reagents recognizing specific forms would be required to ad¬
dress this question. Differential regulation of the expression or
localization of these forms could be used during development
and/or disease pathogenesis. It is clear from the striking phe-
notype displayed by IX-14 mutations that invadolysin illumi¬
nates a previously unsuspected pathway essential for cell divi¬
sion and development in metazoa. Future identification of
invadolysin substrates will help to clarify the role of this pro¬
tein and lead to better understanding of the ways in which




The wild-type strain used was Canton S. We received /(3j/X-/4' from M.
Gatti (University of Rome, Rome, Italy); it was originally generated in an
ICR-170 screen by A. Shearn (Johns Hopkins University, Baltimore, MD).
We generated l(3)IX-144Y7 after local hopping a nearly P transposon inser¬
tion, 1(3)04017, obtained from the Bloomington Stock Center.
DAPI staining of Drosophila neuroblast squashes and polytene
chromosomes
Brains or salivary glands from third instar larvae were processed as de¬
scribed previously (Heck et al., 1993; Loupart et al., 2000) and mounted
in Mowiol/glycerol. Fluorescence was observed using a fluorescence mi¬
croscope (model AX-70 Provis; Olympus) fitted with epifluorescence filters
(Chroma Technology Corp.). Digital images were captured (at <~1 8°C) us¬
ing a camera (model Orca II; Hamamatsu) with Vysis QUIPS software and
processed using Adobe Photoshop 4.0.
Immunofluorescence of third instar larval brains
Analysis of a-tubulin (Sigma-Aldrich), CP190 (provided by W. Whitfield,
University of Dundee, Dundee, Scotland), lamin (provided by P. Fisher,
State University of New York at Stony Brook, Stony Brook, NY), otefin
(provided by Y. Gruenbaum, Hebrew University of Jerusalem, Jerusalem,
Israel), cyclin B (provided by J. Raff, University of Cambridge, Cambridge,
England), and P~H3 (Upstate Biotechnology) antibodies in third instar lar¬
val brains was performed as described previously (Bonaccorsi et al.,
2000). BrdU incorporation and subsequent detection by a rat anti-BrdU
antibody (Harlan Sera) in larval brains was performed as described previ¬
ously (Loupart et al., 2000). Imaging was performed as detailed in the
previous section.
Immunoblotting
Protein extracts were electrophoresed on Novex SDS-PAGE gels (Invitro-
gen), and then transferred to nitrocellulose membrane (Schleicher and
Schuell). Membranes were rinsed for 5 min with PBSTw (PBS + 0.1%
Tween 20), and then blocked for 1 h with Safeway dried skimmed milk
(5% in PBSTw) at RT with shaking. Primary and secondary antibody incu¬
bations were performed in PBSTw for 1 h at RT with shaking, with washes
of 2 X 3 min, 1x15 min, and then 2x5 min after each incubation.
Chemiluminescent detection of HRP-conjugated secondary antibody was
performed using ECL reagents from Amersham Biosciences, according to
the manufacturer's instructions.
Northern blotting
Northern blots were performed as described in Sambrook et al. (1989).
Total RNA was prepared from homogenized third instar larvae using the
RNeasy RNA extraction kit (QIAGEN). 10 pg of total RNA per lane was
electrophoresed on a 1% agarose gel. RNA was transferred to nylon
membrane by capillary action with 20x SSC overnight. RNA was subse-
quently UV-cross-linked to the membrane using a Strata-linker (Stratagene). ^
IHybridization of 32P-dCTP (AP BiotechJ-labeled probes at a specific activ- !|
ity of at least 106 counts per milliliter was performed at 65°C overnight as o
described in Church and Gilbert (1984). The HighPrime kit (Boehringer) q_
was used for all random primer labeling. Autoradiography was done at cl
-80°C using XAR-5 film (Kodak). §*
3
dsRNA-mediated interference ^
dsRNAi was performed on Drosophila S2 cells as described previously ^
(Clemens et al., 2000; Vass et al., 2003), using 15 pg/ml of double ^
stranded IX-14 RNA per 2 ml of cells at 106 cells/ml.
ca
Immunofluorescence of Drosophila S2 and HeLa cultured cells o
S2 cells were grown on either Permanox Chamber Slides (Lab-Tek) for the -p,
RNAi experiments or on poly-L-lysine coverslips in 6-well plates for the g-
EGFP-fusion detection using a rabbit anti-GFP antibody (Molecular Probes). 3
HeLa cells were grown on coverslips in 6-well plates for transfection with ^
EGFP fusion constructs. For immunofluorescence, cells were fixed with 4% ^
PFA in PBS for 3 min, permeabilized in PBS + 0.5% Triton X-100 for
1 min, and washed 2x10 min incubations in PBTx. The cells were o
blocked for 1 h in 3% BSA in PBS at RT. Primary antibody incubation was ^1
overnight at 4°C in 0.3% BSA in PBS. Cells were washed 3x5 min in
PBTx, followed by secondary antibody incubation for 1 h at 37°C (second¬
ary antibodies incubated separately). Final washes were 3x5 min in
PBTx, with the penultimate wash containing 0.1 pg/ml DAPI, and the cov¬
erslips were mounted in Mowiol-glycerol. Imaging was performed as de¬
tailed in the section DAPI staining of Drosophila neuroblast squashes and
polytene chromosomes.
Detection of protease activity by zymography
Zymogram gels (Novex) containing casein as a substrate were used for all
zymography. Wandering third instar larvae were dissected in 1 X EBR.
Brains were transferred to 50 pi of chilled EBR, and then homogenized for
~30-60 s with a hand-held homogenizer. 50 pi of 2x Tris-glycine gel
sample buffer (Novex) plus 1 mM DTT was added, and the samples were
incubated for 10 min at RT. Samples (without boiling) were loaded onto
12% Tris-Glycine Zymogram gels and electrophoresed at 125 V constant,
generally for 3-4 h, at least until the dye front had run off the gel. After
electrophoresis, gels were rinsed in renaturing buffer (2.5% Triton X-100)
for 30 min, equilibrated in Developing buffer (Novex) for 30 min, and incu¬
bated overnight at 37°C in Developing buffer. Gels were stained with Col¬
loidal Coomassie blue (Sigma-Aldrich) to visualize the casein in the gel.
in vitro proteolysis of lamin by invadolysin
375 ng of Lamin in T7-7 vector, IX-14 in pOT2 vector, or GFP control vec¬
tor was added to one 24-pl aliquot of the RTS 500 Escherichia coli Circu¬
lar Template kit (Roche). Each expression aliquot was incubated in a wa¬
ter bath at 30°C for 1 h. 10 pi of IX-14 was mixed with 1 or 4 pi of lamin
or GFP before being incubated in a water bath at either 29 or 37°C for
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15 min, 50 min, or 1 h. In some cases, the incubation was with ZnCb or
ZnS04 or the zinc chelator 1,10-phenanthroline. After the reaction, sam¬
ples were boiled at 100°C for 5 min in SDS-PAGE sample buffer. Lamin
was detected after blotting to nitrocellulose using an mAb generated to the
Drosophila Nh^-terminal head region (amino acids 22-28).
Macrophage isolation and culture
Macrophages were isolated from normal human blood following the pro¬
cedure of Giles et al. (2001). After isolation, the mononuclear cells were
plated at 4 x 106/ml in Iscoves' modified Dulbecco's medium (with L-glut
and 25 mM Hepes) onto glass coverslips in 12-well tissue culture plastic
plates for 1 h. Adherence to the glass coverslips was used to enrich for the
monocytes out of the lymphocytes/monocytes mix (lymphocytes do not at¬
tach). After settling, the plates were washed in Hank's Balanced Salt Solu¬
tion (without divalent cations) to remove nonadherent lymphocytes, and
then 2 ml of Iscoves' modified Dulbecco's medium + 10% autologous se¬
rum was added and the cells were cultured at 37°C, 5% CO2, for 5 d. Af¬
ter 5 d, the cells were washed again to remove any nonadherent cells and
fixed in 3% PFA at RT for 20 min. After washes in PBS, 50 mM NH4CI was
added to the wells for 15 min. Coverslips were permeabilized in 0.1% Tri¬
ton X-100 for 4 min. After washes, the cells were blocked in 10% heat-
inactivated human serum and processed for immunofluorescence as usual.
Detection of germ cells
For the examination of appropriately staged embryos, Canton S wild-type
and 4Y7/TM3 (Kr:GFP) flies were allowed to lay embryos on yeasted red
wine concentrate agar plates either overnight or for 3-h collections, which
were then aged until the desired stage. Embryos were washed and
dechorionated in 50% bleach in dd^O for 4 min and rinsed. Homozy¬
gous 4Y7/4Y7 embryos were hand selected (fluorescence microscopy) by
virtue of lacking the Kr-GFP expression pattern (visible after stage 9;
Casso et al., 2000). The selected embryos were fixed in PFA, permeabi¬
lized by heptane, devitellinized by methanol, and rehydrated as de¬
scribed previously (Theurkauf and Heck, 1999). After a block in 1% BSA
in PBS for 1 h, rabbit Vasa antibody (provided by P. Lasko, McGill Univer¬
sity, Montreal, Canada) was used as 1:500 in PBS + 0.3% Triton X-100
overnight at 4°C. Alexa-594-conjugated secondary antibody was used as
1:500 in PBSTx for 2 h at RT. 4 X 15 min PBSTx washes were performed
before and after antibody incubations. DAPI at 0.1 fxg/ml DAPI was in¬
cluded in the penultimate wash. Embryos were mounted with Vectashield
and imaged as detailed in the section DAPI staining of Drosophila neuro¬
blast squashes and polytene chromosomes.
Online supplemental material
Further details on TUNEL labeling of larval brains, dsRNA-mediated inter¬
ference in S2 cells, and cultured cell transfections (Drosophila and HeLa)
are provided online. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200405155/DC1.
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